,NGenes,Direction,PValue,FDR
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1,2,Up,9.64140950352029e-39,4.35309639083941e-35
TESAR_ALK_TARGETS_HUMAN_ES_4D_DN,1,Up,2.39105856262508e-21,2.69890735256306e-18
TESAR_ALK_TARGETS_HUMAN_ES_5D_DN,1,Up,2.39105856262508e-21,2.69890735256306e-18
BIERIE_INFLAMMATORY_RESPONSE_TGFB1,1,Up,2.39105856262508e-21,2.69890735256306e-18
FUNG_IL2_SIGNALING_2,5,Up,1.651572695429e-13,1.49137014397239e-10
HOFFMAN_CLOCK_TARGETS_UP,4,Up,1.30804845659077e-08,9.84306463584552e-06
REACTOME_RNA_POL_I_PROMOTER_OPENING,49,Down,5.75947332234083e-08,3.71486029290984e-05
MOSERLE_IFNA_RESPONSE,27,Up,1.06313721298496e-07,6.00008064578388e-05
KERLEY_RESPONSE_TO_CISPLATIN_DN,3,Up,1.55749660382048e-07,7.81344129583275e-05
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN,14,Up,1.75792129861277e-07,7.93701466323665e-05
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14,3,Up,3.32726776392382e-07,0.000135296691655818
REACTOME_AMYLOIDS,55,Down,3.59592535962307e-07,0.000135296691655818
REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY,13,Up,7.74497373793146e-07,0.000268988895590466
REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10,12,Up,9.46935016964369e-07,0.000305386542971009
REACTOME_RNA_POL_I_TRANSCRIPTION,68,Down,2.69242007402399e-06,0.000810418442281222
REACTOME_PACKAGING_OF_TELOMERE_ENDS,39,Down,3.15225537227051e-06,0.000889527062862586
REACTOME_MEIOTIC_RECOMBINATION,65,Down,4.27855731970465e-06,0.00113633448814509
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP,7,Down,5.25601698770782e-06,0.00131838426108338
TURJANSKI_MAPK14_TARGETS,10,Up,9.54062602273711e-06,0.00226715402592937
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,75,Down,1.21962598657925e-05,0.00275330566470266
VANDESLUIS_NORMAL_EMBRYOS_DN,14,Up,1.65973311562016e-05,0.00356842619858334
PID_NOTCH_PATHWAY,48,Up,2.30996555004143e-05,0.00474067929928957
TURJANSKI_MAPK7_TARGETS,8,Up,3.58410687998498e-05,0.0068012966422578
SANA_RESPONSE_TO_IFNG_UP,52,Up,3.61530718525332e-05,0.0068012966422578
PID_MYC_PATHWAY,23,Up,4.89123630571613e-05,0.00883357276812334
REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,52,Down,5.5294344559746e-05,0.0096020756033559
REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION,18,Up,5.90951889486653e-05,0.00988202881863791
ROETH_TERT_TARGETS_UP,12,Up,6.13137571738132e-05,0.00988684334427738
CROONQUIST_STROMAL_STIMULATION_DN,9,Up,6.66651156223198e-05,0.00995374332755694
DAUER_STAT3_TARGETS_DN,43,Up,6.73860185964871e-05,0.00995374332755694
TURJANSKI_MAPK1_AND_MAPK2_TARGETS,12,Up,6.83424237329491e-05,0.00995374332755694
SA_MMP_CYTOKINE_CONNECTION,11,Up,7.63660689365462e-05,0.0105846018022785
REACTOME_PEPTIDE_CHAIN_ELONGATION,79,Down,7.7362538089743e-05,0.0105846018022785
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,18,Up,8.05323668513844e-05,0.0106942245980588
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION,17,Up,8.63414410903584e-05,0.0111380459006562
GRANDVAUX_IRF3_TARGETS_UP,13,Up,9.19557757783122e-05,0.0115327868788633
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP,9,Up,9.53827397781328e-05,0.0116392721648181
TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP,6,Up,0.000108534380416427,0.012895598094215
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,20,Up,0.000112686928888556,0.0130456790751752
YAMASHITA_SILENCED_BY_METHYLATION,5,Up,0.00011930269404324,0.0134662915901307
LI_WILMS_TUMOR_ANAPLASTIC_DN,5,Up,0.000124580431109737,0.0135349229620222
REACTOME_MEIOSIS,86,Down,0.000125906260111835,0.0135349229620222
KEGG_RIBOSOME,80,Down,0.00015025566284545,0.0157768445987723
WU_HBX_TARGETS_3_UP,16,Up,0.000223381327191694,0.0229219702788749
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,62,Up,0.000259678077146746,0.0256808216046743
REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION,96,Down,0.000270774240399132,0.0256808216046743
REACTOME_TELOMERE_MAINTENANCE,65,Down,0.000271960264184413,0.0256808216046743
EINAV_INTERFERON_SIGNATURE_IN_CANCER,23,Up,0.000273018701445043,0.0256808216046743
REACTOME_MEIOTIC_SYNAPSIS,56,Down,0.00029633333289401,0.0273049999595195
CHIN_BREAST_CANCER_COPY_NUMBER_UP,20,Up,0.000357382151795258,0.0322716083071118
REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS,11,Up,0.000415478156323552,0.0367820367804086
MOREIRA_RESPONSE_TO_TSA_UP,22,Up,0.000442669340409342,0.0384356167682342
REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION,101,Down,0.000531921016063109,0.0453136488212253
REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX,100,Down,0.000550416293487065,0.0460209178721129
HOWLIN_CITED1_TARGETS_2_UP,10,Up,0.000626963961450369,0.0514680415626985
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,17,Up,0.000665826989585646,0.0536823010353427
REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION,95,Down,0.00069275235462706,0.0548732786165118
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16,7,Up,0.000714932260542582,0.0556537785577544
BAKER_HEMATOPOESIS_STAT5_TARGETS,6,Up,0.000756534323005403,0.0578941096333796
ROZANOV_MMP14_TARGETS_SUBSET,27,Up,0.000869156886454752,0.0654040557057201
FERRANDO_LYL1_NEIGHBORS,10,Up,0.0010146785175111,0.075102844369879
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,20,Up,0.00104918105610916,0.0751434332114989
REACTOME_INFLUENZA_LIFE_CYCLE,128,Down,0.00106292964347493,0.0751434332114989
LY_AGING_MIDDLE_UP,7,Up,0.00106515608539002,0.0751434332114989
BIOCARTA_WNT_PATHWAY,24,Up,0.00120963824150208,0.0840233332366444
TURJANSKI_MAPK11_TARGETS,5,Up,0.00124140194857115,0.0849231787545261
MEISSNER_BRAIN_HCP_WITH_H3K4ME2,7,Up,0.00126058947473841,0.0849486787827452
BIOCARTA_DC_PATHWAY,8,Up,0.0013192292841812,0.0875929443835019
BIOCARTA_PML_PATHWAY,10,Up,0.00138891851794198,0.0899141404851505
BIOCARTA_IL10_PATHWAY,15,Up,0.00139401768194032,0.0899141404851505
XU_AKT1_TARGETS_6HR,24,Up,0.00148027826272972,0.0941331881158405
RIZ_ERYTHROID_DIFFERENTIATION_HBZ,31,Up,0.00153708913660886,0.0963882979415142
BROWNE_INTERFERON_RESPONSIVE_GENES,58,Up,0.00158894817653111,0.0982753563977804
CHANDRAN_METASTASIS_TOP50_UP,33,Up,0.00181920270249674,0.110995948672605
SHIN_B_CELL_LYMPHOMA_CLUSTER_2,24,Up,0.00200532103136047,0.120720326087901
BIOCARTA_CDMAC_PATHWAY,12,Up,0.00211492989310874,0.125643532465605
BIOCARTA_P38MAPK_PATHWAY,36,Up,0.0021798200189165,0.127816719291013
BOWIE_RESPONSE_TO_TAMOXIFEN,15,Up,0.00224474707602435,0.129936321131409
SHIN_B_CELL_LYMPHOMA_CLUSTER_6,6,Up,0.00233233873188018,0.130934110216798
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,61,Down,0.00233936573940397,0.130934110216798
FARMER_BREAST_CANCER_CLUSTER_1,20,Up,0.00234898403711199,0.130934110216798
MURAKAMI_UV_RESPONSE_24HR,13,Up,0.00242000716622062,0.133247955554709
MATZUK_PREOVULATORY_FOLLICLE,7,Up,0.00250815955659314,0.133765149121637
KONG_E2F1_TARGETS,7,Down,0.00251025496792729,0.133765149121637
REACTOME_DAG_AND_IP3_SIGNALING,25,Down,0.00251828076973182,0.133765149121637
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,47,Up,0.00263110371389259,0.136929503414423
PID_IL27_PATHWAY,18,Up,0.00263850870366663,0.136929503414423
PID_SMAD2_3NUCLEAR_PATHWAY,71,Up,0.00276231109893256,0.141725393314551
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,63,Up,0.00286390053662508,0.142122971373633
BIOCARTA_CARDIACEGF_PATHWAY,14,Up,0.00289901761729462,0.142122971373633
REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,101,Down,0.00291123757157334,0.142122971373633
GENTILE_UV_RESPONSE_CLUSTER_D8,39,Up,0.00294231091246021,0.142122971373633
BAKER_HEMATOPOESIS_STAT1_TARGETS,9,Up,0.00295709304041049,0.142122971373633
PID_IL2_STAT5_PATHWAY,19,Up,0.00295892786470022,0.142122971373633
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,129,Up,0.00306552705960474,0.14483359878014
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,20,Down,0.00307951837937838,0.14483359878014
MATZUK_OVULATION,8,Up,0.00313424223150115,0.145762705957249
COLLIS_PRKDC_SUBSTRATES,19,Up,0.00316384167969222,0.145762705957249
DORN_ADENOVIRUS_INFECTION_24HR_UP,10,Up,0.003207683710901,0.145841004853279
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN,4,Down,0.00323014407205491,0.145841004853279
REACTOME_GENERIC_TRANSCRIPTION_PATHWAY,293,Up,0.00328896374786741,0.147026448728924
HENDRICKS_SMARCA4_TARGETS_DN,28,Up,0.00341081085580135,0.150978539352383
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,21,Up,0.00349962575334171,0.15133664530453
MAHADEVAN_RESPONSE_TO_MP470_DN,16,Up,0.00350767360959472,0.15133664530453
ZHANG_INTERFERON_RESPONSE,21,Up,0.00352300977635985,0.15133664530453
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,14,Down,0.00357906267128218,0.15133664530453
DORN_ADENOVIRUS_INFECTION_32HR_UP,10,Up,0.00358649414121477,0.15133664530453
BIOCARTA_TID_PATHWAY,13,Up,0.00364442206736776,0.152357089205236
WANG_LSD1_TARGETS_UP,20,Up,0.0037621847138256,0.155837284246996
PID_LPA4_PATHWAY,12,Down,0.00381785837811262,0.156705732519804
NAGASHIMA_EGF_SIGNALING_UP,48,Up,0.00390952290711944,0.158832203085497
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,15,Up,0.00394002364243094,0.158832203085497
REACTOME_CHROMOSOME_MAINTENANCE,99,Down,0.00399740485226656,0.159719317769766
PID_PS1_PATHWAY,40,Up,0.0041025760284467,0.162251615445971
REACTOME_TRANSLATION,133,Down,0.00415476837110978,0.162251615445971
PID_E2F_PATHWAY,68,Up,0.0041685907844369,0.162251615445971
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,40,Up,0.00440167296837963,0.169859431215676
REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING,30,Up,0.00452950037155145,0.173310967606397
ZHAN_MULTIPLE_MYELOMA_LB_DN,29,Up,0.004595185326397,0.174346737383886
REACTOME_TRANSCRIPTION,181,Down,0.00475870817710268,0.179046395163488
KANNAN_TP53_TARGETS_DN,16,Up,0.00498593742290391,0.186045516234803
FIGUEROA_AML_METHYLATION_CLUSTER_7_DN,1,Up,0.00504098951846976,0.186557931769598
XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP,8,Down,0.00509824288711849,0.187142818173496
PID_HES_HEY_PATHWAY,38,Up,0.0051918785981928,0.189042998958391
BUDHU_LIVER_CANCER_METASTASIS_UP,5,Up,0.00594882650462611,0.214871613347095
SEIKE_LUNG_CANCER_POOR_SURVIVAL,6,Up,0.00605075606996578,0.216818759173774
REACTOME_METABOLISM_OF_MRNA,195,Down,0.0061367817797683,0.21816984043822
PID_TELOMERASE_PATHWAY,60,Up,0.00622832933451607,0.219694585510469
DORN_ADENOVIRUS_INFECTION_48HR_UP,12,Up,0.00631636814606546,0.220465520033097
LEE_LIVER_CANCER_E2F1_UP,47,Up,0.0063478444306318,0.220465520033097
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE,32,Down,0.0065362354984254,0.223902079099919
TAKAYAMA_BOUND_BY_AR,7,Up,0.00658358217408398,0.223902079099919
BROWNE_HCMV_INFECTION_12HR_UP,84,Up,0.00659556512077281,0.223902079099919
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,24,Down,0.0069596749130371,0.234499494271362
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,112,Up,0.00750221795605504,0.250907511641396
MIKKELSEN_ES_LCP_WITH_H3K4ME3,63,Up,0.00755993882903771,0.25097885156695
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,27,Up,0.00772219765967554,0.254494324331643
REACTOME_CA_DEPENDENT_EVENTS,23,Down,0.0081520285197755,0.266713107005698
LIN_MELANOMA_COPY_NUMBER_UP,58,Up,0.00835229085995647,0.271299231889953
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,21,Up,0.00855218625420005,0.275808006697952
NIKOLSKY_BREAST_CANCER_17P11_AMPLICON,7,Down,0.00873213549328851,0.279614125902111
KIM_LRRC3B_TARGETS,15,Up,0.00901434672266414,0.286618136991751
ONDER_CDH1_SIGNALING_VIA_CTNNB1,68,Up,0.00923944446020239,0.291720921243453
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,97,Up,0.00972826309507473,0.303806347987426
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,24,Up,0.00975679301399265,0.303806347987426
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,72,Down,0.00999353733477888,0.309046719633744
BIOCARTA_NO2IL12_PATHWAY,6,Up,0.010333973555287,0.317400616340959
SUZUKI_AMPLIFIED_IN_ORAL_CANCER,9,Up,0.0107476528690207,0.327876031781273
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3,7,Up,0.0111572549236793,0.337649922317874
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,16,Up,0.0112838468422672,0.337649922317874
BOYLAN_MULTIPLE_MYELOMA_C_UP,36,Down,0.0112923894285712,0.337649922317874
CROONQUIST_STROMAL_STIMULATION_UP,46,Up,0.0115297664303778,0.342479575218131
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,56,Up,0.0117451371639627,0.345353409310332
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,81,Up,0.0118538329246007,0.345353409310332
BIOCARTA_ALK_PATHWAY,30,Up,0.0118559863661354,0.345353409310332
TERAO_AOX4_TARGETS_SKIN_DN,16,Up,0.0119992527178419,0.345476258062411
MURAKAMI_UV_RESPONSE_1HR_DN,7,Up,0.0120136560327197,0.345476258062411
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,12,Down,0.0120897560960932,0.345476258062411
BUSA_SAM68_TARGETS_UP,6,Up,0.0127760578311905,0.362791830866823
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,21,Down,0.013070680120914,0.368838254662043
ZHENG_RESPONSE_TO_ARSENITE_DN,17,Up,0.0132541943288734,0.371693710527102
REACTOME_ACYL_CHAIN_REMODELLING_OF_PI,3,Up,0.0133780925191017,0.372852393356446
VERRECCHIA_RESPONSE_TO_TGFB1_C5,19,Up,0.0138454192738478,0.38350961976333
PID_CERAMIDE_PATHWAY,45,Up,0.0140861718398877,0.387799182055444
LIU_IL13_PRIMING_MODEL,13,Up,0.0142710636372145,0.39050819589105
WU_HBX_TARGETS_3_DN,12,Up,0.0143579990787377,0.390520276147594
CONRAD_STEM_CELL,22,Up,0.0145162012426665,0.392458973716403
LU_TUMOR_ENDOTHELIAL_MARKERS_DN,1,Down,0.0146537235315013,0.393818819909097
SAFFORD_T_LYMPHOCYTE_ANERGY,62,Up,0.0147414469753382,0.393832148483148
LIM_MAMMARY_LUMINAL_PROGENITOR_DN,13,Up,0.0148484726703077,0.394357965331995
RICKMAN_HEAD_AND_NECK_CANCER_A,51,Up,0.0150314681633922,0.395757905608511
STAEGE_EWING_FAMILY_TUMOR,16,Up,0.015076491642229,0.395757905608511
KEGG_PPAR_SIGNALING_PATHWAY,40,Down,0.0152699588317096,0.398519445810225
REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX,43,Down,0.0154211732296439,0.400152857079553
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,35,Up,0.0156912128182142,0.400867902072015
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,30,Down,0.015715087190863,0.400867902072015
REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS,30,Down,0.015715087190863,0.400867902072015
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G,77,Down,0.0158713481810915,0.402579421559708
TURJANSKI_MAPK8_AND_MAPK9_TARGETS,8,Up,0.0160732957211819,0.40542419095607
GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,13,Up,0.0162429148717277,0.407426448032504
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,17,Up,0.0167188223811974,0.413534820984441
ODONNELL_METASTASIS_UP,41,Up,0.0167256825434611,0.413534820984441
NOJIMA_SFRP2_TARGETS_DN,20,Up,0.0167612120133229,0.413534820984441
MANN_RESPONSE_TO_AMIFOSTINE_UP,19,Up,0.0174814788092548,0.42896128708579
DANG_MYC_TARGETS_UP,130,Down,0.0180713691219755,0.438996676287185
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN,13,Up,0.0180849129101697,0.438996676287185
LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES,24,Up,0.0184696080977655,0.445061849482858
PID_IL12_2PATHWAY,36,Up,0.0185949958353877,0.445061849482858
MATZUK_POST-IMPLANTATION_AND_POST-PARTUM,11,Up,0.0186654022938773,0.445061849482858
REACTOME_METABOLISM_OF_RNA,236,Down,0.0187290700779054,0.445061849482858
MAHAJAN_RESPONSE_TO_IL1A_UP,56,Up,0.019043628474704,0.450167447975333
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,46,Down,0.0193322760629891,0.454610554293727
BIOCARTA_PPARA_PATHWAY,44,Up,0.0200260451508831,0.468484942260296
BIOCARTA_TEL_PATHWAY,17,Up,0.0205428967425982,0.477940337639662
SESTO_RESPONSE_TO_UV_C2,50,Up,0.0206560010704972,0.477940337639662
REACTOME_RECYCLING_PATHWAY_OF_L1,23,Down,0.0207477976029621,0.477940337639662
BIOCARTA_STATHMIN_PATHWAY,13,Down,0.0209739597162361,0.480697604663989
BIOCARTA_PITX2_PATHWAY,14,Up,0.0211846111586087,0.483073330207667
BIOCARTA_NO1_PATHWAY,21,Down,0.0213189070250065,0.48369279003972
REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE,118,Down,0.0215547103482303,0.486597586111298
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,12,Up,0.0218665915320657,0.490321840597265
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN,5,Down,0.0219368796900659,0.490321840597265
BIOCARTA_RELA_PATHWAY,14,Up,0.0221066913237797,0.491683307028893
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN,9,Up,0.0223759920929922,0.493488519207036
KASLER_HDAC7_TARGETS_2_UP,4,Down,0.0224064554678721,0.493488519207036
OHGUCHI_LIVER_HNF4A_TARGETS_UP,22,Up,0.0226715050272756,0.494564606151952
LAU_APOPTOSIS_CDKN2A_UP,52,Up,0.022674390581053,0.494564606151952
LINDSTEDT_DENDRITIC_CELL_MATURATION_A,46,Up,0.0233806558493925,0.501717709913695
LI_CISPLATIN_RESISTANCE_DN,22,Up,0.0234185249824162,0.501717709913695
BIOCARTA_SODD_PATHWAY,8,Up,0.0234220542053976,0.501717709913695
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,19,Down,0.023446829854217,0.501717709913695
VANHARANTA_UTERINE_FIBROID_DN,55,Up,0.0236564033744458,0.503814439790674
REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING,10,Down,0.0243990171674754,0.516931644418534
PID_AP1_PATHWAY,54,Up,0.0245652485747126,0.516931644418534
LU_TUMOR_VASCULATURE_DN,4,Down,0.0246157925913588,0.516931644418534
ABDULRAHMAN_KIDNEY_CANCER_VHL_UP,4,Down,0.0251349035951819,0.525389304315955
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES,17,Down,0.0262087161908086,0.545310385260372
REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS,55,Up,0.0267802120146511,0.55408072643642
ST_IL_13_PATHWAY,6,Up,0.026982100737718,0.55408072643642
PLASARI_NFIC_TARGETS_BASAL_UP,15,Up,0.0269983964155066,0.55408072643642
CLAUS_PGR_POSITIVE_MENINGIOMA_UP,5,Down,0.0274159873213845,0.560104899348647
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,15,Down,0.0276838216887417,0.560662599381624
YIH_RESPONSE_TO_ARSENITE_C5,9,Down,0.0276916411211743,0.560662599381624
PID_IL2_1PATHWAY,44,Up,0.0279428835565408,0.560899519344893
PARK_APL_PATHOGENESIS_UP,9,Up,0.0280685045269887,0.560899519344893
BECKER_TAMOXIFEN_RESISTANCE_UP,39,Up,0.0281444252841203,0.560899519344893
BIOCARTA_ATRBRCA_PATHWAY,20,Up,0.0282002637632981,0.560899519344893
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,122,Up,0.0283935403764091,0.562266819295996
NABA_COLLAGENS,33,Down,0.0286672144989222,0.563658237585576
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,23,Up,0.0288623838955566,0.563658237585576
VALK_AML_CLUSTER_13,19,Down,0.0289180148995145,0.563658237585576
ABBUD_LIF_SIGNALING_1_UP,29,Up,0.0289869814353501,0.563658237585576
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,20,Up,0.0290880109318802,0.563658237585576
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,160,Down,0.0293793476293275,0.566376275333197
REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,50,Down,0.0295206251803781,0.566376275333197
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,25,Up,0.0296397877584452,0.566376275333197
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,13,Up,0.0297468482340507,0.566376275333197
BIOCARTA_STRESS_PATHWAY,23,Up,0.0298554935834553,0.566376275333197
WALLACE_PROSTATE_CANCER_RACE_UP,154,Up,0.0306400360115832,0.57882745854518
REACTOME_METABOLISM_OF_PROTEINS,355,Down,0.0315157568423285,0.592890175596305
REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,19,Up,0.0318167613244575,0.596069200746579
TIEN_INTESTINE_PROBIOTICS_6HR_UP,51,Down,0.0323812569508497,0.604137913773084
REACTOME_SIGNALING_BY_HIPPO,18,Down,0.0329247210295527,0.607182156453641
REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS,8,Down,0.0329344939254218,0.607182156453641
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,146,Up,0.0330246411288706,0.607182156453641
MOOTHA_PYR,7,Down,0.0330823500526236,0.607182156453641
KIM_GERMINAL_CENTER_T_HELPER_DN,15,Up,0.0333501817242936,0.60830666807988
STEARMAN_TUMOR_FIELD_EFFECT_UP,23,Up,0.0334978444460772,0.60830666807988
PID_SYNDECAN_1_PATHWAY,37,Down,0.0335478096017475,0.60830666807988
MOOTHA_TCA,16,Up,0.0340908212160407,0.615680231161695
WANG_TARGETS_OF_MLL_CBP_FUSION_DN,38,Down,0.0350184451522167,0.622414251574545
ROZANOV_MMP14_TARGETS_UP,190,Up,0.0350287953351706,0.622414251574545
AMIT_EGF_RESPONSE_20_HELA,10,Up,0.0351133154139964,0.622414251574545
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,30,Up,0.0351224123730922,0.622414251574545
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,53,Down,0.0352416467867829,0.622414251574545
BURTON_ADIPOGENESIS_4,42,Down,0.0352908191368956,0.622414251574545
BURTON_ADIPOGENESIS_PEAK_AT_2HR,45,Up,0.0358571668851747,0.627220690568928
WANG_RESPONSE_TO_ANDROGEN_UP,23,Up,0.0359126718015672,0.627220690568928
TAVOR_CEBPA_TARGETS_DN,22,Up,0.0359801016295354,0.627220690568928
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,96,Up,0.0363252785530602,0.627285647800263
RUAN_RESPONSE_TO_TNF_UP,8,Up,0.0363674654367684,0.627285647800263
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,19,Up,0.036754795723938,0.627285647800263
REACTOME_SEROTONIN_RECEPTORS,3,Down,0.0369215392618823,0.627285647800263
CHANG_POU5F1_TARGETS_DN,7,Up,0.0370123005234018,0.627285647800263
DAZARD_RESPONSE_TO_UV_SCC_DN,108,Up,0.0370733757557316,0.627285647800263
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,102,Up,0.0370914458776591,0.627285647800263
ULE_SPLICING_VIA_NOVA2,33,Up,0.0370952974446667,0.627285647800263
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,20,Up,0.03779367544801,0.636321714223782
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP,15,Down,0.0379115262737979,0.636321714223782
BIOCARTA_ETS_PATHWAY,17,Up,0.0380825459515916,0.636824796190504
BIOCARTA_KERATINOCYTE_PATHWAY,37,Up,0.0383287652800977,0.63857703040458
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP,11,Up,0.0386010867576023,0.64074965702417
RASHI_RESPONSE_TO_IONIZING_RADIATION_4,48,Up,0.0400740629169592,0.660464730325683
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP,7,Up,0.0400813590496649,0.660464730325683
DEMAGALHAES_AGING_DN,13,Down,0.0403766946711714,0.662911914328504
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,48,Down,0.0412432621240777,0.674685972790619
BROWNE_HCMV_INFECTION_18HR_DN,125,Up,0.0415263170174352,0.676863975934007
YUAN_ZNF143_PARTNERS,20,Up,0.0423878351602762,0.685669106772842
JEON_SMAD6_TARGETS_UP,19,Up,0.0424688301147201,0.685669106772842
BIOCARTA_NFKB_PATHWAY,21,Up,0.0426069283994425,0.685669106772842
BIOCARTA_CREB_PATHWAY,24,Down,0.0427529687612258,0.685669106772842
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,38,Up,0.0428258445426227,0.685669106772842
GENTILE_UV_RESPONSE_CLUSTER_D7,34,Up,0.0434636791950728,0.693422302352487
PID_NFKAPPAB_CANONICAL_PATHWAY,20,Up,0.0442371326245843,0.703276949999994
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,73,Down,0.0447143489575896,0.708369422959709
HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3,5,Down,0.0462705197125904,0.72898216656759
SU_PANCREAS,27,Up,0.0463977538086851,0.72898216656759
GALI_TP53_TARGETS_APOPTOTIC_DN,4,Up,0.0464998591298928,0.72898216656759
BURTON_ADIPOGENESIS_5,108,Down,0.0468588189561488,0.732067707913536
LI_INDUCED_T_TO_NATURAL_KILLER_DN,80,Up,0.047407895784498,0.738091894713822
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN,11,Up,0.0477933872519903,0.741536575404592
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,17,Up,0.0482035177190399,0.743671588278937
PID_RHOA_PATHWAY,40,Up,0.048260415363395,0.743671588278937
MIKKELSEN_MEF_LCP_WITH_H3K4ME3,82,Up,0.0494814343505147,0.758300055509654
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,40,Up,0.0498927437386681,0.758300055509654
OXFORD_RALA_TARGETS_DN,9,Down,0.0499073173885156,0.758300055509654
GROSS_ELK3_TARGETS_DN,24,Up,0.0500165065347432,0.758300055509654
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR,74,Down,0.0500494831764954,0.758300055509654
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,45,Up,0.0505043143735018,0.762632038114918
ODONNELL_TFRC_TARGETS_DN,102,Down,0.0511397982655646,0.768027643725154
HOOI_ST7_TARGETS_DN,92,Down,0.0512018429150103,0.768027643725154
BIOCARTA_PS1_PATHWAY,11,Up,0.0518806449457505,0.773314943931282
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,123,Up,0.0518968832804382,0.773314943931282
STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS,9,Up,0.0520931679496468,0.773686359515313
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,60,Down,0.0525021360266215,0.776007618585085
KORKOLA_TERATOMA_UP,12,Up,0.0526072410297359,0.776007618585085
REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,12,Up,0.0529580559048739,0.776007618585085
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,25,Down,0.0532515093427691,0.776007618585085
YIH_RESPONSE_TO_ARSENITE_C2,16,Up,0.0532972952719371,0.776007618585085
WHITEHURST_PACLITAXEL_SENSITIVITY,20,Up,0.0534535723947207,0.776007618585085
PID_ERBB2_ERBB3_PATHWAY,40,Down,0.053680755865534,0.776007618585085
BROWNE_HCMV_INFECTION_10HR_UP,79,Up,0.0539163506687866,0.776007618585085
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,142,Up,0.0539203686312967,0.776007618585085
REACTOME_GAP_JUNCTION_DEGRADATION,10,Down,0.0539681931862053,0.776007618585085
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,106,Up,0.0549610319008612,0.784652812075165
PID_MYC_REPRESS_PATHWAY,54,Up,0.0557244060535258,0.784652812075165
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,65,Up,0.0558544131756647,0.784652812075165
ZHAN_EARLY_DIFFERENTIATION_GENES_DN,31,Up,0.055959283003018,0.784652812075165
REACTOME_SIGNALING_BY_EGFR_IN_CANCER,97,Down,0.0559740933463342,0.784652812075165
SENESE_HDAC2_TARGETS_UP,92,Up,0.0562576293489631,0.784652812075165
DUTTA_APOPTOSIS_VIA_NFKB,26,Up,0.0565149678136661,0.784652812075165
TERAO_AOX4_TARGETS_SKIN_UP,33,Up,0.0565758179501966,0.784652812075165
WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP,4,Down,0.0566589895075792,0.784652812075165
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP,61,Up,0.0567338297903601,0.784652812075165
BIOCARTA_CHREBP2_PATHWAY,35,Down,0.0567777242424553,0.784652812075165
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN,1,Up,0.0567969399383218,0.784652812075165
DORSAM_HOXA9_TARGETS_DN,28,Up,0.057195178713796,0.784652812075165
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN,15,Up,0.0572336602689497,0.784652812075165
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN,3,Up,0.0572347985226326,0.784652812075165
CHEN_ETV5_TARGETS_SERTOLI,10,Up,0.0573761132768241,0.784652812075165
HAHTOLA_MYCOSIS_FUNGOIDES_UP,11,Down,0.0576961639771545,0.784652812075165
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,14,Up,0.057815171838616,0.784652812075165
LIU_TARGETS_OF_VMYB_VS_CMYB_UP,11,Up,0.0578714034155105,0.784652812075165
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN,21,Up,0.0587316399535201,0.793932198772884
STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA,15,Down,0.059017821232053,0.79541929212752
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,108,Down,0.0597455020107361,0.802830183269266
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,26,Up,0.0607954287551775,0.807308652149131
STREICHER_LSM1_TARGETS_UP,41,Up,0.061041909499428,0.807308652149131
GEISS_RESPONSE_TO_DSRNA_DN,14,Down,0.0611347401648156,0.807308652149131
MIKKELSEN_ES_HCP_WITH_H3K27ME3,22,Up,0.0611883227111629,0.807308652149131
REACTOME_PYRIMIDINE_METABOLISM,20,Down,0.061330096592535,0.807308652149131
TRACEY_RESISTANCE_TO_IFNA2_DN,25,Up,0.0617997190873874,0.807308652149131
LOPEZ_EPITHELIOID_MESOTHELIOMA,8,Up,0.061851595291304,0.807308652149131
REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS,18,Up,0.06186863348694,0.807308652149131
RADAEVA_RESPONSE_TO_IFNA1_UP,43,Up,0.0621694995257644,0.807308652149131
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,19,Up,0.0622912317398075,0.807308652149131
HECKER_IFNB1_TARGETS,60,Up,0.0623044605298382,0.807308652149131
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,40,Up,0.0623397049511454,0.807308652149131
HENDRICKS_SMARCA4_TARGETS_UP,50,Down,0.0624032601550491,0.807308652149131
KEGG_CHRONIC_MYELOID_LEUKEMIA,67,Up,0.0631385276052517,0.812403580633665
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,19,Up,0.0631914882672046,0.812403580633665
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,54,Up,0.063336890450288,0.812403580633665
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,53,Down,0.0636168145100052,0.813682485871597
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP,9,Down,0.0639850980266512,0.815203232201383
KEGG_GLYCEROLIPID_METABOLISM,33,Down,0.0641918717180683,0.815203232201383
NAKAMURA_METASTASIS_MODEL_DN,34,Down,0.0643902783094907,0.815203232201383
LE_NEURONAL_DIFFERENTIATION_UP,12,Up,0.0646941176055363,0.815203232201383
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,15,Down,0.0647713658183967,0.815203232201383
STAMBOLSKY_BOUND_BY_MUTATED_TP53,12,Up,0.0648190388394898,0.815203232201383
REACTOME_TRANSPORT_OF_ORGANIC_ANIONS,6,Up,0.0654774446337484,0.816651300936571
DER_IFN_BETA_RESPONSE_UP,93,Up,0.0655606729048033,0.816651300936571
MALONEY_RESPONSE_TO_17AAG_UP,33,Up,0.0656358993348701,0.816651300936571
PID_VEGFR1_PATHWAY,23,Down,0.0656576793444021,0.816651300936571
KEGG_OLFACTORY_TRANSDUCTION,18,Down,0.0663624396476353,0.823149491783169
PID_HNF3A_PATHWAY,28,Up,0.0670302722321898,0.829155285283115
BIOCARTA_CERAMIDE_PATHWAY,22,Up,0.0678467627111944,0.835185563205789
THILLAINADESAN_ZNF217_TARGETS_DN,5,Down,0.0678877301653432,0.835185563205789
BIOCARTA_IL5_PATHWAY,2,Up,0.06929108659905,0.847313493245093
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN,23,Down,0.069341084048892,0.847313493245093
NAGY_STAGA_COMPONENTS_HUMAN,11,Up,0.0697438849709223,0.847313493245093
DELASERNA_MYOD_TARGETS_DN,44,Up,0.069773269910304,0.847313493245093
KEGG_THYROID_CANCER,24,Up,0.0698118758554096,0.847313493245093
REACTOME_MITOTIC_G2_G2_M_PHASES,73,Down,0.0703542284073443,0.851606813027237
REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,16,Down,0.070790214536345,0.853159304396995
ROSS_AML_WITH_AML1_ETO_FUSION,56,Down,0.0708604073419432,0.853159304396995
REACTOME_SIGNALING_BY_FGFR,85,Down,0.0715028074408469,0.855642480347472
REACTOME_REGULATION_OF_IFNA_SIGNALING,11,Up,0.0715120702783229,0.855642480347472
BIOCARTA_ARF_PATHWAY,16,Up,0.071717243160998,0.855642480347472
REACTOME_COLLAGEN_FORMATION,47,Down,0.0718246954710281,0.855642480347472
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,59,Up,0.0739939501200079,0.863114041951293
BIOCARTA_IL2RB_PATHWAY,30,Up,0.0740596357941724,0.863114041951293
RIGGINS_TAMOXIFEN_RESISTANCE_UP,53,Down,0.0742564059648329,0.863114041951293
AMUNDSON_GAMMA_RADIATION_RESISTANCE,11,Down,0.0747447274411737,0.863114041951293
WANG_TNF_TARGETS,15,Up,0.0749896750789817,0.863114041951293
DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP,5,Down,0.0749939828352429,0.863114041951293
TRAYNOR_RETT_SYNDROM_UP,37,Up,0.0750444293666145,0.863114041951293
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,37,Down,0.0750981047829497,0.863114041951293
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,25,Down,0.0752626058231379,0.863114041951293
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,50,Up,0.0754370104089964,0.863114041951293
REACTOME_SIGNALING_BY_NOTCH1,60,Up,0.0754598048003953,0.863114041951293
BIOCARTA_MTOR_PATHWAY,21,Down,0.0755551783302792,0.863114041951293
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,92,Up,0.0755637706342641,0.863114041951293
MALONEY_RESPONSE_TO_17AAG_DN,68,Down,0.0759959438028179,0.863114041951293
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,69,Up,0.07605401588472,0.863114041951293
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,150,Up,0.0761772363493972,0.863114041951293
REACTOME_SIGNALING_BY_ERBB2,86,Down,0.0761957760355002,0.863114041951293
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,43,Up,0.0762180052794289,0.863114041951293
BUDHU_LIVER_CANCER_METASTASIS_DN,3,Up,0.0764171574293377,0.863114041951293
IGARASHI_ATF4_TARGETS_UP,4,Down,0.0764438896481597,0.863114041951293
BIOCARTA_GCR_PATHWAY,15,Up,0.0764663603057624,0.863114041951293
STONER_ESOPHAGEAL_CARCINOGENESIS_DN,6,Down,0.0767067586011297,0.863668366793268
REACTOME_LYSOSOME_VESICLE_BIOGENESIS,21,Down,0.078205247966694,0.875891131433068
GALI_TP53_TARGETS_APOPTOTIC_UP,8,Up,0.078511925025987,0.875891131433068
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,24,Down,0.0785124452924139,0.875891131433068
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN,5,Down,0.078599628906815,0.875891131433068
NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON,19,Up,0.0787623032916557,0.875891131433068
REACTOME_MTORC1_MEDIATED_SIGNALLING,11,Down,0.079380003855733,0.875915601626395
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,64,Up,0.0796527451077966,0.875915601626395
INAMURA_LUNG_CANCER_SCC_DN,8,Up,0.0796836171115471,0.875915601626395
SWEET_LUNG_CANCER_KRAS_DN,278,Up,0.0800535004520575,0.875915601626395
REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,15,Down,0.0803070888444722,0.875915601626395
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,22,Up,0.0803091348906785,0.875915601626395
LI_INDUCED_T_TO_NATURAL_KILLER_UP,202,Up,0.0803910314317729,0.875915601626395
BIOCARTA_GLEEVEC_PATHWAY,22,Up,0.0805805956496047,0.875915601626395
ST_TUMOR_NECROSIS_FACTOR_PATHWAY,27,Up,0.0805814004340468,0.875915601626395
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,14,Up,0.0807638030860839,0.875915601626395
HATADA_METHYLATED_IN_LUNG_CANCER_DN,15,Down,0.0810291003547357,0.875915601626395
FARDIN_HYPOXIA_9,7,Down,0.0813341869586456,0.875915601626395
BAKER_HEMATOPOIESIS_STAT3_TARGETS,13,Up,0.0816065643920489,0.875915601626395
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON,26,Down,0.0817562540401338,0.875915601626395
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,9,Up,0.0817642034410111,0.875915601626395
KEGG_DILATED_CARDIOMYOPATHY,64,Down,0.0818685235628657,0.875915601626395
WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP,45,Up,0.0822962189648178,0.878409996752133
UROSEVIC_RESPONSE_TO_IMIQUIMOD,19,Up,0.0829814098693115,0.880061898944307
BIOCARTA_MPR_PATHWAY,28,Down,0.0831768083731202,0.880061898944307
CASTELLANO_NRAS_TARGETS_UP,50,Up,0.083180495335723,0.880061898944307
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS,15,Down,0.0832306602102368,0.880061898944307
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,12,Down,0.0840179084662058,0.886310412908689
EGUCHI_CELL_CYCLE_RB1_TARGETS,23,Down,0.0842538719545624,0.886727813228087
PID_IL23_PATHWAY,21,Up,0.0848841324877388,0.891283391121257
WEBER_METHYLATED_LCP_IN_SPERM_UP,5,Down,0.0862704420026709,0.903312816633527
REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE,16,Up,0.0864299306280584,0.903312816633527
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,82,Down,0.0871667086649045,0.90718497263619
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5,54,Up,0.0874433554504278,0.90718497263619
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,59,Up,0.0874898768624456,0.90718497263619
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,30,Up,0.0876041302479244,0.90718497263619
GALIE_TUMOR_ANGIOGENESIS,4,Up,0.0880663299813963,0.90814717290338
BOYLAN_MULTIPLE_MYELOMA_PCA1_DN,6,Up,0.0881816419245165,0.90814717290338
BIOCARTA_AKT_PATHWAY,20,Up,0.0883004670885014,0.90814717290338
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,47,Up,0.088843141924731,0.911651785886728
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,22,Down,0.0894268917704022,0.912310692796841
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,142,Down,0.0894367857674967,0.912310692796841
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,16,Up,0.0895135408436325,0.912310692796841
BIOCARTA_DEATH_PATHWAY,31,Up,0.0911549330549747,0.924392786524837
REACTOME_PLC_BETA_MEDIATED_EVENTS,33,Down,0.0913362302915807,0.924392786524837
IKEDA_MIR1_TARGETS_UP,51,Down,0.0916847432974801,0.924392786524837
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,46,Down,0.0917796252852753,0.924392786524837
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,30,Down,0.0917955200526677,0.924392786524837
ONO_AML1_TARGETS_DN,19,Up,0.0919641714359755,0.924392786524837
MARSON_FOXP3_CORE_DIRECT_TARGETS,12,Up,0.0921321714144355,0.924392786524837
MARZEC_IL2_SIGNALING_DN,30,Down,0.0941431130803079,0.941630336360067
REACTOME_OPIOID_SIGNALLING,57,Down,0.0942673116356037,0.941630336360067
REACTOME_GAP_JUNCTION_TRAFFICKING,12,Down,0.0945416649691119,0.942286130983532
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,106,Down,0.0948970415780925,0.94304995392904
MODY_HIPPOCAMPUS_PRENATAL,35,Down,0.0950623214623348,0.94304995392904
BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1,11,Down,0.0955925502117713,0.94304995392904
VERHAAK_GLIOBLASTOMA_CLASSICAL,127,Up,0.0956395221403486,0.94304995392904
PECE_MAMMARY_STEM_CELL_UP,110,Down,0.0956626531338871,0.94304995392904
REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX,12,Down,0.0967178474414993,0.948972630338095
WANG_RESPONSE_TO_FORSKOLIN_UP,19,Up,0.0968890972218174,0.948972630338095
BIOCARTA_TRKA_PATHWAY,8,Down,0.0972202691765351,0.948972630338095
REACTOME_CALNEXIN_CALRETICULIN_CYCLE,11,Down,0.0973257570517591,0.948972630338095
BRACHAT_RESPONSE_TO_CISPLATIN,16,Up,0.097442248810737,0.948972630338095
WACKER_HYPOXIA_TARGETS_OF_VHL,11,Down,0.0975245405264399,0.948972630338095
TIAN_TNF_SIGNALING_NOT_VIA_NFKB,18,Up,0.098032552843285,0.948979054315609
SMITH_LIVER_CANCER,40,Down,0.0982524557418617,0.948979054315609
NAKAMURA_ADIPOGENESIS_EARLY_UP,49,Up,0.0982925667574159,0.948979054315609
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN,7,Up,0.0985173809543819,0.948979054315609
REACTOME_SYNTHESIS_OF_DNA,87,Down,0.0985990587817677,0.948979054315609
GAURNIER_PSMD4_TARGETS,24,Up,0.0992348138482779,0.948979054315609
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,15,Down,0.0992829191783541,0.948979054315609
WIELAND_UP_BY_HBV_INFECTION,64,Up,0.0996492356265686,0.948979054315609
REACTOME_HS_GAG_BIOSYNTHESIS,19,Down,0.099724302423928,0.948979054315609
WOTTON_RUNX_TARGETS_UP,15,Down,0.100002398724588,0.948979054315609
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,19,Up,0.100022182014172,0.948979054315609
PID_BETA_CATENIN_NUC_PATHWAY,57,Up,0.100047404175909,0.948979054315609
SCHLESINGER_METHYLATED_IN_COLON_CANCER,2,Up,0.10045041780347,0.949015858856085
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,52,Up,0.10050001535202,0.949015858856085
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,327,Up,0.100681859666016,0.949015858856085
GAVIN_FOXP3_TARGETS_CLUSTER_P6,76,Up,0.101312332853961,0.952969130907572
MIKKELSEN_PLURIPOTENT_STATE_UP,5,Down,0.10262130530745,0.961032543257261
HOELZEL_NF1_TARGETS_DN,67,Up,0.103104403431064,0.961032543257261
KEGG_OOCYTE_MEIOSIS,92,Down,0.103211890344938,0.961032543257261
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,58,Down,0.10327579851173,0.961032543257261
HASLINGER_B_CLL_WITH_6Q21_DELETION,19,Down,0.103322182235684,0.961032543257261
REACTOME_HIV_INFECTION,170,Down,0.103446692363904,0.961032543257261
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,99,Down,0.103707108403197,0.961473499877693
REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21,51,Down,0.1041624095909,0.963715736276461
IRITANI_MAD1_TARGETS_UP,8,Down,0.104546553123482,0.965291794176938
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP,8,Down,0.105011755156577,0.967608315371316
ONGUSAHA_TP53_TARGETS,29,Up,0.105429090879491,0.96947524505275
BIOCARTA_AT1R_PATHWAY,29,Up,0.105815374580529,0.969902840549994
KUMAR_AUTOPHAGY_NETWORK,47,Down,0.105905227107674,0.969902840549994
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,29,Up,0.106323128864398,0.971301185469994
WAKASUGI_HAVE_ZNF143_BINDING_SITES,53,Up,0.106581372937705,0.971301185469994
REACTOME_DARPP_32_EVENTS,21,Down,0.10670329745141,0.971301185469994
REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE,9,Down,0.107413235444168,0.975164120452504
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,47,Down,0.107559630561539,0.975164120452504
BIOCARTA_IL1R_PATHWAY,30,Up,0.108365518483094,0.979725268544297
MARSON_FOXP3_TARGETS_DN,34,Up,0.109221906851325,0.979725268544297
BIOCARTA_IGF1MTOR_PATHWAY,19,Down,0.109277758566794,0.979725268544297
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,39,Down,0.109381254411749,0.979725268544297
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,25,Up,0.109423406657337,0.979725268544297
PID_ATM_PATHWAY,30,Up,0.109471470835154,0.979725268544297
CHEBOTAEV_GR_TARGETS_DN,79,Up,0.109646479758997,0.979725268544297
PID_P73PATHWAY,67,Up,0.109819508411873,0.979725268544297
KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM,4,Up,0.11049927231168,0.979725268544297
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,40,Down,0.110509394866871,0.979725268544297
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,132,Up,0.110618310507786,0.979725268544297
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,98,Down,0.110666641629588,0.979725268544297
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,14,Down,0.111372665316525,0.98404615245423
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,55,Down,0.111654418134282,0.984316931982428
REACTOME_SIGNAL_TRANSDUCTION_BY_L1,30,Down,0.111839332471093,0.984316931982428
ROESSLER_LIVER_CANCER_METASTASIS_UP,80,Up,0.112850143939734,0.991280933634045
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,46,Down,0.113270694951335,0.993043082922867
ZIRN_TRETINOIN_RESPONSE_DN,4,Down,0.113820060874536,0.993105376038609
PHONG_TNF_RESPONSE_NOT_VIA_P38,290,Up,0.113974103119069,0.993105376038609
CHEOK_RESPONSE_TO_HD_MTX_DN,22,Down,0.114276367239116,0.993105376038609
PID_WNT_CANONICAL_PATHWAY,17,Up,0.114319428507723,0.993105376038609
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,12,Down,0.114377584837226,0.993105376038609
REACTOME_SIGNALING_BY_NOTCH,90,Up,0.114606135388587,0.993179848904936
RAFFEL_VEGFA_TARGETS_UP,8,Up,0.115851450737598,0.999485802679459
HOWLIN_PUBERTAL_MAMMARY_GLAND,38,Up,0.116237332746905,0.999485802679459
REACTOME_METABOLISM_OF_CARBOHYDRATES,169,Down,0.116325147564626,0.999485802679459
ZWANG_DOWN_BY_2ND_EGF_PULSE,172,Up,0.117021175865968,0.999485802679459
LANDIS_BREAST_CANCER_PROGRESSION_DN,59,Up,0.117354676959211,0.999485802679459
CAIRO_HEPATOBLASTOMA_CLASSES_DN,148,Up,0.117377142886387,0.999485802679459
VALK_AML_WITH_CEBPA,24,Up,0.117430408366726,0.999485802679459
WNT_SIGNALING,70,Up,0.117831332812375,0.999485802679459
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN,5,Down,0.117842289989077,0.999485802679459
REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING,10,Down,0.117924764223857,0.999485802679459
KEGG_TGF_BETA_SIGNALING_PATHWAY,72,Up,0.118026415134403,0.999485802679459
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP,4,Down,0.118536995094997,0.999485802679459
REACTOME_SIGNALLING_BY_NGF,185,Down,0.118976143631826,0.999485802679459
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,28,Down,0.119167223611552,0.999485802679459
IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM,23,Up,0.119288615049847,0.999485802679459
BIOCARTA_GPCR_PATHWAY,29,Down,0.119970536747033,0.999485802679459
BROWNE_HCMV_INFECTION_30MIN_UP,32,Up,0.120105715405505,0.999485802679459
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,291,Up,0.120286298625225,0.999485802679459
BENPORATH_NOS_TARGETS,129,Up,0.120388187484569,0.999485802679459
PETROVA_PROX1_TARGETS_UP,26,Up,0.120718324697361,0.999485802679459
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,56,Down,0.120743841536289,0.999485802679459
WILLIAMS_ESR1_TARGETS_UP,18,Down,0.120941109475141,0.999485802679459
MATZUK_SPERMATID_DIFFERENTIATION,23,Down,0.121098222541791,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_MS_UP,32,Down,0.121558421513033,0.999485802679459
REACTOME_METABOLISM_OF_POLYAMINES,13,Down,0.121579366251443,0.999485802679459
REN_BOUND_BY_E2F,60,Down,0.121745505195656,0.999485802679459
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1,21,Down,0.121773286422939,0.999485802679459
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,79,Down,0.122040447029287,0.999485802679459
REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS,8,Down,0.122168907378816,0.999485802679459
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,12,Up,0.122218198820637,0.999485802679459
SANSOM_WNT_PATHWAY_REQUIRE_MYC,48,Up,0.123550690098888,0.999485802679459
IRITANI_MAD1_TARGETS_DN,42,Down,0.123822882586219,0.999485802679459
MARSON_FOXP3_TARGETS_UP,53,Up,0.123876716400161,0.999485802679459
MOOTHA_ROS,6,Down,0.12397322729065,0.999485802679459
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,51,Up,0.124241817016256,0.999485802679459
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,40,Up,0.124281541065282,0.999485802679459
REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES,53,Down,0.124323225406569,0.999485802679459
SHIN_B_CELL_LYMPHOMA_CLUSTER_3,19,Up,0.124765242622639,0.999485802679459
REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,46,Down,0.125128481832586,0.999485802679459
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,25,Down,0.125251134728075,0.999485802679459
LEE_EARLY_T_LYMPHOCYTE_DN,35,Up,0.125964033148477,0.999485802679459
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP,13,Down,0.125992865019114,0.999485802679459
PID_TRAIL_PATHWAY,25,Up,0.126566662704294,0.999485802679459
BIOCARTA_EGF_PATHWAY,29,Up,0.126933708269409,0.999485802679459
PENG_GLUTAMINE_DEPRIVATION_DN,302,Down,0.127314125739638,0.999485802679459
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,73,Down,0.127616597085966,0.999485802679459
PID_HDAC_CLASSI_PATHWAY,60,Up,0.127777720177093,0.999485802679459
GALLUZZI_PERMEABILIZE_MITOCHONDRIA,37,Down,0.128053445680927,0.999485802679459
GROSS_HYPOXIA_VIA_ELK3_UP,190,Down,0.128103753815284,0.999485802679459
DER_IFN_ALPHA_RESPONSE_UP,66,Up,0.128280750471968,0.999485802679459
SILIGAN_BOUND_BY_EWS_FLT1_FUSION,31,Up,0.128352334465023,0.999485802679459
SANSOM_APC_TARGETS,145,Up,0.128394617568364,0.999485802679459
GAVIN_FOXP3_TARGETS_CLUSTER_P2,44,Up,0.128451269380109,0.999485802679459
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,8,Down,0.128478666166815,0.999485802679459
KEGG_FATTY_ACID_METABOLISM,29,Down,0.128736244357039,0.999485802679459
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,60,Up,0.128776514602541,0.999485802679459
PID_CDC42_REG_PATHWAY,28,Down,0.129370847351845,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,39,Down,0.12957964298029,0.999485802679459
BIOCARTA_CSK_PATHWAY,11,Down,0.130092546071793,0.999485802679459
LIANG_SILENCED_BY_METHYLATION_DN,9,Down,0.130139877789871,0.999485802679459
PID_CD8_TCR_DOWNSTREAM_PATHWAY,30,Up,0.130218423172306,0.999485802679459
BIOCARTA_IGF1R_PATHWAY,21,Down,0.131067687622655,0.999485802679459
KEGG_ACUTE_MYELOID_LEUKEMIA,49,Up,0.131226995860008,0.999485802679459
REACTOME_SYNTHESIS_OF_PC,11,Down,0.131457424763005,0.999485802679459
AMIT_EGF_RESPONSE_240_HELA,54,Up,0.131863875409732,0.999485802679459
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,60,Down,0.13224987646968,0.999485802679459
RUAN_RESPONSE_TO_TROGLITAZONE_UP,18,Down,0.132514876104497,0.999485802679459
FRIDMAN_SENESCENCE_DN,9,Down,0.133145978752642,0.999485802679459
BOYLAN_MULTIPLE_MYELOMA_D_UP,68,Up,0.133318772183834,0.999485802679459
LIU_SMARCA4_TARGETS,38,Down,0.133866332902568,0.999485802679459
TOMLINS_PROSTATE_CANCER_UP,32,Up,0.134159715065676,0.999485802679459
DOANE_BREAST_CANCER_CLASSES_DN,32,Up,0.134175612490953,0.999485802679459
BROWNE_HCMV_INFECTION_8HR_DN,38,Up,0.134356707676522,0.999485802679459
BIOCARTA_AKAP13_PATHWAY,10,Down,0.134527306837647,0.999485802679459
SABATES_COLORECTAL_ADENOMA_DN,97,Up,0.134527654990155,0.999485802679459
REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE,74,Down,0.134614736725839,0.999485802679459
VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP,9,Down,0.134756419621068,0.999485802679459
HOFMANN_CELL_LYMPHOMA_UP,41,Up,0.134881434709372,0.999485802679459
PID_INTEGRIN4_PATHWAY,11,Down,0.134946480346551,0.999485802679459
TOOKER_GEMCITABINE_RESISTANCE_UP,65,Up,0.13573040456911,0.999485802679459
BIOCARTA_TFF_PATHWAY,19,Up,0.135744974906793,0.999485802679459
NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON,2,Up,0.136353496675144,0.999485802679459
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,62,Down,0.136367159852185,0.999485802679459
KEGG_PROTEASOME,37,Down,0.136410210548848,0.999485802679459
SESTO_RESPONSE_TO_UV_C5,46,Up,0.136448530811398,0.999485802679459
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,63,Down,0.136800082133192,0.999485802679459
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,20,Up,0.136843046109392,0.999485802679459
BIOCARTA_PAR1_PATHWAY,30,Up,0.137489229750877,0.999485802679459
KEGG_ENDOMETRIAL_CANCER,47,Up,0.137798804698231,0.999485802679459
REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY,8,Down,0.138395052536544,0.999485802679459
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,96,Down,0.138413558775118,0.999485802679459
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,24,Down,0.13849981658179,0.999485802679459
ST_TYPE_I_INTERFERON_PATHWAY,8,Up,0.138564782481964,0.999485802679459
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,130,Down,0.139094749016167,0.999485802679459
NUMATA_CSF3_SIGNALING_VIA_STAT3,19,Up,0.139125129777411,0.999485802679459
PID_ERBB4_PATHWAY,32,Down,0.139429167936946,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,62,Down,0.139604355725844,0.999485802679459
CROMER_METASTASIS_UP,65,Down,0.139726798814287,0.999485802679459
IWANAGA_CARCINOGENESIS_BY_KRAS_DN,81,Up,0.139868659659588,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,9,Down,0.140035082493152,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_DN,19,Down,0.140738249348219,0.999485802679459
REACTOME_M_G1_TRANSITION,73,Down,0.14077909356681,0.999485802679459
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,23,Up,0.142200959843916,0.999485802679459
KIM_MYC_AMPLIFICATION_TARGETS_DN,74,Up,0.142244531451287,0.999485802679459
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,37,Up,0.142304357818874,0.999485802679459
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP,7,Up,0.142495986055372,0.999485802679459
SA_PROGRAMMED_CELL_DEATH,11,Up,0.142540128112771,0.999485802679459
ALFANO_MYC_TARGETS,197,Up,0.142608448035738,0.999485802679459
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,9,Down,0.142785562201366,0.999485802679459
NIELSEN_LEIOMYOSARCOMA_UP,13,Up,0.143322483178985,0.999485802679459
BURTON_ADIPOGENESIS_1,30,Up,0.14417522841659,0.999485802679459
HAN_JNK_SINGALING_UP,28,Up,0.144491775028098,0.999485802679459
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,27,Down,0.144509568734045,0.999485802679459
APPIERTO_RESPONSE_TO_FENRETINIDE_DN,42,Down,0.144915025537445,0.999485802679459
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,57,Up,0.14494887222202,0.999485802679459
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,13,Down,0.145210385592182,0.999485802679459
KEGG_LYSOSOME,110,Down,0.145232042596218,0.999485802679459
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,29,Up,0.145264448947107,0.999485802679459
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,97,Up,0.1453960125687,0.999485802679459
VANASSE_BCL2_TARGETS_UP,22,Up,0.14543253648268,0.999485802679459
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,27,Down,0.145613707365793,0.999485802679459
LIN_NPAS4_TARGETS_UP,123,Down,0.145810883946113,0.999485802679459
REACTOME_KINESINS,17,Down,0.146460309141936,0.999485802679459
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,16,Up,0.14678457776456,0.999485802679459
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,51,Up,0.147326101530413,0.999485802679459
REACTOME_GLYCOSPHINGOLIPID_METABOLISM,26,Down,0.147465826418312,0.999485802679459
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,17,Up,0.147856338944999,0.999485802679459
KRASNOSELSKAYA_ILF3_TARGETS_DN,35,Down,0.148238288329217,0.999485802679459
WONG_ENDMETRIUM_CANCER_DN,41,Up,0.148269773810651,0.999485802679459
REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE,49,Down,0.148549197247679,0.999485802679459
PID_IL12_STAT4_PATHWAY,16,Up,0.148592899999415,0.999485802679459
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN,9,Up,0.148853787029111,0.999485802679459
KEGG_STEROID_HORMONE_BIOSYNTHESIS,15,Down,0.149528726213154,0.999485802679459
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1,4,Down,0.149822665182329,0.999485802679459
VALK_AML_CLUSTER_3,22,Down,0.150156655206661,0.999485802679459
SMID_BREAST_CANCER_LUMINAL_A_UP,41,Down,0.150722433576063,0.999485802679459
DING_LUNG_CANCER_MUTATED_RECURRENTLY,6,Up,0.151002618168075,0.999485802679459
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,3,Up,0.151277595843717,0.999485802679459
JEON_SMAD6_TARGETS_DN,14,Up,0.151490429315151,0.999485802679459
REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS,17,Down,0.151590192948494,0.999485802679459
REACTOME_METABOLISM_OF_NUCLEOTIDES,65,Down,0.151977809943753,0.999485802679459
KEGG_ARGININE_AND_PROLINE_METABOLISM,37,Down,0.152280933112668,0.999485802679459
KEGG_STEROID_BIOSYNTHESIS,15,Up,0.152374911454989,0.999485802679459
REACTOME_SIGNALING_BY_PDGF,105,Down,0.152558685820736,0.999485802679459
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP,7,Down,0.152872347629523,0.999485802679459
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN,7,Up,0.153180504951436,0.999485802679459
KEGG_JAK_STAT_SIGNALING_PATHWAY,89,Up,0.153495063958297,0.999485802679459
CLIMENT_BREAST_CANCER_COPY_NUMBER_DN,6,Down,0.153632906194328,0.999485802679459
REACTOME_TRIGLYCERIDE_BIOSYNTHESIS,33,Down,0.154085601719062,0.999485802679459
NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA,2,Down,0.154429825314645,0.999485802679459
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,13,Up,0.154771219350218,0.999485802679459
TIEN_INTESTINE_PROBIOTICS_24HR_DN,195,Down,0.155019738132365,0.999485802679459
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,41,Up,0.15510521533809,0.999485802679459
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,19,Up,0.15520002165847,0.999485802679459
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN,4,Up,0.15537422580919,0.999485802679459
GOZGIT_ESR1_TARGETS_UP,102,Down,0.155563662983567,0.999485802679459
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,24,Up,0.155618896859008,0.999485802679459
REACTOME_PYRIMIDINE_CATABOLISM,8,Down,0.156179899444337,0.999485802679459
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,48,Down,0.156461042543217,0.999485802679459
SCHURINGA_STAT5A_TARGETS_UP,16,Up,0.156737695270674,0.999485802679459
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,88,Up,0.157210905933274,0.999485802679459
LIANG_SILENCED_BY_METHYLATION_2,38,Up,0.157235187230536,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP,10,Down,0.157765285505251,0.999485802679459
REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING,17,Down,0.158047440670913,0.999485802679459
PID_INTEGRIN1_PATHWAY,56,Down,0.158291867205057,0.999485802679459
LENAOUR_DENDRITIC_CELL_MATURATION_UP,78,Up,0.159064883854162,0.999485802679459
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,62,Down,0.159455898313626,0.999485802679459
ST_GA13_PATHWAY,33,Up,0.159577247582997,0.999485802679459
BILANGES_SERUM_RESPONSE_TRANSLATION,27,Down,0.159914973409468,0.999485802679459
REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES,9,Down,0.159930295059901,0.999485802679459
REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY,11,Down,0.160100637049373,0.999485802679459
REICHERT_MITOSIS_LIN9_TARGETS,26,Down,0.160200988962349,0.999485802679459
RUAN_RESPONSE_TO_TROGLITAZONE_DN,15,Down,0.160518282657833,0.999485802679459
REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC,45,Down,0.160626913129213,0.999485802679459
KIM_ALL_DISORDERS_CALB1_CORR_DN,17,Down,0.160750434854404,0.999485802679459
BIOCARTA_NFAT_PATHWAY,41,Down,0.160904170959276,0.999485802679459
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,127,Down,0.161068901405445,0.999485802679459
REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS,10,Up,0.161733783937582,0.999485802679459
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,12,Down,0.161845281783025,0.999485802679459
ZEMBUTSU_SENSITIVITY_TO_CISPLATIN,16,Down,0.162425037588371,0.999485802679459
KOINUMA_COLON_CANCER_MSI_UP,13,Up,0.16253857862286,0.999485802679459
REACTOME_MRNA_SPLICING,102,Down,0.162591751333785,0.999485802679459
INGRAM_SHH_TARGETS,6,Up,0.162804660018184,0.999485802679459
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,6,Down,0.162842438615273,0.999485802679459
MANTOVANI_NFKB_TARGETS_UP,29,Up,0.163648158621161,0.999485802679459
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,133,Down,0.163853020220557,0.999485802679459
REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,39,Down,0.163963672968603,0.999485802679459
BURTON_ADIPOGENESIS_10,26,Up,0.164353569173809,0.999485802679459
REACTOME_PI3K_CASCADE,50,Down,0.16437313874506,0.999485802679459
BAE_BRCA1_TARGETS_DN,28,Down,0.164411807509201,0.999485802679459
BIOCARTA_IL22BP_PATHWAY,14,Up,0.16499977126819,0.999485802679459
SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM,3,Up,0.165083517324017,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN,11,Up,0.165717356689143,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,18,Up,0.166009652478987,0.999485802679459
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,23,Up,0.166309670672123,0.999485802679459
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,55,Down,0.166610859217566,0.999485802679459
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP,18,Up,0.166635485238641,0.999485802679459
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,26,Down,0.166886985382022,0.999485802679459
JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP,91,Down,0.167196517462772,0.999485802679459
BIOCARTA_CK1_PATHWAY,13,Down,0.1673438416175,0.999485802679459
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,45,Down,0.167405976316395,0.999485802679459
RICKMAN_HEAD_AND_NECK_CANCER_F,31,Up,0.167778959938775,0.999485802679459
REACTOME_ERK_MAPK_TARGETS,21,Down,0.168237750469486,0.999485802679459
PID_NETRIN_PATHWAY,30,Down,0.168330815975029,0.999485802679459
XU_GH1_AUTOCRINE_TARGETS_DN,106,Down,0.16852106185464,0.999485802679459
RIGGI_EWING_SARCOMA_PROGENITOR_UP,278,Up,0.17002101112349,0.999485802679459
MOTAMED_RESPONSE_TO_ANDROGEN_DN,6,Down,0.170226401078419,0.999485802679459
CAFFAREL_RESPONSE_TO_THC_8HR_3_DN,10,Down,0.170534081117372,0.999485802679459
BIOCARTA_AKAP95_PATHWAY,11,Down,0.170666803401424,0.999485802679459
SUMI_HNF4A_TARGETS,12,Down,0.170716279159283,0.999485802679459
SESTO_RESPONSE_TO_UV_C7,59,Down,0.170763443488383,0.999485802679459
BIOCARTA_INFLAM_PATHWAY,14,Up,0.170948033426176,0.999485802679459
REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT,25,Down,0.171305253593021,0.999485802679459
REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,31,Down,0.171431710557356,0.999485802679459
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,45,Up,0.171840390830707,0.999485802679459
VANTVEER_BREAST_CANCER_METASTASIS_UP,43,Up,0.172305680837437,0.999485802679459
REACTOME_PURINE_CATABOLISM,9,Down,0.17278738912616,0.999485802679459
ISHIKAWA_STING_SIGNALING,6,Up,0.172829844778069,0.999485802679459
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,29,Up,0.173235567287342,0.999485802679459
REACTOME_DNA_STRAND_ELONGATION,30,Down,0.173303912232662,0.999485802679459
BIOCARTA_MYOSIN_PATHWAY,25,Up,0.174372990636054,0.999485802679459
REACTOME_HIV_LIFE_CYCLE,101,Down,0.174383543621901,0.999485802679459
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,42,Up,0.174681734332404,0.999485802679459
GALIE_TUMOR_STEMNESS_GENES,5,Up,0.174990289312168,0.999485802679459
REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,43,Down,0.175273643635553,0.999485802679459
BIOCARTA_RANMS_PATHWAY,10,Down,0.176269518719033,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN,13,Up,0.176401061638875,0.999485802679459
REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0,47,Down,0.176499359667706,0.999485802679459
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,61,Up,0.176716933661865,0.999485802679459
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC,19,Down,0.176795140800567,0.999485802679459
RASHI_RESPONSE_TO_IONIZING_RADIATION_5,115,Down,0.177230703631726,0.999485802679459
LI_AMPLIFIED_IN_LUNG_CANCER,147,Down,0.177878063970019,0.999485802679459
BIOCARTA_GABA_PATHWAY,5,Down,0.177972527471952,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,84,Down,0.178484415196507,0.999485802679459
TOMIDA_METASTASIS_DN,17,Down,0.178529075128163,0.999485802679459
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN,5,Down,0.178680261837928,0.999485802679459
KIM_GLIS2_TARGETS_DN,3,Down,0.179028859277066,0.999485802679459
KEGG_GRAFT_VERSUS_HOST_DISEASE,4,Up,0.179145497074616,0.999485802679459
REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING,5,Down,0.179413032096703,0.999485802679459
REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1,43,Down,0.179688049563284,0.999485802679459
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,24,Down,0.179845025047532,0.999485802679459
KYNG_DNA_DAMAGE_BY_UV,50,Down,0.179879954935547,0.999485802679459
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,13,Down,0.180033668997078,0.999485802679459
HADDAD_B_LYMPHOCYTE_PROGENITOR,217,Down,0.180116029151466,0.999485802679459
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,64,Down,0.180820318500138,0.999485802679459
HOEBEKE_LYMPHOID_STEM_CELL_DN,70,Up,0.180931283374969,0.999485802679459
REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS,8,Down,0.18104615696175,0.999485802679459
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,14,Down,0.18130478713964,0.999485802679459
REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C,54,Down,0.181487113849494,0.999485802679459
KEGG_PYRIMIDINE_METABOLISM,90,Down,0.181867664936164,0.999485802679459
REACTOME_PURINE_METABOLISM,31,Down,0.181966870434242,0.999485802679459
GILMORE_CORE_NFKB_PATHWAY,14,Up,0.182879125360543,0.999485802679459
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,18,Down,0.183347712369561,0.999485802679459
JACKSON_DNMT1_TARGETS_UP,64,Up,0.183365672426942,0.999485802679459
REACTOME_MEMBRANE_TRAFFICKING,104,Down,0.183390378049477,0.999485802679459
NELSON_RESPONSE_TO_ANDROGEN_UP,69,Down,0.18397117365587,0.999485802679459
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,20,Up,0.184333065196126,0.999485802679459
NGUYEN_NOTCH1_TARGETS_DN,74,Up,0.184466309894791,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP,40,Down,0.185234749124434,0.999485802679459
DAZARD_UV_RESPONSE_CLUSTER_G1,53,Down,0.185301364725616,0.999485802679459
MA_PITUITARY_FETAL_VS_ADULT_DN,14,Down,0.185341372771379,0.999485802679459
KEGG_PENTOSE_PHOSPHATE_PATHWAY,20,Down,0.186061873788409,0.999485802679459
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,7,Down,0.186236854291678,0.999485802679459
NAKAMURA_ADIPOGENESIS_LATE_UP,86,Up,0.186779788104467,0.999485802679459
NIKOLSKY_BREAST_CANCER_19P13_AMPLICON,4,Down,0.186836378440712,0.999485802679459
BIOCARTA_PDGF_PATHWAY,30,Up,0.187385886507599,0.999485802679459
WAESCH_ANAPHASE_PROMOTING_COMPLEX,11,Down,0.187806315625377,0.999485802679459
LUND_SILENCED_BY_METHYLATION,14,Down,0.187836854260269,0.999485802679459
ST_G_ALPHA_I_PATHWAY,29,Up,0.187901579409493,0.999485802679459
JISON_SICKLE_CELL_DISEASE_DN,151,Down,0.188411105724673,0.999485802679459
REACTOME_INNATE_IMMUNE_SYSTEM,170,Up,0.18851389176713,0.999485802679459
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,14,Down,0.188717036731578,0.999485802679459
REACTOME_SYNTHESIS_OF_PE,8,Down,0.188872701178224,0.999485802679459
NEWMAN_ERCC6_TARGETS_UP,17,Down,0.189029696058148,0.999485802679459
MIKKELSEN_IPS_LCP_WITH_H3K4ME3,86,Up,0.189840455782656,0.999485802679459
LEE_CALORIE_RESTRICTION_MUSCLE_UP,29,Down,0.189888461875626,0.999485802679459
PID_AR_NONGENOMIC_PATHWAY,27,Down,0.189926867889242,0.999485802679459
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,51,Down,0.190130251833275,0.999485802679459
WENG_POR_TARGETS_LIVER_DN,13,Down,0.190323012144852,0.999485802679459
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_,63,Down,0.190487460495858,0.999485802679459
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,372,Down,0.190677584203785,0.999485802679459
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,169,Down,0.190852684679659,0.999485802679459
FARMER_BREAST_CANCER_CLUSTER_6,14,Up,0.191059449577739,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,152,Down,0.191088272336073,0.999485802679459
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,34,Up,0.191904833788172,0.999485802679459
KEGG_DORSO_VENTRAL_AXIS_FORMATION,19,Up,0.192167061955899,0.999485802679459
SASSON_RESPONSE_TO_FORSKOLIN_DN,79,Up,0.192280743228658,0.999485802679459
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX,51,Down,0.192301268187298,0.999485802679459
LOPES_METHYLATED_IN_COLON_CANCER_DN,19,Up,0.192401093730506,0.999485802679459
NAGASHIMA_NRG1_SIGNALING_DN,48,Up,0.19302281401503,0.999485802679459
BIOCARTA_EIF4_PATHWAY,21,Down,0.193083225951681,0.999485802679459
REACTOME_PKB_MEDIATED_EVENTS,27,Down,0.193107624196145,0.999485802679459
REACTOME_ER_PHAGOSOME_PATHWAY,48,Down,0.193311881659991,0.999485802679459
HELLER_SILENCED_BY_METHYLATION_UP,176,Up,0.193637711881253,0.999485802679459
DALESSIO_TSA_RESPONSE,17,Up,0.193734864706766,0.999485802679459
REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE,90,Down,0.194021221646905,0.999485802679459
ZHANG_ADIPOGENESIS_BY_BMP7,12,Down,0.194257827059941,0.999485802679459
WINTER_HYPOXIA_UP,80,Down,0.194259371947084,0.999485802679459
YE_METASTATIC_LIVER_CANCER,16,Up,0.194336420103382,0.999485802679459
LEE_EARLY_T_LYMPHOCYTE_UP,84,Down,0.194610683162541,0.999485802679459
DURCHDEWALD_SKIN_CARCINOGENESIS_UP,57,Down,0.194659050772295,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,131,Down,0.194765392277246,0.999485802679459
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,84,Up,0.194789338637641,0.999485802679459
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP,6,Down,0.195288937204885,0.999485802679459
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,96,Up,0.195342871745848,0.999485802679459
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,135,Down,0.195593535023434,0.999485802679459
REACTOME_MRNA_PROCESSING,146,Down,0.195770032636576,0.999485802679459
ABRAMSON_INTERACT_WITH_AIRE,43,Down,0.196304526296635,0.999485802679459
MOOTHA_PGC,351,Down,0.1963367755927,0.999485802679459
MIKKELSEN_IPS_WITH_HCP_H3K27ME3,45,Up,0.196588900692954,0.999485802679459
WALLACE_PROSTATE_CANCER_UP,15,Up,0.196609211955586,0.999485802679459
SCHRAMM_INHBA_TARGETS_DN,21,Down,0.196773849770339,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,29,Up,0.197026865747032,0.999485802679459
MARCHINI_TRABECTEDIN_RESISTANCE_DN,44,Down,0.197394807822599,0.999485802679459
REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION,13,Down,0.197584634296057,0.999485802679459
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,9,Up,0.198351264193128,0.999485802679459
MAHADEVAN_IMATINIB_RESISTANCE_DN,6,Down,0.198411123255881,0.999485802679459
PID_CXCR4_PATHWAY,79,Down,0.198808781166788,0.999485802679459
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN,15,Down,0.199184162127127,0.999485802679459
PID_IL2_PI3K_PATHWAY,28,Up,0.199201023128294,0.999485802679459
BIOCARTA_CARM1_PATHWAY,12,Down,0.199897546030458,0.999485802679459
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,94,Down,0.200257600616813,0.999485802679459
LEE_LIVER_CANCER_MYC_UP,38,Down,0.200291247743033,0.999485802679459
ROME_INSULIN_TARGETS_IN_MUSCLE_UP,369,Down,0.200309485340295,0.999485802679459
KEGG_WNT_SIGNALING_PATHWAY,117,Up,0.200681631679296,0.999485802679459
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,25,Up,0.200811611070749,0.999485802679459
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE,26,Up,0.200829271995299,0.999485802679459
LUI_THYROID_CANCER_CLUSTER_3,25,Down,0.201484525558703,0.999485802679459
KEGG_LIMONENE_AND_PINENE_DEGRADATION,7,Down,0.201944695292956,0.999485802679459
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,50,Up,0.202200397700162,0.999485802679459
LAMB_CCND1_TARGETS,14,Down,0.202465315911117,0.999485802679459
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,27,Down,0.202703644475971,0.999485802679459
RICKMAN_HEAD_AND_NECK_CANCER_B,18,Down,0.203496880505722,0.999485802679459
PID_S1P_S1P3_PATHWAY,26,Down,0.203681944843437,0.999485802679459
REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT,45,Down,0.203751598464598,0.999485802679459
LEE_LIVER_CANCER_DENA_UP,45,Down,0.203962501113118,0.999485802679459
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1,29,Down,0.204132227584724,0.999485802679459
SESTO_RESPONSE_TO_UV_C3,18,Up,0.204172446699073,0.999485802679459
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,38,Up,0.204408766136999,0.999485802679459
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP,11,Down,0.20457126837028,0.999485802679459
MURAKAMI_UV_RESPONSE_6HR_DN,14,Up,0.20476235474123,0.999485802679459
HILLION_HMGA1_TARGETS,61,Down,0.204856076708135,0.999485802679459
REACTOME_REGULATION_OF_APOPTOSIS,51,Down,0.205270977756408,0.999485802679459
PID_ERB_GENOMIC_PATHWAY,11,Up,0.205857179852176,0.999485802679459
COWLING_MYCN_TARGETS,30,Up,0.205895327493037,0.999485802679459
BIOCARTA_INTRINSIC_PATHWAY,11,Up,0.206155162700673,0.999485802679459
ROESSLER_LIVER_CANCER_METASTASIS_DN,36,Up,0.20635373091067,0.999485802679459
DELASERNA_MYOD_TARGETS_UP,57,Down,0.206726984538288,0.999485802679459
WONG_ADULT_TISSUE_STEM_MODULE,524,Up,0.206811021057388,0.999485802679459
MCGOWAN_RSP6_TARGETS_UP,9,Down,0.206873067691066,0.999485802679459
AMUNDSON_GAMMA_RADIATION_RESPONSE,37,Down,0.207617837100109,0.999485802679459
REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE,16,Down,0.207884909106639,0.999485802679459
YEMELYANOV_GR_TARGETS_DN,9,Up,0.208194645135239,0.999485802679459
SPIRA_SMOKERS_LUNG_CANCER_DN,13,Up,0.208386111605233,0.999485802679459
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP,14,Down,0.208668937329401,0.999485802679459
BIOCARTA_MAPK_PATHWAY,82,Up,0.208747023331066,0.999485802679459
REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE,5,Down,0.208829304032084,0.999485802679459
REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE,5,Down,0.208829304032084,0.999485802679459
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,23,Up,0.209209077922742,0.999485802679459
NAKAMURA_CANCER_MICROENVIRONMENT_UP,15,Up,0.209338180981217,0.999485802679459
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,23,Down,0.209371292602809,0.999485802679459
REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT,5,Down,0.209417416236307,0.999485802679459
DORMOY_ELAVL1_TARGETS,15,Down,0.209418370349481,0.999485802679459
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES,11,Down,0.209661262595369,0.999485802679459
KIM_PTEN_TARGETS_UP,16,Up,0.209725654475505,0.999485802679459
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,47,Down,0.209765516126642,0.999485802679459
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION,33,Down,0.209981300999403,0.999485802679459
BIOCARTA_TNFR1_PATHWAY,28,Up,0.210091757567218,0.999485802679459
ST_WNT_BETA_CATENIN_PATHWAY,26,Up,0.210646059211715,0.999485802679459
PID_BETA_CATENIN_DEG_PATHWAY,16,Up,0.211237405703704,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_CD2_DN,34,Down,0.212057535383531,0.999485802679459
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,39,Up,0.212081519253996,0.999485802679459
YAMAZAKI_TCEB3_TARGETS_DN,177,Down,0.212304144639246,0.999485802679459
REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE,15,Down,0.212502741244759,0.999485802679459
SANA_TNF_SIGNALING_UP,62,Up,0.213508291469255,0.999485802679459
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,232,Up,0.213567652942523,0.999485802679459
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,30,Down,0.214332921509457,0.999485802679459
BIOCARTA_ERK_PATHWAY,24,Up,0.214592169094455,0.999485802679459
POS_RESPONSE_TO_HISTAMINE_UP,10,Down,0.214961103860532,0.999485802679459
VANTVEER_BREAST_CANCER_METASTASIS_DN,102,Down,0.215176208597648,0.999485802679459
CAFFAREL_RESPONSE_TO_THC_24HR_3_DN,10,Down,0.215269735958527,0.999485802679459
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN,5,Down,0.215715266245408,0.999485802679459
LEE_NAIVE_T_LYMPHOCYTE,13,Down,0.216228972562963,0.999485802679459
PID_RHODOPSIN_PATHWAY,7,Down,0.216266436030755,0.999485802679459
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,39,Up,0.216374377909792,0.999485802679459
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,77,Down,0.216482455695161,0.999485802679459
REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL,74,Down,0.216657800846221,0.999485802679459
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,39,Down,0.216721998457599,0.999485802679459
KRASNOSELSKAYA_ILF3_TARGETS_UP,29,Up,0.217084657019575,0.999485802679459
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,42,Up,0.217978588329495,0.999485802679459
LIM_MAMMARY_LUMINAL_PROGENITOR_UP,33,Down,0.218062393707136,0.999485802679459
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,149,Up,0.218244535324227,0.999485802679459
LU_TUMOR_VASCULATURE_UP,23,Up,0.218493707308793,0.999485802679459
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,178,Up,0.218806714459376,0.999485802679459
REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX,60,Down,0.218849530392024,0.999485802679459
CAMPS_COLON_CANCER_COPY_NUMBER_DN,21,Up,0.218940855838664,0.999485802679459
PID_CMYB_PATHWAY,65,Up,0.218962642550356,0.999485802679459
URS_ADIPOCYTE_DIFFERENTIATION_UP,44,Down,0.219199330236406,0.999485802679459
REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G,44,Down,0.219320362245384,0.999485802679459
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,137,Up,0.219360384588209,0.999485802679459
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,19,Up,0.219552292350549,0.999485802679459
RASHI_RESPONSE_TO_IONIZING_RADIATION_1,34,Down,0.219590139314825,0.999485802679459
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,83,Down,0.22011069333642,0.999485802679459
KEGG_MTOR_SIGNALING_PATHWAY,45,Down,0.220200017489355,0.999485802679459
MULLIGHAN_MLL_SIGNATURE_1_DN,155,Up,0.220397327556447,0.999485802679459
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN,401,Down,0.220605434002157,0.999485802679459
FRASOR_TAMOXIFEN_RESPONSE_UP,44,Up,0.221158735396538,0.999485802679459
ZHENG_FOXP3_TARGETS_IN_THYMUS_DN,6,Up,0.221612358706192,0.999485802679459
BOSCO_TH1_CYTOTOXIC_MODULE,55,Up,0.222017462786569,0.999485802679459
LEE_LIVER_CANCER_MYC_DN,30,Up,0.222677619590849,0.999485802679459
LINDSTEDT_DENDRITIC_CELL_MATURATION_B,45,Down,0.223062285831804,0.999485802679459
LEE_DOUBLE_POLAR_THYMOCYTE,18,Up,0.223367781058256,0.999485802679459
WAGNER_APO2_SENSITIVITY,13,Down,0.223403425289843,0.999485802679459
DELACROIX_RAR_TARGETS_UP,34,Up,0.223487027737415,0.999485802679459
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,60,Down,0.224001922230544,0.999485802679459
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,320,Up,0.224638430937784,0.999485802679459
KOBAYASHI_EGFR_SIGNALING_24HR_UP,78,Down,0.224747043249834,0.999485802679459
REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING,21,Down,0.224818720465571,0.999485802679459
INGA_TP53_TARGETS,15,Up,0.224851186172888,0.999485802679459
LANDEMAINE_LUNG_METASTASIS,12,Up,0.225170113063651,0.999485802679459
KEGG_CITRATE_CYCLE_TCA_CYCLE,28,Up,0.225173937611841,0.999485802679459
MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS,12,Down,0.225245313700841,0.999485802679459
KEGG_BASAL_CELL_CARCINOMA,41,Up,0.225254169603568,0.999485802679459
RIZ_ERYTHROID_DIFFERENTIATION_6HR,25,Up,0.225834876889496,0.999485802679459
FARMER_BREAST_CANCER_CLUSTER_5,17,Up,0.225891206375192,0.999485802679459
BIOCARTA_NOS1_PATHWAY,15,Down,0.226048498927393,0.999485802679459
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,73,Up,0.226178943596274,0.999485802679459
HARRIS_BRAIN_CANCER_PROGENITORS,21,Up,0.226563418691022,0.999485802679459
AMIT_EGF_RESPONSE_20_MCF10A,10,Down,0.226604691664414,0.999485802679459
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN,408,Up,0.227000374242579,0.999485802679459
BROWNE_HCMV_INFECTION_16HR_DN,69,Down,0.227705446601906,0.999485802679459
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,45,Up,0.228015198267883,0.999485802679459
HSIAO_LIVER_SPECIFIC_GENES,110,Up,0.228602030955425,0.999485802679459
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP,7,Up,0.229177862622346,0.999485802679459
MORI_PRE_BI_LYMPHOCYTE_DN,59,Up,0.229437927771709,0.999485802679459
KIM_GLIS2_TARGETS_UP,50,Up,0.229475322969237,0.999485802679459
BIOCARTA_PLCE_PATHWAY,10,Down,0.229546776826354,0.999485802679459
KEGG_TIGHT_JUNCTION,89,Down,0.229592045085443,0.999485802679459
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,57,Down,0.230008646488239,0.999485802679459
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT,61,Down,0.230034145215159,0.999485802679459
YANAGISAWA_LUNG_CANCER_RECURRENCE,8,Down,0.230098684333948,0.999485802679459
ROSS_AML_WITH_MLL_FUSIONS,53,Up,0.230723478089425,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_LB_UP,31,Up,0.230825445493778,0.999485802679459
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,22,Up,0.230845552137867,0.999485802679459
CUI_GLUCOSE_DEPRIVATION,44,Down,0.230855015620363,0.999485802679459
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,46,Down,0.231037906271147,0.999485802679459
REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS,5,Down,0.231219068655774,0.999485802679459
REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS,26,Down,0.231284655154099,0.999485802679459
REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS,26,Down,0.231284655154099,0.999485802679459
BIOCARTA_CDC42RAC_PATHWAY,16,Down,0.231467576517176,0.999485802679459
TING_SILENCED_BY_DICER,20,Up,0.231883445151085,0.999485802679459
BOYLAN_MULTIPLE_MYELOMA_C_DN,45,Up,0.232463320553854,0.999485802679459
BIOCARTA_LECTIN_PATHWAY,2,Up,0.233012607358798,0.999485802679459
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP,10,Down,0.233328902015656,0.999485802679459
DELYS_THYROID_CANCER_DN,144,Up,0.233574257939274,0.999485802679459
KEGG_PEROXISOME,66,Down,0.233902449566198,0.999485802679459
KIM_HYPOXIA,21,Down,0.233912605575316,0.999485802679459
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,28,Up,0.23403832507597,0.999485802679459
BIOCARTA_CBL_PATHWAY,11,Up,0.234348884343311,0.999485802679459
CHANG_CORE_SERUM_RESPONSE_DN,171,Up,0.234589658927032,0.999485802679459
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP,33,Down,0.234616934557903,0.999485802679459
SERVITJA_ISLET_HNF1A_TARGETS_UP,115,Up,0.234634985619835,0.999485802679459
VALK_AML_CLUSTER_1,20,Up,0.234812392411349,0.999485802679459
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN,8,Down,0.234900292525772,0.999485802679459
REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT,2,Up,0.235336500952767,0.999485802679459
BENPORATH_OCT4_TARGETS,221,Up,0.235436673923718,0.999485802679459
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP,34,Up,0.235795943400094,0.999485802679459
REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE,16,Down,0.235966258220132,0.999485802679459
PID_AR_TF_PATHWAY,42,Up,0.236125347094725,0.999485802679459
REACTOME_INSULIN_RECEPTOR_RECYCLING,20,Up,0.23652971808004,0.999485802679459
PHESSE_TARGETS_OF_APC_AND_MBD2_DN,9,Down,0.236765121877815,0.999485802679459
WEINMANN_ADAPTATION_TO_HYPOXIA_DN,38,Down,0.237332280831232,0.999485802679459
BIDUS_METASTASIS_DN,113,Up,0.237745283556239,0.999485802679459
PID_IL6_7_PATHWAY,41,Up,0.238170103804241,0.999485802679459
REACTOME_SIGNAL_AMPLIFICATION,23,Down,0.238322797648139,0.999485802679459
GRATIAS_RETINOBLASTOMA_16Q24,14,Up,0.238396245739436,0.999485802679459
ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL,14,Up,0.238687723444236,0.999485802679459
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,175,Up,0.23870466458526,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,22,Up,0.23906301230112,0.999485802679459
HOLLMANN_APOPTOSIS_VIA_CD40_DN,213,Up,0.239442061603329,0.999485802679459
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,12,Down,0.239711647427629,0.999485802679459
REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION,10,Down,0.239790646638767,0.999485802679459
FRASOR_RESPONSE_TO_ESTRADIOL_DN,69,Up,0.239858853248195,0.999485802679459
PID_TRKR_PATHWAY,51,Down,0.239989753353635,0.999485802679459
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,64,Up,0.240448628052448,0.999485802679459
CHIBA_RESPONSE_TO_TSA,39,Down,0.240551180442001,0.999485802679459
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,30,Down,0.240633106496556,0.999485802679459
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,17,Down,0.241166341933407,0.999485802679459
WANG_ESOPHAGUS_CANCER_PROGRESSION_UP,5,Down,0.241681647586479,0.999485802679459
WANG_RESPONSE_TO_BEXAROTENE_DN,24,Down,0.242409087561462,0.999485802679459
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,122,Down,0.24240930766368,0.999485802679459
LI_ADIPOGENESIS_BY_ACTIVATED_PPARG,9,Down,0.242451883616277,0.999485802679459
PID_HIV_NEF_PATHWAY,31,Up,0.242563979244506,0.999485802679459
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,58,Down,0.242709241251181,0.999485802679459
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,45,Down,0.242986555004207,0.999485802679459
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,256,Down,0.243178646591141,0.999485802679459
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES,4,Up,0.243456929114149,0.999485802679459
MELLMAN_TUT1_TARGETS_DN,40,Down,0.243486278900206,0.999485802679459
PID_INSULIN_GLUCOSE_PATHWAY,21,Down,0.243536390387041,0.999485802679459
ISSAEVA_MLL2_TARGETS,45,Up,0.244164567191605,0.999485802679459
KEGG_CARDIAC_MUSCLE_CONTRACTION,50,Down,0.244192361854737,0.999485802679459
MAYBURD_RESPONSE_TO_L663536_UP,23,Down,0.24426396915819,0.999485802679459
REACTOME_L1CAM_INTERACTIONS,68,Down,0.244818463234876,0.999485802679459
REACTOME_MRNA_3_END_PROCESSING,33,Down,0.244901146050008,0.999485802679459
KANG_GIST_WITH_PDGFRA_UP,32,Up,0.246016458105213,0.999485802679459
ENGELMANN_CANCER_PROGENITORS_UP,44,Up,0.246436090035079,0.999485802679459
MASSARWEH_RESPONSE_TO_ESTRADIOL,52,Down,0.246844931444732,0.999485802679459
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,22,Up,0.247245497509668,0.999485802679459
PID_FOXM1_PATHWAY,37,Up,0.247457274272033,0.999485802679459
SANSOM_APC_TARGETS_DN,227,Up,0.247465509315863,0.999485802679459
LIU_COMMON_CANCER_GENES,56,Down,0.247590233752962,0.999485802679459
REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK,9,Down,0.248323999549923,0.999485802679459
BROWNE_HCMV_INFECTION_12HR_DN,80,Down,0.248527974972338,0.999485802679459
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,14,Up,0.248622589057591,0.999485802679459
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,15,Down,0.24964285764367,0.999485802679459
REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS,10,Up,0.250069082642941,0.999485802679459
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,26,Down,0.250098551514135,0.999485802679459
REACTOME_PHOSPHOLIPID_METABOLISM,144,Down,0.250264653728583,0.999485802679459
YAGI_AML_WITH_T_8_21_TRANSLOCATION,273,Up,0.250343459689597,0.999485802679459
FARMER_BREAST_CANCER_CLUSTER_2,31,Down,0.250438426489907,0.999485802679459
REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION,11,Down,0.250771789302882,0.999485802679459
REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION,10,Down,0.251003552804453,0.999485802679459
WHITFIELD_CELL_CYCLE_G1_S,119,Down,0.251007272202566,0.999485802679459
REACTOME_REGULATION_OF_COMPLEMENT_CASCADE,8,Up,0.25151554129545,0.999485802679459
FOSTER_TOLERANT_MACROPHAGE_UP,103,Up,0.251537567066317,0.999485802679459
REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,8,Down,0.251821464718546,0.999485802679459
PID_IL4_2PATHWAY,40,Up,0.25187298187825,0.999485802679459
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,32,Up,0.251896221994118,0.999485802679459
ZHAN_LATE_DIFFERENTIATION_GENES_UP,28,Down,0.251933577628726,0.999485802679459
LEE_AGING_CEREBELLUM_DN,56,Down,0.252021994489326,0.999485802679459
LI_PROSTATE_CANCER_EPIGENETIC,19,Down,0.252054615435186,0.999485802679459
CHO_NR4A1_TARGETS,22,Up,0.252109806112697,0.999485802679459
VERNELL_RETINOBLASTOMA_PATHWAY_UP,66,Down,0.252449694845434,0.999485802679459
ST_JAK_STAT_PATHWAY,8,Down,0.252831155646369,0.999485802679459
WHITFIELD_CELL_CYCLE_LITERATURE,43,Down,0.253085370479499,0.999485802679459
PID_A6B1_A6B4_INTEGRIN_PATHWAY,41,Down,0.253208637705135,0.999485802679459
BIOCARTA_NTHI_PATHWAY,22,Up,0.253365334979002,0.999485802679459
CAFFAREL_RESPONSE_TO_THC_8HR_5_DN,9,Down,0.253856340875328,0.999485802679459
MORI_IMMATURE_B_LYMPHOCYTE_DN,85,Down,0.254414302939186,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_PR_DN,36,Up,0.254722619274727,0.999485802679459
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,42,Up,0.254758703845241,0.999485802679459
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,62,Down,0.255202150214684,0.999485802679459
KONDO_HYPOXIA,4,Down,0.255488125848036,0.999485802679459
LUI_THYROID_CANCER_CLUSTER_5,6,Up,0.255544251097156,0.999485802679459
KONDO_PROSTATE_CANCER_WITH_H3K27ME3,39,Up,0.255610131795378,0.999485802679459
REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,28,Down,0.255740129772793,0.999485802679459
PIEPOLI_LGI1_TARGETS_UP,10,Up,0.256318878622968,0.999485802679459
PID_VEGF_VEGFR_PATHWAY,8,Down,0.256367816288671,0.999485802679459
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,38,Down,0.256467946198926,0.999485802679459
SIMBULAN_UV_RESPONSE_NORMAL_DN,29,Up,0.256502183027197,0.999485802679459
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA,13,Down,0.256951726122929,0.999485802679459
HUNSBERGER_EXERCISE_REGULATED_GENES,18,Down,0.256983516887231,0.999485802679459
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP,22,Up,0.257183206072547,0.999485802679459
ONGUSAHA_BRCA1_TARGETS_UP,12,Down,0.257665091313312,0.999485802679459
NIELSEN_GIST,76,Up,0.257699235552431,0.999485802679459
PID_ERA_GENOMIC_PATHWAY,49,Up,0.257943745993487,0.999485802679459
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN,3,Up,0.257969792749387,0.999485802679459
SHIN_B_CELL_LYMPHOMA_CLUSTER_9,6,Down,0.258392464039747,0.999485802679459
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,7,Down,0.258818635676731,0.999485802679459
PID_NEPHRIN_NEPH1_PATHWAY,27,Down,0.258820368252034,0.999485802679459
TENEDINI_MEGAKARYOCYTE_MARKERS,51,Up,0.259553642415795,0.999485802679459
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,38,Up,0.25958924753846,0.999485802679459
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP,20,Down,0.259906638233362,0.999485802679459
REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS,24,Down,0.260158447959968,0.999485802679459
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP,12,Down,0.260233567327528,0.999485802679459
KEGG_HUNTINGTONS_DISEASE,137,Down,0.26041987208748,0.999485802679459
CHIBA_RESPONSE_TO_TSA_UP,41,Up,0.260568254786769,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,171,Up,0.260785706884548,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_SPIKED,7,Up,0.261229229650988,0.999485802679459
KEGG_MAPK_SIGNALING_PATHWAY,194,Up,0.261379981187561,0.999485802679459
REACTOME_MICRORNA_MIRNA_BIOGENESIS,21,Down,0.2614475216081,0.999485802679459
MULLIGHAN_MLL_SIGNATURE_2_DN,194,Up,0.261541634655275,0.999485802679459
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,30,Down,0.261596848193537,0.999485802679459
HALMOS_CEBPA_TARGETS_DN,33,Down,0.261760118360717,0.999485802679459
TERAO_AOX4_TARGETS_HG_UP,24,Down,0.261832516514352,0.999485802679459
SUZUKI_RESPONSE_TO_TSA,14,Up,0.261956516892168,0.999485802679459
MUELLER_METHYLATED_IN_GLIOBLASTOMA,21,Up,0.262015077950014,0.999485802679459
REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS,7,Up,0.26205232751051,0.999485802679459
REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY,11,Down,0.26224269185616,0.999485802679459
SENESE_HDAC2_TARGETS_DN,98,Up,0.262787547568237,0.999485802679459
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,60,Down,0.262851873735136,0.999485802679459
REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING,20,Down,0.262967028141236,0.999485802679459
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,47,Up,0.262984245662575,0.999485802679459
KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS,8,Down,0.263128857945724,0.999485802679459
PENG_RAPAMYCIN_RESPONSE_UP,144,Up,0.263153083567721,0.999485802679459
WEBER_METHYLATED_ICP_IN_SPERM_DN,3,Down,0.263305527774299,0.999485802679459
BROWNE_HCMV_INFECTION_16HR_UP,184,Up,0.263337225094048,0.999485802679459
RUIZ_TNC_TARGETS_UP,131,Up,0.263445944150211,0.999485802679459
KEGG_COLORECTAL_CANCER,59,Up,0.263481777084373,0.999485802679459
PID_AMB2_NEUTROPHILS_PATHWAY,28,Down,0.263583415858208,0.999485802679459
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,12,Up,0.263665934259467,0.999485802679459
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,16,Up,0.263770822660299,0.999485802679459
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,41,Up,0.263970176555329,0.999485802679459
REACTOME_G1_S_TRANSITION,102,Down,0.263989241609112,0.999485802679459
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN,88,Down,0.264535972062528,0.999485802679459
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,15,Down,0.264827643638122,0.999485802679459
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,39,Up,0.264895030920226,0.999485802679459
NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON,7,Down,0.264900852943618,0.999485802679459
BIOCARTA_CFTR_PATHWAY,10,Down,0.264957076719768,0.999485802679459
KEGG_APOPTOSIS,70,Up,0.265131789012092,0.999485802679459
BIOCARTA_CTCF_PATHWAY,20,Up,0.265277759199365,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,87,Down,0.265856354029296,0.999485802679459
REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1,17,Down,0.266195971467428,0.999485802679459
HUMMERICH_SKIN_CANCER_PROGRESSION_UP,70,Up,0.266585320315037,0.999485802679459
REACTOME_ACYL_CHAIN_REMODELLING_OF_PC,10,Up,0.266785486290304,0.999485802679459
PID_NECTIN_PATHWAY,25,Down,0.266872452343277,0.999485802679459
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,221,Up,0.266992095918167,0.999485802679459
SA_G1_AND_S_PHASES,13,Up,0.267343400946436,0.999485802679459
REACTOME_ADP_SIGNALLING_THROUGH_P2RY1,18,Down,0.26737224323244,0.999485802679459
BILBAN_B_CLL_LPL_DN,34,Up,0.267480184027929,0.999485802679459
MARKS_HDAC_TARGETS_UP,21,Up,0.267610671257504,0.999485802679459
LINDSTEDT_DENDRITIC_CELL_MATURATION_C,51,Up,0.267624896011248,0.999485802679459
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,111,Down,0.267707592216894,0.999485802679459
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,122,Up,0.267787755728926,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,51,Up,0.26785583429104,0.999485802679459
BILANGES_RAPAMYCIN_SENSITIVE_GENES,31,Down,0.26820414006338,0.999485802679459
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE,9,Down,0.268229612667046,0.999485802679459
GAVIN_FOXP3_TARGETS_CLUSTER_T4,71,Up,0.268263058323581,0.999485802679459
MA_MYELOID_DIFFERENTIATION_DN,30,Up,0.268273383056073,0.999485802679459
REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS,20,Down,0.268509107330732,0.999485802679459
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,34,Down,0.268520000788612,0.999485802679459
MATTHEWS_AP1_TARGETS,14,Up,0.26853283172693,0.999485802679459
REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,139,Down,0.268594660948062,0.999485802679459
FARMER_BREAST_CANCER_CLUSTER_3,14,Up,0.2687300068393,0.999485802679459
MCCABE_HOXC6_TARGETS_UP,6,Up,0.269537500381245,0.999485802679459
CHOI_ATL_ACUTE_STAGE,5,Up,0.270400218151302,0.999485802679459
KEGG_REGULATION_OF_AUTOPHAGY,19,Down,0.270444444660436,0.999485802679459
PETRETTO_HEART_MASS_QTL_CIS_DN,19,Up,0.270551285581859,0.999485802679459
VILIMAS_NOTCH1_TARGETS_UP,27,Up,0.270667910542662,0.999485802679459
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,85,Up,0.270678881300672,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP,4,Down,0.271094783934751,0.999485802679459
PID_RB_1PATHWAY,53,Up,0.271282836890755,0.999485802679459
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,28,Down,0.271788711697519,0.999485802679459
BIOCARTA_CASPASE_PATHWAY,21,Up,0.272176412060757,0.999485802679459
KEGG_ABC_TRANSPORTERS,25,Up,0.272492680797758,0.999485802679459
REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS,22,Up,0.272702326060253,0.999485802679459
LI_CYTIDINE_ANALOG_PATHWAY,13,Down,0.272978842782289,0.999485802679459
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,46,Up,0.273224868486685,0.999485802679459
ALONSO_METASTASIS_DN,11,Up,0.273584690467927,0.999485802679459
FINETTI_BREAST_CANCERS_KINOME_BLUE,16,Down,0.274115802091674,0.999485802679459
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN,5,Down,0.274229352826159,0.999485802679459
REACTOME_ADP_SIGNALLING_THROUGH_P2RY12,14,Down,0.27441853312061,0.999485802679459
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,170,Down,0.274562110893157,0.999485802679459
NELSON_RESPONSE_TO_ANDROGEN_DN,17,Up,0.274835251621496,0.999485802679459
BIOCARTA_HCMV_PATHWAY,17,Up,0.275067070324454,0.999485802679459
KEGG_NITROGEN_METABOLISM,10,Down,0.275248488044913,0.999485802679459
KEGG_NOTCH_SIGNALING_PATHWAY,38,Up,0.275375873151739,0.999485802679459
ABE_VEGFA_TARGETS_2HR,21,Up,0.275468082953166,0.999485802679459
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,221,Down,0.275609085645221,0.999485802679459
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,11,Down,0.275665023360501,0.999485802679459
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED,8,Down,0.275804585288181,0.999485802679459
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,207,Down,0.277201185627939,0.999485802679459
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,33,Up,0.277709147059279,0.999485802679459
BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS,6,Up,0.278228215713173,0.999485802679459
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,11,Down,0.278957432316103,0.999485802679459
WILLIAMS_ESR1_TARGETS_DN,6,Down,0.279389919491595,0.999485802679459
WELCSH_BRCA1_TARGETS_UP,176,Down,0.280518819499702,0.999485802679459
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,24,Down,0.280534056603265,0.999485802679459
WHITFIELD_CELL_CYCLE_G2_M,173,Down,0.281043682259671,0.999485802679459
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,31,Up,0.281156319788468,0.999485802679459
REACTOME_LAGGING_STRAND_SYNTHESIS,19,Down,0.281532484485383,0.999485802679459
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN,13,Down,0.281809880320465,0.999485802679459
MANN_RESPONSE_TO_AMIFOSTINE_DN,10,Up,0.281814257366338,0.999485802679459
MCCLUNG_DELTA_FOSB_TARGETS_8WK,38,Up,0.281981589442336,0.999485802679459
BIOCARTA_41BB_PATHWAY,14,Up,0.282127516288496,0.999485802679459
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,82,Down,0.28219723077915,0.999485802679459
MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH,13,Up,0.282781728031956,0.999485802679459
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,61,Down,0.283273404958501,0.999485802679459
PID_S1P_S1P1_PATHWAY,17,Down,0.283398662958829,0.999485802679459
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE,38,Up,0.283516506036514,0.999485802679459
SHI_SPARC_TARGETS_UP,20,Up,0.283571006128753,0.999485802679459
DURAND_STROMA_S_UP,209,Up,0.283642357272234,0.999485802679459
PID_THROMBIN_PAR4_PATHWAY,11,Up,0.284121349955119,0.999485802679459
STEGER_ADIPOGENESIS_UP,9,Up,0.284304313868157,0.999485802679459
MARTENS_TRETINOIN_RESPONSE_UP,269,Down,0.284746982318816,0.999485802679459
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,55,Down,0.284816034053631,0.999485802679459
RIZKI_TUMOR_INVASIVENESS_3D_DN,198,Up,0.285458934242836,0.999485802679459
BIOCARTA_TH1TH2_PATHWAY,8,Up,0.285856402957332,0.999485802679459
GROSS_HIF1A_TARGETS_UP,5,Up,0.286016770000437,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,16,Up,0.286148137589774,0.999485802679459
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,38,Up,0.286350090261184,0.999485802679459
REACTOME_CD28_CO_STIMULATION,25,Down,0.286489126819581,0.999485802679459
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS,5,Down,0.286919722534846,0.999485802679459
REACTOME_S_PHASE,103,Down,0.286984035502819,0.999485802679459
LIU_CDX2_TARGETS_DN,4,Down,0.28705198746899,0.999485802679459
PID_RANBP2_PATHWAY,11,Down,0.287295116960861,0.999485802679459
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,79,Up,0.287648709630869,0.999485802679459
MARTIN_INTERACT_WITH_HDAC,38,Up,0.287862195483119,0.999485802679459
MIKKELSEN_NPC_ICP_WITH_H3K27ME3,4,Down,0.287875551364417,0.999485802679459
JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN,68,Down,0.287896935871991,0.999485802679459
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,46,Down,0.288273767650624,0.999485802679459
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,13,Down,0.288401419667894,0.999485802679459
ISHIDA_E2F_TARGETS,50,Down,0.288531525731904,0.999485802679459
ZHANG_BREAST_CANCER_PROGENITORS_UP,375,Down,0.288657802892065,0.999485802679459
REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT,32,Down,0.288756231237736,0.999485802679459
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,44,Up,0.288911221296839,0.999485802679459
SESTO_RESPONSE_TO_UV_C6,35,Down,0.28946603791577,0.999485802679459
REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING,13,Down,0.289505462000626,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,40,Down,0.289565661133284,0.999485802679459
DE_YY1_TARGETS_DN,85,Up,0.289607980510106,0.999485802679459
VALK_AML_CLUSTER_9,19,Down,0.289832856139139,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,120,Down,0.289928999415303,0.999485802679459
LIM_MAMMARY_LUMINAL_MATURE_DN,78,Up,0.29063202122726,0.999485802679459
PID_AVB3_OPN_PATHWAY,28,Up,0.291182095032686,0.999485802679459
MEISSNER_NPC_HCP_WITH_H3K4ME2,300,Up,0.291317669635906,0.999485802679459
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,43,Up,0.291325438669218,0.999485802679459
PETRETTO_BLOOD_PRESSURE_UP,9,Up,0.29144644794627,0.999485802679459
LEIN_PONS_MARKERS,55,Down,0.292006766285782,0.999485802679459
SMID_BREAST_CANCER_NORMAL_LIKE_DN,5,Down,0.292435304147534,0.999485802679459
REACTOME_SIGNALLING_TO_ERKS,31,Down,0.292553510473527,0.999485802679459
BIOCARTA_HIVNEF_PATHWAY,54,Up,0.292832109298823,0.999485802679459
HEIDENBLAD_AMPLICON_8Q24_DN,39,Down,0.292929726752696,0.999485802679459
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,85,Down,0.294485219533674,0.999485802679459
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,13,Down,0.294593116313235,0.999485802679459
TSAI_DNAJB4_TARGETS_DN,6,Down,0.29475899630135,0.999485802679459
AKL_HTLV1_INFECTION_UP,22,Down,0.295506937943602,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS,28,Down,0.295548913057481,0.999485802679459
HUMMEL_BURKITTS_LYMPHOMA_DN,12,Up,0.295796062256904,0.999485802679459
BEIER_GLIOMA_STEM_CELL_DN,49,Up,0.295966630687929,0.999485802679459
PASTURAL_RIZ1_TARGETS_UP,4,Up,0.29611209641758,0.999485802679459
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,42,Up,0.296113811502318,0.999485802679459
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,23,Down,0.296437478139418,0.999485802679459
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,95,Up,0.296493866509797,0.999485802679459
KEGG_BLADDER_CANCER,37,Up,0.296546590403022,0.999485802679459
MOHANKUMAR_TLX1_TARGETS_DN,108,Down,0.29669943247914,0.999485802679459
BIOCARTA_IL12_PATHWAY,12,Up,0.297155768684089,0.999485802679459
BIOCARTA_FIBRINOLYSIS_PATHWAY,4,Down,0.297488623038383,0.999485802679459
REACTOME_CELL_CYCLE_CHECKPOINTS,105,Down,0.297527834541657,0.999485802679459
BIOCARTA_RANKL_PATHWAY,13,Up,0.297531091073646,0.999485802679459
GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION,10,Up,0.297598460969068,0.999485802679459
LIU_BREAST_CANCER,18,Down,0.297621153799134,0.999485802679459
BIOCARTA_GSK3_PATHWAY,24,Up,0.297738364504668,0.999485802679459
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,29,Down,0.297848397418105,0.999485802679459
SCHEIDEREIT_IKK_TARGETS,16,Up,0.297972222604144,0.999485802679459
YIH_RESPONSE_TO_ARSENITE_C1,23,Up,0.29810982392712,0.999485802679459
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX,12,Down,0.2983324802351,0.999485802679459
MEISSNER_ES_ICP_WITH_H3K4ME3,19,Up,0.298348744081034,0.999485802679459
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,55,Up,0.298359831643148,0.999485802679459
REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN,17,Down,0.298393499787693,0.999485802679459
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,17,Up,0.298497317190924,0.999485802679459
KORKOLA_CHORIOCARCINOMA_DN,5,Up,0.298811938995479,0.999485802679459
HSIAO_HOUSEKEEPING_GENES,343,Down,0.298818020915615,0.999485802679459
PID_HDAC_CLASSIII_PATHWAY,24,Up,0.298954461062997,0.999485802679459
OLSSON_E2F3_TARGETS_DN,41,Down,0.299184842427044,0.999485802679459
LIU_IL13_MEMORY_MODEL_DN,5,Up,0.299436256300619,0.999485802679459
REACTOME_PROTEIN_FOLDING,46,Down,0.299481869722461,0.999485802679459
DITTMER_PTHLH_TARGETS_UP,102,Down,0.300241577414488,0.999485802679459
LEE_LIVER_CANCER_CIPROFIBRATE_DN,27,Up,0.300453078214603,0.999485802679459
LEE_LIVER_CANCER,16,Down,0.300487496260954,0.999485802679459
NEBEN_AML_WITH_FLT3_OR_NRAS_DN,11,Down,0.300551671822858,0.999485802679459
CHANG_CYCLING_GENES,129,Down,0.301032595597097,0.999485802679459
KEGG_PURINE_METABOLISM,128,Down,0.301150847261271,0.999485802679459
REACTOME_COMPLEMENT_CASCADE,11,Up,0.301625795746694,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,38,Up,0.301752644813731,0.999485802679459
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,32,Up,0.301877632982277,0.999485802679459
BIOCARTA_AKAPCENTROSOME_PATHWAY,14,Down,0.30216644274614,0.999485802679459
REACTOME_INTERFERON_GAMMA_SIGNALING,38,Up,0.302354504566338,0.999485802679459
MARTINEZ_RESPONSE_TO_TRABECTEDIN,39,Down,0.303118921375979,0.999485802679459
VERRECCHIA_RESPONSE_TO_TGFB1_C1,18,Down,0.303343898515355,0.999485802679459
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,249,Up,0.303533645904044,0.999485802679459
KEGG_RENAL_CELL_CARCINOMA,60,Down,0.303585415146986,0.999485802679459
ZHANG_TLX_TARGETS_UP,90,Up,0.303602143056793,0.999485802679459
DITTMER_PTHLH_TARGETS_DN,64,Down,0.303663107241797,0.999485802679459
REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING,36,Down,0.303989550049172,0.999485802679459
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,11,Down,0.304511421016821,0.999485802679459
RUTELLA_RESPONSE_TO_HGF_DN,169,Up,0.304556838788032,0.999485802679459
ZAMORA_NOS2_TARGETS_UP,61,Down,0.304835732748646,0.999485802679459
KONG_E2F3_TARGETS,85,Down,0.304979841560463,0.999485802679459
GOUYER_TATI_TARGETS_DN,11,Up,0.305182540517564,0.999485802679459
LEE_LIVER_CANCER_CIPROFIBRATE_UP,40,Up,0.305271295321545,0.999485802679459
MORI_PLASMA_CELL_DN,24,Up,0.305411551591896,0.999485802679459
MANTOVANI_VIRAL_GPCR_SIGNALING_DN,33,Up,0.305983844378938,0.999485802679459
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,14,Up,0.306362383620815,0.999485802679459
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,35,Up,0.306430277438887,0.999485802679459
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,24,Down,0.307147221472215,0.999485802679459
PID_VEGFR1_2_PATHWAY,63,Down,0.307622282508642,0.999485802679459
PID_INTEGRIN5_PATHWAY,13,Down,0.307723321200556,0.999485802679459
BYSTROEM_CORRELATED_WITH_IL5_UP,37,Down,0.307777031732215,0.999485802679459
MOOTHA_VOXPHOS,64,Down,0.307802007165152,0.999485802679459
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN,41,Down,0.308079268953377,0.999485802679459
SU_KIDNEY,4,Down,0.30825912593324,0.999485802679459
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,177,Up,0.308381503731237,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,37,Up,0.308575164349647,0.999485802679459
REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS,6,Up,0.308681170719769,0.999485802679459
REACTOME_PEROXISOMAL_LIPID_METABOLISM,19,Down,0.308692540208251,0.999485802679459
BIOCARTA_STEM_PATHWAY,7,Up,0.308731038553417,0.999485802679459
REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS,6,Down,0.308766259317377,0.999485802679459
REACTOME_G_PROTEIN_ACTIVATION,16,Down,0.309161653572866,0.999485802679459
GYORFFY_DOXORUBICIN_RESISTANCE,32,Up,0.309643996107074,0.999485802679459
BHATTACHARYA_EMBRYONIC_STEM_CELL,73,Down,0.310295687490871,0.999485802679459
REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING,12,Down,0.310578081224977,0.999485802679459
LABBE_TGFB1_TARGETS_UP,74,Down,0.310867093476444,0.999485802679459
ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS,35,Down,0.310908612558321,0.999485802679459
LY_AGING_OLD_DN,52,Down,0.311322375285569,0.999485802679459
VALK_AML_CLUSTER_5,19,Down,0.311464791819443,0.999485802679459
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,26,Down,0.311571223868866,0.999485802679459
TSAI_DNAJB4_TARGETS_UP,13,Up,0.311804827462613,0.999485802679459
BURTON_ADIPOGENESIS_2,68,Down,0.31196478257497,0.999485802679459
KEGG_N_GLYCAN_BIOSYNTHESIS,44,Down,0.312109433043584,0.999485802679459
DANG_MYC_TARGETS_DN,27,Up,0.312219693703486,0.999485802679459
REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING,18,Down,0.312582250928035,0.999485802679459
TSAI_RESPONSE_TO_RADIATION_THERAPY,28,Up,0.312829303042945,0.999485802679459
PID_CD40_PATHWAY,27,Up,0.312894473862146,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8,10,Up,0.313005707828054,0.999485802679459
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1,7,Up,0.313159914814576,0.999485802679459
REACTOME_REGULATION_OF_INSULIN_SECRETION,58,Down,0.313302096240216,0.999485802679459
BIOCARTA_SARS_PATHWAY,9,Down,0.313825962910806,0.999485802679459
BIOCARTA_CLASSIC_PATHWAY,4,Up,0.314051893787206,0.999485802679459
BIOCARTA_COMP_PATHWAY,4,Up,0.314051893787206,0.999485802679459
REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR,16,Down,0.315019732837476,0.999485802679459
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,53,Up,0.315983234286184,0.999485802679459
MEISSNER_BRAIN_ICP_WITH_H3K4ME3,20,Up,0.316419560953164,0.999485802679459
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC,15,Down,0.317198601143283,0.999485802679459
WINTER_HYPOXIA_DN,29,Up,0.317604586044328,0.999485802679459
REACTOME_GABA_B_RECEPTOR_ACTIVATION,23,Down,0.317658905833141,0.999485802679459
REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,33,Down,0.317744236605347,0.999485802679459
SWEET_KRAS_ONCOGENIC_SIGNATURE,70,Down,0.317918686910912,0.999485802679459
PID_CASPASE_PATHWAY,47,Up,0.317926382443011,0.999485802679459
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,14,Up,0.318006916601076,0.999485802679459
REACTOME_RNA_POL_II_TRANSCRIPTION,93,Down,0.318274972769943,0.999485802679459
REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,10,Down,0.318275733848972,0.999485802679459
LASTOWSKA_COAMPLIFIED_WITH_MYCN,30,Up,0.318813163333968,0.999485802679459
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,25,Up,0.319712188886313,0.999485802679459
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,15,Down,0.319807452301521,0.999485802679459
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP,20,Up,0.320425806765594,0.999485802679459
KEGG_RETINOL_METABOLISM,13,Down,0.320534123465052,0.999485802679459
PID_HEDGEHOG_2PATHWAY,17,Up,0.32063710852761,0.999485802679459
SMID_BREAST_CANCER_NORMAL_LIKE_UP,237,Up,0.320765315645953,0.999485802679459
KEGG_OTHER_GLYCAN_DEGRADATION,13,Down,0.320877677642733,0.999485802679459
KANG_IMMORTALIZED_BY_TERT_UP,66,Up,0.320927908986805,0.999485802679459
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,54,Up,0.320973651133846,0.999485802679459
MIZUKAMI_HYPOXIA_DN,5,Up,0.321000505475332,0.999485802679459
WEBER_METHYLATED_HCP_IN_SPERM_DN,7,Up,0.321696671290205,0.999485802679459
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,414,Down,0.321811712358215,0.999485802679459
ZHAN_LATE_DIFFERENTIATION_GENES_DN,10,Up,0.321852080990263,0.999485802679459
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,16,Up,0.321967668934637,0.999485802679459
DORN_ADENOVIRUS_INFECTION_12HR_DN,31,Up,0.322022291133426,0.999485802679459
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP,12,Up,0.322163687581414,0.999485802679459
OKAWA_NEUROBLASTOMA_1P36_31_DELETION,18,Up,0.322365807556365,0.999485802679459
IKEDA_MIR30_TARGETS_UP,105,Down,0.322439699723258,0.999485802679459
ABDELMOHSEN_ELAVL4_TARGETS,14,Down,0.322609745612498,0.999485802679459
ABBUD_LIF_SIGNALING_2_DN,5,Up,0.322681283968363,0.999485802679459
SABATES_COLORECTAL_ADENOMA_SIZE_DN,6,Up,0.322693749887594,0.999485802679459
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM,25,Down,0.322821584747047,0.999485802679459
ELVIDGE_HIF1A_TARGETS_UP,56,Up,0.323095348068865,0.999485802679459
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,49,Up,0.323162171209331,0.999485802679459
LEE_NEURAL_CREST_STEM_CELL_UP,97,Up,0.323392526917862,0.999485802679459
FAELT_B_CLL_WITH_VH3_21_UP,39,Up,0.323544992198918,0.999485802679459
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,38,Down,0.323580926366557,0.999485802679459
KOHOUTEK_CCNT2_TARGETS,31,Down,0.323611806030527,0.999485802679459
SMID_BREAST_CANCER_ERBB2_DN,2,Up,0.323641113818442,0.999485802679459
MANTOVANI_VIRAL_GPCR_SIGNALING_UP,54,Up,0.324742517880457,0.999485802679459
GROSS_HYPOXIA_VIA_HIF1A_DN,89,Down,0.324765883508189,0.999485802679459
REACTOME_P2Y_RECEPTORS,3,Up,0.325288295068345,0.999485802679459
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN,13,Up,0.325373136453776,0.999485802679459
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,25,Down,0.326611840626791,0.999485802679459
REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS,24,Up,0.326699301103433,0.999485802679459
MOOTHA_GLYCOLYSIS,15,Up,0.327035136436624,0.999485802679459
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND,15,Down,0.327190634023927,0.999485802679459
WILLIAMS_ESR2_TARGETS_UP,20,Up,0.327325517278295,0.999485802679459
NADLER_OBESITY_UP,47,Up,0.32743108845709,0.999485802679459
KEGG_SPLICEOSOME,113,Down,0.327471097346655,0.999485802679459
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS,345,Down,0.327678710098136,0.999485802679459
PID_ARF6_TRAFFICKING_PATHWAY,41,Down,0.327708135575163,0.999485802679459
ZHOU_TNF_SIGNALING_4HR,46,Down,0.328352221184818,0.999485802679459
PLASARI_TGFB1_TARGETS_1HR_DN,6,Up,0.329408940307503,0.999485802679459
DOANE_BREAST_CANCER_ESR1_DN,23,Up,0.329584058222425,0.999485802679459
JU_AGING_TERC_TARGETS_UP,4,Up,0.330155749696474,0.999485802679459
PID_RHOA_REG_PATHWAY,38,Up,0.330168108603124,0.999485802679459
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,58,Down,0.330660738508228,0.999485802679459
KEGG_RENIN_ANGIOTENSIN_SYSTEM,9,Down,0.331132522720535,0.999485802679459
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION,21,Down,0.331157627590397,0.999485802679459
JIANG_AGING_HYPOTHALAMUS_DN,36,Down,0.33138488039316,0.999485802679459
CHEOK_RESPONSE_TO_HD_MTX_UP,11,Up,0.331434198074305,0.999485802679459
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,143,Up,0.331712161573017,0.999485802679459
REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE,12,Down,0.331858390807849,0.999485802679459
YAMASHITA_LIVER_CANCER_STEM_CELL_UP,35,Up,0.332119392628497,0.999485802679459
GALE_APL_WITH_FLT3_MUTATED_DN,13,Down,0.332491056214977,0.999485802679459
VALK_AML_CLUSTER_11,29,Down,0.332494561353028,0.999485802679459
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,56,Down,0.33250243712197,0.999485802679459
REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,10,Down,0.33253034862236,0.999485802679459
REACTOME_ERKS_ARE_INACTIVATED,12,Down,0.332644528546013,0.999485802679459
LIU_SOX4_TARGETS_UP,105,Up,0.332799270198051,0.999485802679459
WENG_POR_DOSAGE,13,Down,0.33293700440556,0.999485802679459
HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC,49,Down,0.333244302180169,0.999485802679459
WU_HBX_TARGETS_1_DN,19,Up,0.333326716445425,0.999485802679459
REACTOME_UNWINDING_OF_DNA,11,Down,0.333434765265886,0.999485802679459
PID_NFAT_3PATHWAY,49,Down,0.33350945240167,0.999485802679459
REACTOME_NOD1_2_SIGNALING_PATHWAY,28,Up,0.333600696106517,0.999485802679459
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN,6,Up,0.335036373910315,0.999485802679459
RAFFEL_VEGFA_TARGETS_DN,2,Down,0.335787006528853,0.999485802679459
DUAN_PRDM5_TARGETS,56,Up,0.335863449097472,0.999485802679459
HANSON_HRAS_SIGNALING_VIA_NFKB,13,Up,0.335949838366493,0.999485802679459
TANG_SENESCENCE_TP53_TARGETS_DN,49,Down,0.335960808654646,0.999485802679459
YAGI_AML_WITH_INV_16_TRANSLOCATION,313,Down,0.336376643314309,0.999485802679459
PID_TNF_PATHWAY,42,Up,0.336491524800699,0.999485802679459
LEE_LIVER_CANCER_MYC_E2F1_UP,40,Up,0.33692995370758,0.999485802679459
WANG_CISPLATIN_RESPONSE_AND_XPC_UP,144,Down,0.337108361895613,0.999485802679459
LEE_LIVER_CANCER_ACOX1_DN,33,Up,0.338089751297338,0.999485802679459
STEIN_ESRRA_TARGETS_DN,91,Up,0.338257272137612,0.999485802679459
BIOCARTA_DNAFRAGMENT_PATHWAY,9,Down,0.33843447438736,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,115,Up,0.338541845380205,0.999485802679459
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA,16,Down,0.33864687861746,0.999485802679459
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,16,Down,0.338738245330827,0.999485802679459
PID_INTEGRIN_A4B1_PATHWAY,31,Down,0.338936227559004,0.999485802679459
MORI_PRE_BI_LYMPHOCYTE_UP,64,Down,0.339179649846981,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN,9,Up,0.339286084257435,0.999485802679459
LE_SKI_TARGETS_UP,16,Down,0.339317945153791,0.999485802679459
NIELSEN_SYNOVIAL_SARCOMA_UP,11,Down,0.339353426292025,0.999485802679459
PENG_GLUCOSE_DEPRIVATION_DN,139,Down,0.340173517069733,0.999485802679459
REACTOME_ETHANOL_OXIDATION,2,Up,0.34018301194312,0.999485802679459
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP,57,Up,0.340235500124293,0.999485802679459
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,85,Up,0.340701959475035,0.999485802679459
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,84,Up,0.340939662322409,0.999485802679459
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,107,Up,0.340988886363456,0.999485802679459
ST_STAT3_PATHWAY,10,Down,0.341025299699488,0.999485802679459
WANG_TUMOR_INVASIVENESS_UP,326,Down,0.341319105606553,0.999485802679459
URS_ADIPOCYTE_DIFFERENTIATION_DN,26,Up,0.341864106008241,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,14,Down,0.341957801485513,0.999485802679459
HASINA_NOL7_TARGETS_DN,11,Up,0.342053885541398,0.999485802679459
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S,41,Up,0.342174142671502,0.999485802679459
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,29,Up,0.342416224922396,0.999485802679459
HUPER_BREAST_BASAL_VS_LUMINAL_DN,44,Down,0.342778785575745,0.999485802679459
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS,16,Down,0.343364089756586,0.999485802679459
KUMAR_TARGETS_OF_MLL_AF9_FUSION,268,Up,0.343588541050902,0.999485802679459
PID_ENDOTHELIN_PATHWAY,48,Down,0.343710621772271,0.999485802679459
GENTILE_UV_RESPONSE_CLUSTER_D6,33,Up,0.343941875527425,0.999485802679459
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,79,Up,0.34408679559051,0.999485802679459
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,46,Up,0.344541451135126,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,65,Down,0.34497727026757,0.999485802679459
REACTOME_RAP1_SIGNALLING,14,Down,0.344983087216048,0.999485802679459
REACTOME_INTERFERON_SIGNALING,116,Up,0.345515967925508,0.999485802679459
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,170,Down,0.345857061018663,0.999485802679459
SINGH_NFE2L2_TARGETS,15,Up,0.346226106450348,0.999485802679459
GUO_HEX_TARGETS_UP,72,Up,0.346455038607298,0.999485802679459
BIOCARTA_EGFR_SMRTE_PATHWAY,9,Up,0.34692851035844,0.999485802679459
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,28,Up,0.347246444148349,0.999485802679459
ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN,13,Down,0.347555202799924,0.999485802679459
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,17,Down,0.348065125857964,0.999485802679459
YU_MYC_TARGETS_UP,39,Down,0.348408072334441,0.999485802679459
REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS,8,Up,0.34852681963004,0.999485802679459
CHIN_BREAST_CANCER_COPY_NUMBER_DN,10,Down,0.348696002702932,0.999485802679459
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,200,Up,0.349090306662094,0.999485802679459
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,52,Down,0.349456548899584,0.999485802679459
ABE_INNER_EAR,34,Up,0.35004803839447,0.999485802679459
BROWNE_HCMV_INFECTION_24HR_UP,118,Up,0.350051939022701,0.999485802679459
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,200,Up,0.350122242024062,0.999485802679459
ST_GAQ_PATHWAY,25,Up,0.350234040477499,0.999485802679459
WILLERT_WNT_SIGNALING,19,Up,0.350334399466078,0.999485802679459
ST_B_CELL_ANTIGEN_RECEPTOR,35,Up,0.350339527164503,0.999485802679459
WONG_PROTEASOME_GENE_MODULE,47,Down,0.350559863588485,0.999485802679459
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,176,Up,0.350676413637919,0.999485802679459
LEE_AGING_NEOCORTEX_DN,48,Down,0.350953731764619,0.999485802679459
RADAEVA_RESPONSE_TO_IFNA1_DN,8,Up,0.350997836584434,0.999485802679459
REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK,16,Down,0.351030549146389,0.999485802679459
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP,12,Down,0.351030939758689,0.999485802679459
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,20,Down,0.351304745752883,0.999485802679459
RUAN_RESPONSE_TO_TNF_DN,62,Down,0.351924934160459,0.999485802679459
HU_GENOTOXIC_DAMAGE_24HR,30,Down,0.352237724069489,0.999485802679459
BOQUEST_STEM_CELL_DN,141,Up,0.352589529218112,0.999485802679459
COATES_MACROPHAGE_M1_VS_M2_UP,58,Down,0.352595819676624,0.999485802679459
FU_INTERACT_WITH_ALKBH8,12,Down,0.353995387137874,0.999485802679459
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE,15,Down,0.354179404200214,0.999485802679459
JIANG_AGING_CEREBRAL_CORTEX_UP,31,Down,0.35420258970637,0.999485802679459
REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS,15,Down,0.354302314113594,0.999485802679459
DAZARD_UV_RESPONSE_CLUSTER_G5,9,Down,0.354343414772751,0.999485802679459
GAZIN_EPIGENETIC_SILENCING_BY_KRAS,19,Up,0.35458247467154,0.999485802679459
MASSARWEH_TAMOXIFEN_RESISTANCE_DN,181,Down,0.35485802250103,0.999485802679459
BIOCARTA_SET_PATHWAY,8,Down,0.354979901829834,0.999485802679459
DOANE_RESPONSE_TO_ANDROGEN_DN,198,Up,0.355483520160101,0.999485802679459
REACTOME_SPHINGOLIPID_METABOLISM,49,Down,0.355610340684158,0.999485802679459
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,28,Up,0.355716094236395,0.999485802679459
LEIN_CEREBELLUM_MARKERS,55,Down,0.35575931665118,0.999485802679459
LANDIS_ERBB2_BREAST_TUMORS_65_UP,20,Down,0.355844232534423,0.999485802679459
STARK_HYPPOCAMPUS_22Q11_DELETION_DN,14,Down,0.355995327282942,0.999485802679459
KAPOSI_LIVER_CANCER_MET_UP,17,Down,0.356445860846686,0.999485802679459
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,54,Down,0.356532782788174,0.999485802679459
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,116,Up,0.356682397019624,0.999485802679459
REACTOME_SIGNALING_BY_FGFR_MUTANTS,30,Down,0.356733173639162,0.999485802679459
TRAYNOR_RETT_SYNDROM_DN,13,Up,0.35679266022655,0.999485802679459
HAHTOLA_CTCL_PATHOGENESIS,2,Down,0.356914862280193,0.999485802679459
REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,38,Down,0.357172435810193,0.999485802679459
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP,8,Down,0.357463372200075,0.999485802679459
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,82,Up,0.357637846876704,0.999485802679459
LUI_THYROID_CANCER_PAX8_PPARG_UP,36,Up,0.357675960882883,0.999485802679459
SASSON_RESPONSE_TO_FORSKOLIN_UP,73,Down,0.35804358114504,0.999485802679459
LIU_TARGETS_OF_VMYB_VS_CMYB_DN,34,Up,0.358151225798202,0.999485802679459
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,71,Up,0.358307112731837,0.999485802679459
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,13,Down,0.358741280302591,0.999485802679459
GROSS_HYPOXIA_VIA_ELK3_DN,125,Up,0.35920800025735,0.999485802679459
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,18,Up,0.359816619500945,0.999485802679459
FERRARI_RESPONSE_TO_FENRETINIDE_DN,3,Up,0.359861888441298,0.999485802679459
NABA_ECM_REGULATORS,127,Down,0.359910073552236,0.999485802679459
LEE_AGING_MUSCLE_DN,34,Down,0.360109835626961,0.999485802679459
ONO_FOXP3_TARGETS_DN,23,Up,0.360637396887651,0.999485802679459
PID_INSULIN_PATHWAY,42,Down,0.361064949105743,0.999485802679459
PID_RAC1_REG_PATHWAY,32,Down,0.361141651208282,0.999485802679459
REACTOME_AMINE_LIGAND_BINDING_RECEPTORS,11,Down,0.361544525275251,0.999485802679459
LUI_THYROID_CANCER_CLUSTER_2,34,Up,0.361557547118145,0.999485802679459
REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D,9,Up,0.361594038956928,0.999485802679459
REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC,23,Down,0.361792626869475,0.999485802679459
BAKKER_FOXO3_TARGETS_DN,134,Up,0.362365970110476,0.999485802679459
LEE_NEURAL_CREST_STEM_CELL_DN,83,Up,0.362390769401367,0.999485802679459
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,36,Up,0.362581611836301,0.999485802679459
OXFORD_RALA_TARGETS_UP,7,Down,0.362624130962391,0.999485802679459
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,73,Up,0.362715944649569,0.999485802679459
QI_HYPOXIA,115,Up,0.362789736039394,0.999485802679459
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,130,Down,0.363365934470755,0.999485802679459
REACTOME_BINDING_AND_ENTRY_OF_HIV_VIRION,2,Down,0.36356606040624,0.999485802679459
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3,7,Down,0.363674165612795,0.999485802679459
MARZEC_IL2_SIGNALING_UP,85,Up,0.364219930851712,0.999485802679459
SASAKI_TARGETS_OF_TP73_AND_TP63,8,Up,0.364224770849612,0.999485802679459
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,49,Down,0.364275545262262,0.999485802679459
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,125,Down,0.364434460306486,0.999485802679459
COLDREN_GEFITINIB_RESISTANCE_UP,72,Down,0.364538264928101,0.999485802679459
VANTVEER_BREAST_CANCER_BRCA1_UP,23,Up,0.364682824933095,0.999485802679459
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,93,Up,0.364866952681792,0.999485802679459
BIOCARTA_CELLCYCLE_PATHWAY,20,Down,0.365058909730517,0.999485802679459
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,36,Up,0.365437563805462,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP,16,Up,0.367472749627699,0.999485802679459
YANG_MUC2_TARGETS_COLON_3MO_DN,4,Up,0.367766401429895,0.999485802679459
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,72,Up,0.367827547659892,0.999485802679459
REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND,10,Down,0.367831930553244,0.999485802679459
VARELA_ZMPSTE24_TARGETS_UP,34,Up,0.367998948631653,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN,6,Up,0.368213981253646,0.999485802679459
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,15,Down,0.368229610812238,0.999485802679459
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,16,Up,0.368359439932193,0.999485802679459
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,48,Up,0.368360972581879,0.999485802679459
MURATA_VIRULENCE_OF_H_PILORI,17,Up,0.368437764052924,0.999485802679459
REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS,51,Down,0.368638292737493,0.999485802679459
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,47,Up,0.368662750381968,0.999485802679459
MAHAJAN_RESPONSE_TO_IL1A_DN,67,Down,0.368781393420645,0.999485802679459
KEGG_PARKINSONS_DISEASE,83,Down,0.369630449641544,0.999485802679459
KEGG_GALACTOSE_METABOLISM,19,Down,0.369776647985495,0.999485802679459
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,29,Down,0.369947374310698,0.999485802679459
ZHU_SKIL_TARGETS_DN,8,Down,0.370000274339463,0.999485802679459
PID_INTEGRIN2_PATHWAY,16,Down,0.370181653977257,0.999485802679459
LABBE_TGFB1_TARGETS_DN,56,Down,0.370201880606586,0.999485802679459
BIOCARTA_SALMONELLA_PATHWAY,12,Down,0.37024185340896,0.999485802679459
WATANABE_COLON_CANCER_MSI_VS_MSS_DN,42,Up,0.370500980709501,0.999485802679459
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,34,Down,0.371116069902056,0.999485802679459
SA_B_CELL_RECEPTOR_COMPLEXES,20,Up,0.371133548772171,0.999485802679459
SESTO_RESPONSE_TO_UV_C1,58,Down,0.371361670078119,0.999485802679459
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,46,Up,0.37139606739859,0.999485802679459
IKEDA_MIR133_TARGETS_DN,7,Up,0.371633453734747,0.999485802679459
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,72,Up,0.371815548951901,0.999485802679459
ABBUD_LIF_SIGNALING_2_UP,11,Up,0.371846908797304,0.999485802679459
KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS,13,Down,0.372316528034541,0.999485802679459
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,169,Up,0.372404749874111,0.999485802679459
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,57,Up,0.372685915241281,0.999485802679459
LIAN_LIPA_TARGETS_3M,25,Up,0.372869442498202,0.999485802679459
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,152,Up,0.373327931147379,0.999485802679459
REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_,42,Down,0.373355832365038,0.999485802679459
XU_CREBBP_TARGETS_UP,21,Down,0.373705058982512,0.999485802679459
REACTOME_GABA_RECEPTOR_ACTIVATION,26,Down,0.373722716846023,0.999485802679459
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,134,Up,0.374007632790344,0.999485802679459
CHANDRAN_METASTASIS_DN,202,Down,0.374253369990136,0.999485802679459
KEGG_LEISHMANIA_INFECTION,43,Up,0.374340376507469,0.999485802679459
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN,52,Down,0.374628967434503,0.999485802679459
IGLESIAS_E2F_TARGETS_DN,6,Down,0.374880296309523,0.999485802679459
HE_PTEN_TARGETS_DN,7,Down,0.375141653928217,0.999485802679459
REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS,17,Up,0.375220185031295,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP,5,Down,0.375280562247018,0.999485802679459
TERAMOTO_OPN_TARGETS_CLUSTER_6,22,Up,0.375290297564852,0.999485802679459
GHANDHI_DIRECT_IRRADIATION_DN,19,Up,0.37593909279246,0.999485802679459
WANG_SMARCE1_TARGETS_UP,226,Up,0.375969360510436,0.999485802679459
WINNEPENNINCKX_MELANOMA_METASTASIS_DN,23,Up,0.376202130455091,0.999485802679459
REACTOME_MITOTIC_G1_G1_S_PHASES,123,Down,0.376422516697887,0.999485802679459
BIOCARTA_CACAM_PATHWAY,12,Down,0.376669470657208,0.999485802679459
REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR,13,Down,0.377094345434047,0.999485802679459
TAKAO_RESPONSE_TO_UVB_RADIATION_UP,74,Down,0.377819734562279,0.999485802679459
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP,10,Down,0.377824512627149,0.999485802679459
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP,714,Down,0.377869626549664,0.999485802679459
BIOCARTA_RB_PATHWAY,12,Down,0.378544059989226,0.999485802679459
DANG_BOUND_BY_MYC,944,Down,0.378573977539359,0.999485802679459
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,66,Up,0.3786450859875,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29,7,Up,0.378766717477546,0.999485802679459
HUANG_GATA2_TARGETS_UP,108,Down,0.379021927807844,0.999485802679459
CARD_MIR302A_TARGETS,67,Up,0.379065389673154,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G2,24,Up,0.379122819956182,0.999485802679459
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,75,Up,0.379440244747622,0.999485802679459
PARK_HSC_MARKERS,38,Up,0.379892261156571,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,137,Down,0.380121431277632,0.999485802679459
PID_RAS_PATHWAY,22,Down,0.380127415790346,0.999485802679459
KEGG_OXIDATIVE_PHOSPHORYLATION,87,Down,0.380274669418638,0.999485802679459
GENTILE_UV_RESPONSE_CLUSTER_D1,17,Up,0.38078110719826,0.999485802679459
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS,21,Down,0.380801536082356,0.999485802679459
ZHANG_GATA6_TARGETS_UP,6,Down,0.380881072085543,0.999485802679459
NABA_BASEMENT_MEMBRANES,33,Down,0.381169486977686,0.999485802679459
DAZARD_RESPONSE_TO_UV_NHEK_UP,175,Down,0.381385948246558,0.999485802679459
KEGG_HEMATOPOIETIC_CELL_LINEAGE,38,Up,0.381510011331317,0.999485802679459
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP,10,Down,0.381630212190636,0.999485802679459
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,66,Up,0.381691139456159,0.999485802679459
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP,29,Down,0.383279687006431,0.999485802679459
LI_DCP2_BOUND_MRNA,78,Down,0.383310596089664,0.999485802679459
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,16,Up,0.383672085000408,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,37,Down,0.384371528855041,0.999485802679459
VANHARANTA_UTERINE_FIBROID_UP,35,Down,0.384454397002144,0.999485802679459
RICKMAN_HEAD_AND_NECK_CANCER_D,6,Up,0.384716168424872,0.999485802679459
BAELDE_DIABETIC_NEPHROPATHY_UP,54,Up,0.384868765665019,0.999485802679459
BURTON_ADIPOGENESIS_6,146,Down,0.385321147932839,0.999485802679459
KANG_FLUOROURACIL_RESISTANCE_UP,20,Up,0.385379129177117,0.999485802679459
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,20,Down,0.385791779267642,0.999485802679459
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP,5,Up,0.385828140838291,0.999485802679459
BURTON_ADIPOGENESIS_PEAK_AT_0HR,46,Up,0.386526275049934,0.999485802679459
HUANG_GATA2_TARGETS_DN,58,Down,0.387040543423257,0.999485802679459
CHEN_LIVER_METABOLISM_QTL_CIS,62,Down,0.387081997347718,0.999485802679459
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,125,Down,0.387366901905478,0.999485802679459
PID_PLK1_PATHWAY,44,Down,0.387649967162734,0.999485802679459
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,66,Up,0.388557406956757,0.999485802679459
MARKEY_RB1_ACUTE_LOF_DN,158,Up,0.388977955774319,0.999485802679459
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN,2,Up,0.38901240245216,0.999485802679459
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE,12,Down,0.389370253551228,0.999485802679459
ROVERSI_GLIOMA_COPY_NUMBER_DN,36,Down,0.389496725974955,0.999485802679459
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,247,Up,0.38985821421966,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN,15,Up,0.390004030303273,0.999485802679459
BENPORATH_ES_CORE_NINE_CORRELATED,89,Up,0.390137651887611,0.999485802679459
REACTOME_EGFR_DOWNREGULATION,24,Down,0.390215380188507,0.999485802679459
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,39,Down,0.39034890444444,0.999485802679459
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,52,Up,0.390373477050793,0.999485802679459
REACTOME_CRMPS_IN_SEMA3A_SIGNALING,13,Down,0.390619692932011,0.999485802679459
REACTOME_REGULATION_OF_IFNG_SIGNALING,11,Up,0.390659106029497,0.999485802679459
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,115,Up,0.391139611382335,0.999485802679459
POS_RESPONSE_TO_HISTAMINE_DN,9,Down,0.391142583652971,0.999485802679459
MOOTHA_FFA_OXYDATION,18,Down,0.391335010249215,0.999485802679459
MATZUK_IMPLANTATION_AND_UTERINE,11,Up,0.39155325720099,0.999485802679459
LEIN_ASTROCYTE_MARKERS,27,Down,0.391770092871209,0.999485802679459
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,243,Down,0.391847593670459,0.999485802679459
DORSEY_GAB2_TARGETS,23,Down,0.391931183249335,0.999485802679459
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,13,Down,0.392005294271282,0.999485802679459
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,50,Up,0.392024114621905,0.999485802679459
KEGG_ASCORBATE_AND_ALDARATE_METABOLISM,5,Down,0.392725976970128,0.999485802679459
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,33,Up,0.392891472093123,0.999485802679459
REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM,17,Down,0.393066559308937,0.999485802679459
KEGG_TRYPTOPHAN_METABOLISM,26,Down,0.393710271683104,0.999485802679459
KYNG_NORMAL_AGING_DN,22,Down,0.39382354197154,0.999485802679459
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,27,Up,0.393844489342679,0.999485802679459
FUNG_IL2_SIGNALING_1,8,Up,0.393952214281799,0.999485802679459
CASTELLANO_HRAS_AND_NRAS_TARGETS_UP,4,Up,0.394736720838489,0.999485802679459
PID_HIF1A_PATHWAY,13,Down,0.394949311226387,0.999485802679459
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,46,Down,0.395024801238214,0.999485802679459
YU_BAP1_TARGETS,26,Up,0.395085998280811,0.999485802679459
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP,11,Down,0.395541287679365,0.999485802679459
ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN,12,Down,0.39661362971428,0.999485802679459
VERRECCHIA_RESPONSE_TO_TGFB1_C2,23,Up,0.397348106556064,0.999485802679459
REACTOME_POL_SWITCHING,13,Down,0.398116403354616,0.999485802679459
REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION,18,Down,0.398368247938482,0.999485802679459
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,59,Down,0.398778028559873,0.999485802679459
WEINMANN_ADAPTATION_TO_HYPOXIA_UP,25,Down,0.398859974052455,0.999485802679459
OUYANG_PROSTATE_CANCER_PROGRESSION_UP,14,Up,0.399156951255946,0.999485802679459
KYNG_DNA_DAMAGE_BY_4NQO,31,Down,0.399272565071556,0.999485802679459
REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN,7,Up,0.399590144731433,0.999485802679459
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,157,Up,0.399619871701419,0.999485802679459
GRADE_COLON_AND_RECTAL_CANCER_UP,252,Down,0.399671081545855,0.999485802679459
WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP,10,Down,0.399845523414915,0.999485802679459
CHEN_HOXA5_TARGETS_9HR_DN,36,Up,0.39999550226508,0.999485802679459
NIELSEN_LIPOSARCOMA_DN,16,Up,0.400045233414187,0.999485802679459
REACTOME_POTASSIUM_CHANNELS,44,Up,0.400287355691677,0.999485802679459
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP,9,Down,0.400343064132477,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,24,Down,0.400368639938012,0.999485802679459
CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN,5,Up,0.400590432256529,0.999485802679459
MIKKELSEN_IPS_ICP_WITH_H3K27ME3,14,Up,0.400679481466504,0.999485802679459
MOOTHA_GLYCOGEN_METABOLISM,16,Up,0.40109350004396,0.999485802679459
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,124,Down,0.40141927706236,0.999485802679459
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP,112,Down,0.401524681232195,0.999485802679459
CHESLER_BRAIN_D6MIT150_QTL_CIS,3,Up,0.40178054213719,0.999485802679459
KEGG_BETA_ALANINE_METABOLISM,16,Down,0.401873053558997,0.999485802679459
CHANDRAN_METASTASIS_UP,159,Up,0.402314918220345,0.999485802679459
MARTINEZ_RB1_AND_TP53_TARGETS_UP,419,Down,0.402860963073444,0.999485802679459
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP,12,Down,0.402996796381736,0.999485802679459
PID_SMAD2_3PATHWAY,17,Up,0.403769179133561,0.999485802679459
WIERENGA_STAT5A_TARGETS_GROUP1,87,Down,0.403785664812982,0.999485802679459
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,47,Up,0.404130940206522,0.999485802679459
KEGG_GAP_JUNCTION,69,Down,0.404502481267094,0.999485802679459
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7,15,Down,0.405391161934311,0.999485802679459
HILLION_HMGA1B_TARGETS,66,Down,0.405896699566191,0.999485802679459
ONDER_CDH1_TARGETS_2_DN,316,Up,0.405908257372289,0.999485802679459
BERNARD_PPAPDC1B_TARGETS_UP,34,Down,0.405971179560424,0.999485802679459
ZHANG_TLX_TARGETS_36HR_UP,185,Up,0.406092980224032,0.999485802679459
FARDIN_HYPOXIA_11,31,Down,0.406127004977245,0.999485802679459
PID_PI3K_PLC_TRK_PATHWAY,32,Down,0.406137239213718,0.999485802679459
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,25,Down,0.406565916934014,0.999485802679459
MIZUSHIMA_AUTOPHAGOSOME_FORMATION,16,Down,0.407770211074476,0.999485802679459
RATTENBACHER_BOUND_BY_CELF1,294,Down,0.407913474545483,0.999485802679459
NOJIMA_SFRP2_TARGETS_UP,22,Up,0.408113936300142,0.999485802679459
LEIN_MIDBRAIN_MARKERS,50,Down,0.409469913651152,0.999485802679459
KIM_MYCN_AMPLIFICATION_TARGETS_DN,78,Up,0.409535770668566,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_CD1_UP,28,Down,0.409538430719579,0.999485802679459
PID_SYNDECAN_2_PATHWAY,29,Down,0.409704214157333,0.999485802679459
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,27,Down,0.409770538415248,0.999485802679459
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,11,Up,0.409939418861068,0.999485802679459
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,329,Down,0.410166313076554,0.999485802679459
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,268,Up,0.410775661395401,0.999485802679459
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,21,Up,0.410923602208876,0.999485802679459
KEGG_MISMATCH_REPAIR,22,Down,0.410971033160097,0.999485802679459
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,36,Up,0.411085185629942,0.999485802679459
REACTOME_CIRCADIAN_CLOCK,48,Up,0.411139401166015,0.999485802679459
ZAMORA_NOS2_TARGETS_DN,76,Up,0.411413375630095,0.999485802679459
WESTON_VEGFA_TARGETS_6HR,45,Down,0.411503566113949,0.999485802679459
REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS,57,Down,0.411545716917298,0.999485802679459
BIOCARTA_MCM_PATHWAY,18,Down,0.411614212769134,0.999485802679459
CHEN_HOXA5_TARGETS_9HR_UP,200,Up,0.412299171838637,0.999485802679459
TSENG_IRS1_TARGETS_UP,85,Up,0.412316162136842,0.999485802679459
YIH_RESPONSE_TO_ARSENITE_C3,30,Down,0.412538024290012,0.999485802679459
WONG_EMBRYONIC_STEM_CELL_CORE,310,Down,0.412549579628112,0.999485802679459
PID_SYNDECAN_4_PATHWAY,24,Down,0.412630476043478,0.999485802679459
NAKAMURA_ALVEOLAR_EPITHELIUM,2,Up,0.412784944326042,0.999485802679459
THUM_MIR21_TARGETS_HEART_DISEASE_DN,5,Down,0.41334457762347,0.999485802679459
CERVERA_SDHB_TARGETS_1_DN,9,Down,0.41361896507721,0.999485802679459
REACTOME_PHOSPHORYLATION_OF_THE_APC_C,17,Down,0.413828742013648,0.999485802679459
KORKOLA_EMBRYONAL_CARCINOMA_UP,31,Up,0.414109002093564,0.999485802679459
REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY,26,Down,0.414201571680244,0.999485802679459
OSMAN_BLADDER_CANCER_DN,315,Down,0.414249457784936,0.999485802679459
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,14,Down,0.414295990182565,0.999485802679459
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,144,Down,0.414503747828102,0.999485802679459
KEGG_HISTIDINE_METABOLISM,15,Down,0.415295859533508,0.999485802679459
BIOCARTA_VEGF_PATHWAY,25,Down,0.415428182386347,0.999485802679459
REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM,143,Down,0.416269379744545,0.999485802679459
BIOCARTA_ACE2_PATHWAY,8,Up,0.41655397271662,0.999485802679459
BIOCARTA_TOLL_PATHWAY,31,Up,0.416912710282461,0.999485802679459
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,189,Down,0.416919857952336,0.999485802679459
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,58,Down,0.416923405229769,0.999485802679459
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,23,Up,0.417038229975046,0.999485802679459
VALK_AML_WITH_EVI1,15,Down,0.417090044663867,0.999485802679459
REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS,5,Down,0.418097480256152,0.999485802679459
RHODES_CANCER_META_SIGNATURE,60,Down,0.418474751219366,0.999485802679459
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,12,Down,0.419431440301754,0.999485802679459
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,58,Down,0.419443784101051,0.999485802679459
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,10,Down,0.419785295882569,0.999485802679459
BIOCARTA_PTEN_PATHWAY,17,Down,0.420263219360761,0.999485802679459
POS_HISTAMINE_RESPONSE_NETWORK,27,Down,0.420710198427361,0.999485802679459
FRASOR_TAMOXIFEN_RESPONSE_DN,10,Down,0.420808654941999,0.999485802679459
BIOCARTA_SRCRPTP_PATHWAY,10,Down,0.420926875013717,0.999485802679459
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,29,Up,0.421259952013451,0.999485802679459
BIOCARTA_GRANULOCYTES_PATHWAY,7,Up,0.421442789332211,0.999485802679459
KEGG_LYSINE_DEGRADATION,35,Down,0.421607655699918,0.999485802679459
HASINA_NOL7_TARGETS_UP,11,Up,0.421634796310752,0.999485802679459
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,43,Down,0.421694749859312,0.999485802679459
HORIUCHI_WTAP_TARGETS_UP,232,Up,0.421969737593715,0.999485802679459
KEGG_ADHERENS_JUNCTION,62,Up,0.422072833806373,0.999485802679459
VERHAAK_GLIOBLASTOMA_NEURAL,87,Up,0.42234988607968,0.999485802679459
VALK_AML_CLUSTER_15,24,Up,0.422517929589448,0.999485802679459
NICK_RESPONSE_TO_PROC_TREATMENT_DN,22,Up,0.422535270046225,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,42,Up,0.422714130764956,0.999485802679459
HEDENFALK_BREAST_CANCER_BRACX_DN,17,Down,0.422777774503756,0.999485802679459
STOSSI_RESPONSE_TO_ESTRADIOL,33,Down,0.423466936312973,0.999485802679459
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN,14,Down,0.42363526976724,0.999485802679459
PHONG_TNF_TARGETS_DN,5,Down,0.424060512038556,0.999485802679459
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,69,Up,0.424547244709695,0.999485802679459
REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,25,Down,0.425340952625952,0.999485802679459
ROZANOV_MMP14_CORRELATED,10,Up,0.425406918922862,0.999485802679459
GENTILE_UV_RESPONSE_CLUSTER_D5,38,Down,0.425412571025838,0.999485802679459
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,32,Up,0.425479181902986,0.999485802679459
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,25,Down,0.425677258930421,0.999485802679459
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI,14,Up,0.425693330093778,0.999485802679459
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,263,Down,0.425900318409545,0.999485802679459
REACTOME_GLUCOSE_METABOLISM,54,Down,0.425958305577401,0.999485802679459
LUDWICZEK_TREATING_IRON_OVERLOAD,5,Down,0.425982870279353,0.999485802679459
MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3,634,Up,0.426194276924502,0.999485802679459
HU_GENOTOXIC_DAMAGE_4HR,34,Up,0.426268332119715,0.999485802679459
WONG_IFNA2_RESISTANCE_DN,25,Up,0.427106295616781,0.999485802679459
REACTOME_ACYL_CHAIN_REMODELLING_OF_PE,9,Up,0.427201749146694,0.999485802679459
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP,15,Up,0.427330021060258,0.999485802679459
PID_S1P_S1P4_PATHWAY,12,Down,0.427340853896535,0.999485802679459
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,67,Up,0.427711596277359,0.999485802679459
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,36,Up,0.42805674447869,0.999485802679459
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,64,Up,0.428237897767888,0.999485802679459
REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE,6,Down,0.428685186791877,0.999485802679459
JAEGER_METASTASIS_UP,39,Down,0.429028709300526,0.999485802679459
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,30,Up,0.429232145784698,0.999485802679459
FERRANDO_TAL1_NEIGHBORS,11,Down,0.429391119652974,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,33,Up,0.429493367279193,0.999485802679459
MEISSNER_NPC_ICP_WITH_H3K4ME3,11,Up,0.429547375662789,0.999485802679459
MATZUK_CUMULUS_EXPANSION,4,Down,0.429764224634502,0.999485802679459
SANSOM_APC_TARGETS_REQUIRE_MYC,165,Up,0.429783250410958,0.999485802679459
KONDO_EZH2_TARGETS,170,Up,0.430097375418474,0.999485802679459
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,31,Up,0.430562704238495,0.999485802679459
PID_TXA2PATHWAY,38,Down,0.431253837875835,0.999485802679459
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,237,Up,0.4313992463442,0.999485802679459
CAFFAREL_RESPONSE_TO_THC_UP,30,Up,0.431645931984054,0.999485802679459
REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS,18,Down,0.431650973925178,0.999485802679459
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,26,Down,0.431768115107406,0.999485802679459
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,303,Down,0.431945175050207,0.999485802679459
SEIDEN_MET_SIGNALING,19,Down,0.432220110630227,0.999485802679459
TERAMOTO_OPN_TARGETS_CLUSTER_8,4,Up,0.432347423274067,0.999485802679459
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,122,Up,0.432376458627749,0.999485802679459
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,83,Down,0.432558000640785,0.999485802679459
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,100,Up,0.432606101827143,0.999485802679459
KEEN_RESPONSE_TO_ROSIGLITAZONE_DN,76,Up,0.433192356317882,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_MF_UP,27,Down,0.433315572014858,0.999485802679459
KEGG_BUTANOATE_METABOLISM,25,Down,0.433783792945698,0.999485802679459
PID_WNT_NONCANONICAL_PATHWAY,32,Up,0.435183203233719,0.999485802679459
LEE_INTRATHYMIC_T_PROGENITOR,12,Up,0.435611166147568,0.999485802679459
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,22,Up,0.436077447311502,0.999485802679459
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,133,Down,0.436341282880796,0.999485802679459
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,17,Down,0.436461797233665,0.999485802679459
CHOW_RASSF1_TARGETS_DN,26,Down,0.436637687386033,0.999485802679459
KEGG_PROPANOATE_METABOLISM,27,Down,0.436997509057934,0.999485802679459
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN,51,Down,0.43702803262025,0.999485802679459
WEBER_METHYLATED_ICP_IN_FIBROBLAST,4,Down,0.437045189304043,0.999485802679459
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,23,Down,0.437323568879433,0.999485802679459
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,17,Up,0.437494138035709,0.999485802679459
KASLER_HDAC7_TARGETS_2_DN,28,Up,0.437584643493331,0.999485802679459
MARTINEZ_TP53_TARGETS_UP,423,Down,0.437782670358673,0.999485802679459
BIOCARTA_CELL2CELL_PATHWAY,11,Up,0.437999484068776,0.999485802679459
KAMIKUBO_MYELOID_CEBPA_NETWORK,16,Down,0.438095999876247,0.999485802679459
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP,12,Down,0.438135291908207,0.999485802679459
REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION,17,Down,0.438156671068425,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3,3,Down,0.43876492414205,0.999485802679459
EPPERT_CE_HSC_LSC,24,Up,0.439470617290239,0.999485802679459
PID_LYMPH_ANGIOGENESIS_PATHWAY,24,Down,0.439489687705835,0.999485802679459
BIOCARTA_TCRA_PATHWAY,2,Down,0.439791061610117,0.999485802679459
PID_PRL_SIGNALING_EVENTS_PATHWAY,22,Down,0.439857825590542,0.999485802679459
SCIBETTA_KDM5B_TARGETS_DN,63,Down,0.43989149322822,0.999485802679459
REACTOME_PD1_SIGNALING,3,Up,0.440122689253142,0.999485802679459
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP,9,Down,0.440344138389006,0.999485802679459
PID_TCR_CALCIUM_PATHWAY,20,Down,0.440347125827179,0.999485802679459
BIOCARTA_G2_PATHWAY,23,Down,0.440677820135426,0.999485802679459
SCHLOSSER_SERUM_RESPONSE_UP,99,Up,0.440898802537921,0.999485802679459
BIOCARTA_ATM_PATHWAY,19,Up,0.440978728748027,0.999485802679459
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,11,Up,0.441853167440196,0.999485802679459
LUI_THYROID_CANCER_CLUSTER_1,42,Up,0.441887900048585,0.999485802679459
LINDVALL_IMMORTALIZED_BY_TERT_DN,60,Down,0.441994305334094,0.999485802679459
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,145,Up,0.442232332592576,0.999485802679459
NIELSEN_SCHWANNOMA_UP,9,Up,0.442418866601809,0.999485802679459
REACTOME_IL_RECEPTOR_SHC_SIGNALING,15,Down,0.442864141173148,0.999485802679459
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,59,Up,0.443400384351316,0.999485802679459
REACTOME_ADAPTIVE_IMMUNE_SYSTEM,391,Down,0.443514210061834,0.999485802679459
MATZUK_FERTILIZATION,6,Down,0.443666341464678,0.999485802679459
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,65,Up,0.444092576957614,0.999485802679459
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN,9,Down,0.44458907766851,0.999485802679459
NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON,12,Down,0.444799277367462,0.999485802679459
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,58,Up,0.444809651533461,0.999485802679459
EHLERS_ANEUPLOIDY_DN,7,Down,0.444926768275203,0.999485802679459
HOWLIN_CITED1_TARGETS_1_DN,30,Up,0.445075031061191,0.999485802679459
ZHU_CMV_24_HR_DN,75,Up,0.445311817810342,0.999485802679459
TERAO_AOX4_TARGETS_HG_DN,5,Up,0.44556643121061,0.999485802679459
DAZARD_UV_RESPONSE_CLUSTER_G24,17,Down,0.445821811333341,0.999485802679459
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,21,Up,0.446354573771148,0.999485802679459
REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM,11,Down,0.446360349508402,0.999485802679459
REACTOME_NEURONAL_SYSTEM,144,Down,0.446444766101911,0.999485802679459
LIU_CMYB_TARGETS_UP,134,Down,0.446457030694547,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_MF_DN,33,Up,0.446615927962498,0.999485802679459
MORI_IMMATURE_B_LYMPHOCYTE_UP,37,Up,0.44665408620912,0.999485802679459
SMID_BREAST_CANCER_BASAL_UP,427,Up,0.446716386741739,0.999485802679459
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,17,Down,0.44717409839742,0.999485802679459
REACTOME_PECAM1_INTERACTIONS,7,Down,0.447425472596172,0.999485802679459
OUYANG_PROSTATE_CANCER_PROGRESSION_DN,19,Down,0.447508109846296,0.999485802679459
PEDRIOLI_MIR31_TARGETS_UP,134,Down,0.44752284445733,0.999485802679459
REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS,14,Down,0.447569002340143,0.999485802679459
AMIT_SERUM_RESPONSE_480_MCF10A,25,Down,0.44773535973172,0.999485802679459
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,86,Down,0.448119843169051,0.999485802679459
CERVERA_SDHB_TARGETS_2,65,Down,0.448269596652902,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_UP,52,Down,0.448458743813678,0.999485802679459
AIGNER_ZEB1_TARGETS,23,Up,0.449106643005127,0.999485802679459
ALONSO_METASTASIS_EMT_UP,30,Up,0.449454818420997,0.999485802679459
KANG_DOXORUBICIN_RESISTANCE_DN,16,Up,0.449515976445079,0.999485802679459
REACTOME_SIGNALING_BY_FGFR1_MUTANTS,22,Down,0.449662045564646,0.999485802679459
BIOCARTA_CCR5_PATHWAY,13,Down,0.449824903760623,0.999485802679459
MAHADEVAN_RESPONSE_TO_MP470_UP,11,Down,0.450430301927474,0.999485802679459
AKL_HTLV1_INFECTION_DN,48,Down,0.450467099259516,0.999485802679459
KEGG_ECM_RECEPTOR_INTERACTION,63,Down,0.450495383630556,0.999485802679459
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES,30,Up,0.450664096108067,0.999485802679459
SESTO_RESPONSE_TO_UV_C0,94,Down,0.450849992468841,0.999485802679459
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,60,Up,0.451195116746846,0.999485802679459
BIOCARTA_ACTINY_PATHWAY,18,Down,0.452244504633671,0.999485802679459
REACTOME_CELL_JUNCTION_ORGANIZATION,46,Down,0.452365912484032,0.999485802679459
PENG_GLUCOSE_DEPRIVATION_UP,36,Up,0.45248187425417,0.999485802679459
LABBE_WNT3A_TARGETS_UP,78,Down,0.452774917204963,0.999485802679459
BURTON_ADIPOGENESIS_7,44,Down,0.452955165490646,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,48,Up,0.45336625870281,0.999485802679459
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,56,Up,0.453727246542777,0.999485802679459
REACTOME_SIGNALING_BY_RHO_GTPASES,93,Up,0.453734436133396,0.999485802679459
REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,38,Down,0.454006509123458,0.999485802679459
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,108,Down,0.454048101852514,0.999485802679459
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2,5,Down,0.454076565331068,0.999485802679459
IKEDA_MIR1_TARGETS_DN,6,Up,0.454116267045165,0.999485802679459
MILI_PSEUDOPODIA,36,Down,0.454170820005422,0.999485802679459
LIU_CMYB_TARGETS_DN,6,Down,0.454225723601107,0.999485802679459
ROETH_TERT_TARGETS_DN,3,Up,0.454340278406015,0.999485802679459
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP,5,Up,0.45581786873768,0.999485802679459
KEGG_LINOLEIC_ACID_METABOLISM,6,Up,0.456401324570803,0.999485802679459
MILI_PSEUDOPODIA_CHEMOTAXIS_UP,61,Down,0.45667946864485,0.999485802679459
KOHOUTEK_CCNT1_TARGETS,35,Down,0.456753508852736,0.999485802679459
LIU_VMYB_TARGETS_UP,107,Down,0.456914217331772,0.999485802679459
CORRE_MULTIPLE_MYELOMA_UP,49,Down,0.457967672204557,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,63,Up,0.45828382287968,0.999485802679459
REACTOME_INTRINSIC_PATHWAY,6,Up,0.458412139628441,0.999485802679459
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM,26,Down,0.45851630899509,0.999485802679459
BIOCARTA_BARRESTIN_PATHWAY,9,Down,0.458750416018154,0.999485802679459
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,368,Up,0.458809992961817,0.999485802679459
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,86,Down,0.458895743846128,0.999485802679459
BIOCARTA_LEPTIN_PATHWAY,9,Down,0.458904640188653,0.999485802679459
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,24,Down,0.459098159655499,0.999485802679459
COLLER_MYC_TARGETS_DN,6,Down,0.459131520524884,0.999485802679459
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,36,Up,0.459422562701634,0.999485802679459
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,34,Down,0.459491074167832,0.999485802679459
REACTOME_SIGNALING_BY_NODAL,12,Up,0.45960547328961,0.999485802679459
STARK_BRAIN_22Q11_DELETION,9,Up,0.459824308527561,0.999485802679459
MCCLUNG_COCAIN_REWARD_4WK,48,Down,0.459931508759183,0.999485802679459
JAEGER_METASTASIS_DN,144,Up,0.459966749507353,0.999485802679459
BROWNE_HCMV_INFECTION_8HR_UP,76,Down,0.460001291631386,0.999485802679459
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,34,Down,0.460231773636664,0.999485802679459
ST_ERK1_ERK2_MAPK_PATHWAY,31,Down,0.460644586232312,0.999485802679459
MIKKELSEN_MEF_ICP_WITH_H3K27ME3,64,Up,0.460760669301625,0.999485802679459
SWEET_KRAS_TARGETS_DN,50,Down,0.46100573023097,0.999485802679459
REACTOME_SIGNALLING_TO_RAS,23,Down,0.461308020742831,0.999485802679459
HINATA_NFKB_TARGETS_KERATINOCYTE_DN,14,Down,0.462165293605589,0.999485802679459
BIOCARTA_HSP27_PATHWAY,10,Up,0.462566570493986,0.999485802679459
MEISSNER_NPC_HCP_WITH_H3K27ME3,30,Up,0.462695977754452,0.999485802679459
REACTOME_SIGNALING_BY_ERBB4,72,Down,0.462734947671855,0.999485802679459
HORIUCHI_WTAP_TARGETS_DN,265,Down,0.462881337593288,0.999485802679459
SA_REG_CASCADE_OF_CYCLIN_EXPR,11,Down,0.463388799415098,0.999485802679459
REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION,19,Down,0.463539850307831,0.999485802679459
REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1,13,Down,0.463737456056487,0.999485802679459
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,92,Down,0.463931340417992,0.999485802679459
CHANGOLKAR_H2AFY_TARGETS_DN,28,Up,0.46406761753988,0.999485802679459
SIG_CHEMOTAXIS,39,Up,0.464397874121516,0.999485802679459
WANG_LSD1_TARGETS_DN,22,Down,0.464499793253301,0.999485802679459
OUILLETTE_CLL_13Q14_DELETION_UP,52,Up,0.464670776222099,0.999485802679459
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,138,Down,0.464804377559751,0.999485802679459
ZHU_CMV_8_HR_DN,46,Up,0.46480541544165,0.999485802679459
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP,11,Down,0.465196990483497,0.999485802679459
NOUSHMEHR_GBM_SOMATIC_MUTATED,8,Down,0.465604220021926,0.999485802679459
PID_FAS_PATHWAY,35,Down,0.466030924690831,0.999485802679459
MCGOWAN_RSP6_TARGETS_DN,3,Up,0.466080428138143,0.999485802679459
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3,27,Up,0.466135936834259,0.999485802679459
BASSO_CD40_SIGNALING_UP,69,Up,0.466263936446082,0.999485802679459
RASHI_RESPONSE_TO_IONIZING_RADIATION_6,52,Up,0.467071709565782,0.999485802679459
NEBEN_AML_WITH_FLT3_OR_NRAS_UP,8,Up,0.467266163355616,0.999485802679459
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,81,Down,0.467423127015316,0.999485802679459
NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON,36,Up,0.467997040370592,0.999485802679459
NABA_PROTEOGLYCANS,12,Up,0.468470868752974,0.999485802679459
BERNARD_PPAPDC1B_TARGETS_DN,39,Down,0.468490271822813,0.999485802679459
MODY_HIPPOCAMPUS_NEONATAL,30,Down,0.468678465965359,0.999485802679459
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP,198,Up,0.468740514630685,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP,13,Up,0.46875673334469,0.999485802679459
ABE_VEGFA_TARGETS_30MIN,14,Up,0.468860572404731,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_5_UP,11,Down,0.46905385695388,0.999485802679459
BILANGES_SERUM_SENSITIVE_VIA_TSC2,30,Down,0.469402209245332,0.999485802679459
PID_RETINOIC_ACID_PATHWAY,27,Down,0.46962238182458,0.999485802679459
BIOCARTA_PLATELETAPP_PATHWAY,9,Down,0.471112861371801,0.999485802679459
APPEL_IMATINIB_RESPONSE,26,Down,0.471173384338989,0.999485802679459
WEI_MIR34A_TARGETS,124,Down,0.471538707680355,0.999485802679459
MULLIGHAN_MLL_SIGNATURE_2_UP,333,Up,0.471544684271892,0.999485802679459
BIOCARTA_UCALPAIN_PATHWAY,15,Up,0.472371170786366,0.999485802679459
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,164,Up,0.472945435750713,0.999485802679459
LUI_TARGETS_OF_PAX8_PPARG_FUSION,30,Down,0.473073092397899,0.999485802679459
PID_IL1_PATHWAY,32,Up,0.473323420802093,0.999485802679459
WU_HBX_TARGETS_2_UP,18,Up,0.473423756571734,0.999485802679459
REACTOME_ACYL_CHAIN_REMODELLING_OF_PS,5,Up,0.473600488303156,0.999485802679459
TERAMOTO_OPN_TARGETS_CLUSTER_4,12,Up,0.473972925047806,0.999485802679459
NIKOLSKY_BREAST_CANCER_5P15_AMPLICON,16,Down,0.474238312778801,0.999485802679459
PUJANA_BREAST_CANCER_LIT_INT_NETWORK,97,Up,0.474490867276719,0.999485802679459
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,14,Down,0.47525779142259,0.999485802679459
ABDULRAHMAN_KIDNEY_CANCER_VHL_DN,11,Down,0.475358634255132,0.999485802679459
NIELSEN_SYNOVIAL_SARCOMA_DN,12,Down,0.475475838397032,0.999485802679459
SCHAVOLT_TARGETS_OF_TP53_AND_TP63,16,Down,0.47566277718139,0.999485802679459
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,37,Up,0.475934471821563,0.999485802679459
KEGG_NUCLEOTIDE_EXCISION_REPAIR,41,Down,0.476163930990152,0.999485802679459
COLDREN_GEFITINIB_RESISTANCE_DN,133,Down,0.476348946052636,0.999485802679459
SMITH_TERT_TARGETS_UP,130,Down,0.476781000927853,0.999485802679459
BIOCARTA_RARRXR_PATHWAY,15,Up,0.476838457808372,0.999485802679459
ZHENG_BOUND_BY_FOXP3,358,Up,0.476842933606855,0.999485802679459
RODRIGUES_DCC_TARGETS_DN,107,Up,0.477267706373088,0.999485802679459
GERY_CEBP_TARGETS,97,Down,0.477384962008107,0.999485802679459
REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES,243,Down,0.4792588159474,0.999485802679459
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,52,Up,0.480114598739452,0.999485802679459
BORCZUK_MALIGNANT_MESOTHELIOMA_DN,58,Up,0.480219909328958,0.999485802679459
CUI_TCF21_TARGETS_UP,26,Up,0.48042650688971,0.999485802679459
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,74,Down,0.480588957344408,0.999485802679459
PETRETTO_BLOOD_PRESSURE_DN,6,Down,0.480787869828005,0.999485802679459
GAVIN_FOXP3_TARGETS_CLUSTER_P4,60,Down,0.480917352657519,0.999485802679459
REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS,3,Down,0.480996297985246,0.999485802679459
SANA_TNF_SIGNALING_DN,63,Down,0.481075706692881,0.999485802679459
TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN,13,Up,0.481319091203405,0.999485802679459
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,138,Down,0.481548073329236,0.999485802679459
SA_G2_AND_M_PHASES,8,Down,0.482418557607169,0.999485802679459
PEART_HDAC_PROLIFERATION_CLUSTER_UP,54,Down,0.48257677532783,0.999485802679459
CHOI_ATL_CHRONIC_VS_ACUTE_DN,17,Down,0.48260839697347,0.999485802679459
MA_MYELOID_DIFFERENTIATION_UP,30,Down,0.482758118271141,0.999485802679459
ONKEN_UVEAL_MELANOMA_DN,447,Down,0.482930315055124,0.999485802679459
HOLLEMAN_DAUNORUBICIN_ALL_DN,6,Up,0.483303255979602,0.999485802679459
ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP,300,Down,0.483446720502738,0.999485802679459
REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,16,Down,0.483713422165831,0.999485802679459
REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX,26,Up,0.484123203260425,0.999485802679459
KASLER_HDAC7_TARGETS_1_DN,16,Up,0.484435486168604,0.999485802679459
REACTOME_ENDOGENOUS_STEROLS,2,Up,0.484656843203733,0.999485802679459
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,73,Down,0.484914362253363,0.999485802679459
ZHOU_TNF_SIGNALING_30MIN,44,Down,0.484963518292525,0.999485802679459
BIOCARTA_TCYTOTOXIC_PATHWAY,4,Down,0.485333701308191,0.999485802679459
DANG_REGULATED_BY_MYC_UP,64,Up,0.485871485073857,0.999485802679459
PID_IL3_PATHWAY,21,Down,0.486070383112835,0.999485802679459
KOBAYASHI_EGFR_SIGNALING_6HR_UP,6,Up,0.486529839361986,0.999485802679459
XU_GH1_EXOGENOUS_TARGETS_DN,77,Down,0.486711044489034,0.999485802679459
REACTOME_LIPOPROTEIN_METABOLISM,17,Down,0.486739190888213,0.999485802679459
SEKI_INFLAMMATORY_RESPONSE_LPS_DN,17,Down,0.486938835619239,0.999485802679459
DAIRKEE_CANCER_PRONE_RESPONSE_E2,22,Down,0.487186306499201,0.999485802679459
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,83,Down,0.487236434042198,0.999485802679459
LANDIS_ERBB2_BREAST_TUMORS_324_DN,118,Up,0.487382339598203,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_CD1_DN,32,Down,0.48761774052055,0.999485802679459
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,71,Down,0.487642736411279,0.999485802679459
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,292,Down,0.487817506712136,0.999485802679459
YIH_RESPONSE_TO_ARSENITE_C4,17,Up,0.488090552544592,0.999485802679459
REACTOME_REGULATORY_RNA_PATHWAYS,24,Down,0.488158160014354,0.999485802679459
KAMIKUBO_MYELOID_MN1_NETWORK,17,Down,0.488297858139578,0.999485802679459
CHUANG_OXIDATIVE_STRESS_RESPONSE_DN,11,Down,0.488619196478142,0.999485802679459
KIM_WT1_TARGETS_12HR_UP,138,Up,0.488712536872236,0.999485802679459
GENTILE_UV_RESPONSE_CLUSTER_D4,53,Down,0.489088350609053,0.999485802679459
KEGG_DNA_REPLICATION,35,Down,0.489250609543869,0.999485802679459
KAMMINGA_SENESCENCE,28,Up,0.489565433482491,0.999485802679459
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,150,Down,0.489593036680678,0.999485802679459
REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE,12,Up,0.489829500294528,0.999485802679459
ZWANG_EGF_PERSISTENTLY_DN,40,Up,0.490422583154676,0.999485802679459
CUI_TCF21_TARGETS_2_UP,312,Down,0.490772443568734,0.999485802679459
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,83,Up,0.490799192902363,0.999485802679459
AMIT_EGF_RESPONSE_120_HELA,61,Up,0.490948227498682,0.999485802679459
RAGHAVACHARI_PLATELET_SPECIFIC_GENES,56,Down,0.49131468771516,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22,9,Down,0.491420247076209,0.999485802679459
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN,21,Down,0.491517424912246,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7,7,Up,0.491522346753694,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,58,Down,0.492235852912485,0.999485802679459
KEGG_INSULIN_SIGNALING_PATHWAY,111,Down,0.492596860878673,0.999485802679459
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,75,Down,0.492902833194651,0.999485802679459
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,209,Down,0.493070741406784,0.999485802679459
LAIHO_COLORECTAL_CANCER_SERRATED_DN,68,Down,0.493856920941652,0.999485802679459
PID_ERBB_NETWORK_PATHWAY,11,Down,0.493937958257587,0.999485802679459
PID_LIS1_PATHWAY,23,Down,0.49468687343877,0.999485802679459
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,27,Down,0.495016043653982,0.999485802679459
REACTOME_PYRUVATE_METABOLISM,17,Down,0.495050483354528,0.999485802679459
TIEN_INTESTINE_PROBIOTICS_2HR_UP,26,Down,0.495107688435773,0.999485802679459
HOFMANN_CELL_LYMPHOMA_DN,32,Up,0.495179151067671,0.999485802679459
BOQUEST_STEM_CELL_UP,178,Up,0.495344309689012,0.999485802679459
GU_PDEF_TARGETS_UP,67,Down,0.495667239959983,0.999485802679459
OXFORD_RALB_TARGETS_DN,9,Down,0.495750787680046,0.999485802679459
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN,49,Down,0.496101828218625,0.999485802679459
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,15,Up,0.496232606854742,0.999485802679459
ZWANG_EGF_PERSISTENTLY_UP,26,Up,0.496255656562951,0.999485802679459
RAMASWAMY_METASTASIS_DN,41,Up,0.496650506603044,0.999485802679459
SCHMAHL_PDGF_SIGNALING,8,Up,0.496817975526116,0.999485802679459
LI_CYTIDINE_ANALOGS_CYCTOTOXICITY,12,Down,0.496886758571086,0.999485802679459
BOYLAN_MULTIPLE_MYELOMA_C_D_UP,107,Down,0.497087638967229,0.999485802679459
NIELSEN_LIPOSARCOMA_UP,8,Down,0.497148625606074,0.999485802679459
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,107,Down,0.497578181944935,0.999485802679459
BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING,403,Up,0.498410713540499,0.999485802679459
SU_THYMUS,10,Up,0.498843236840193,0.999485802679459
WEBER_METHYLATED_LCP_IN_SPERM_DN,3,Up,0.498858911676057,0.999485802679459
KANG_GLIS3_TARGETS,11,Up,0.498968935431805,0.999485802679459
REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1,12,Down,0.499041680596054,0.999485802679459
REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_,60,Down,0.499394147469499,0.999485802679459
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,64,Up,0.50003373008351,0.999485802679459
GRABARCZYK_BCL11B_TARGETS_UP,59,Down,0.500198636727836,0.999485802679459
VALK_AML_WITH_FLT3_ITD,31,Down,0.500208194282259,0.999485802679459
MCDOWELL_ACUTE_LUNG_INJURY_UP,38,Up,0.500256169279224,0.999485802679459
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,68,Up,0.5006926145108,0.999485802679459
YANG_BREAST_CANCER_ESR1_LASER_UP,24,Up,0.500707258942314,0.999485802679459
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,10,Up,0.500938849853266,0.999485802679459
REACTOME_HS_GAG_DEGRADATION,16,Down,0.501056506109792,0.999485802679459
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN,12,Down,0.501115559115219,0.999485802679459
LEE_LIVER_CANCER_MYC_TGFA_UP,43,Down,0.501220306649049,0.999485802679459
KYNG_WERNER_SYNDROM_DN,23,Down,0.501380879934268,0.999485802679459
AMIT_SERUM_RESPONSE_40_MCF10A,28,Up,0.501823762209973,0.999485802679459
REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE,11,Down,0.501875570442054,0.999485802679459
LEE_DIFFERENTIATING_T_LYMPHOCYTE,121,Up,0.502100384685645,0.999485802679459
DASU_IL6_SIGNALING_DN,6,Up,0.502389135545684,0.999485802679459
SMITH_TERT_TARGETS_DN,75,Up,0.502396383772336,0.999485802679459
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP,570,Down,0.502739111755286,0.999485802679459
PID_TCR_RAS_PATHWAY,11,Up,0.502830710033065,0.999485802679459
KIM_TIAL1_TARGETS,27,Down,0.503086422073392,0.999485802679459
REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT,10,Down,0.503761193447119,0.999485802679459
ONDER_CDH1_TARGETS_3_DN,29,Down,0.503836919941005,0.999485802679459
LEI_MYB_TARGETS,270,Up,0.504073036488044,0.999485802679459
REACTOME_COPI_MEDIATED_TRANSPORT,10,Down,0.50419244113852,0.999485802679459
PID_MET_PATHWAY,73,Down,0.504350884889166,0.999485802679459
PID_RXR_VDR_PATHWAY,20,Down,0.504461576243342,0.999485802679459
REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP,17,Down,0.504989831398327,0.999485802679459
KEGG_RNA_POLYMERASE,28,Down,0.505287366255566,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,141,Down,0.505362992335684,0.999485802679459
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,16,Up,0.505479305460983,0.999485802679459
WANG_BARRETTS_ESOPHAGUS_DN,18,Down,0.505511677107946,0.999485802679459
WENG_POR_TARGETS_LIVER_UP,26,Up,0.505529033986962,0.999485802679459
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,105,Down,0.506437897613538,0.999485802679459
MATHEW_FANCONI_ANEMIA_GENES,11,Down,0.506494962964873,0.999485802679459
MODY_HIPPOCAMPUS_POSTNATAL,53,Down,0.506576018855084,0.999485802679459
REACTOME_STEROID_HORMONES,7,Up,0.506834743820259,0.999485802679459
CHESLER_BRAIN_QTL_TRANS,5,Down,0.506882110652903,0.999485802679459
REACTOME_PURINE_SALVAGE,12,Down,0.506968773502418,0.999485802679459
MANALO_HYPOXIA_UP,166,Up,0.507405006366047,0.999485802679459
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP,11,Up,0.507580712167776,0.999485802679459
NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON,12,Down,0.507660005830105,0.999485802679459
LIU_SOX4_TARGETS_DN,267,Down,0.507703433286439,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27,7,Down,0.507768180484725,0.999485802679459
FINETTI_BREAST_CANCER_KINOME_RED,16,Down,0.508435572787009,0.999485802679459
MOTAMED_RESPONSE_TO_ANDROGEN_UP,3,Up,0.508573879775937,0.999485802679459
KAMMINGA_EZH2_TARGETS,40,Down,0.509067085358107,0.999485802679459
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,19,Down,0.509150246061177,0.999485802679459
GYORFFY_MITOXANTRONE_RESISTANCE,39,Up,0.509246986215958,0.999485802679459
KEGG_AXON_GUIDANCE,101,Down,0.509273422200588,0.999485802679459
LIAN_LIPA_TARGETS_6M,32,Up,0.509339080371732,0.999485802679459
PID_BMP_PATHWAY,33,Up,0.509511170241298,0.999485802679459
PID_P38_ALPHA_BETA_PATHWAY,26,Down,0.509773620669325,0.999485802679459
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,58,Up,0.510015750779421,0.999485802679459
NAM_FXYD5_TARGETS_DN,18,Down,0.510265601305751,0.999485802679459
BIOCARTA_CYTOKINE_PATHWAY,8,Up,0.51063882980502,0.999485802679459
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,64,Up,0.510645458079586,0.999485802679459
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN,18,Up,0.510701492637224,0.999485802679459
KYNG_WERNER_SYNDROM_UP,15,Down,0.510856326191404,0.999485802679459
GROSS_HYPOXIA_VIA_HIF1A_ONLY,6,Up,0.511570798752082,0.999485802679459
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,31,Down,0.511778883984707,0.999485802679459
BIOCARTA_NKT_PATHWAY,11,Up,0.511807916989555,0.999485802679459
WILENSKY_RESPONSE_TO_DARAPLADIB,14,Down,0.512327649176113,0.999485802679459
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN,2,Up,0.51301684071016,0.999485802679459
NABA_MATRISOME_ASSOCIATED,333,Down,0.513022756352081,0.999485802679459
CHANG_IMMORTALIZED_BY_HPV31_UP,58,Down,0.513399703706987,0.999485802679459
PETRETTO_HEART_MASS_QTL_CIS_UP,21,Up,0.513551937722086,0.999485802679459
BIOCARTA_CCR3_PATHWAY,16,Up,0.513622676874366,0.999485802679459
VANTVEER_BREAST_CANCER_ESR1_DN,181,Down,0.513981871653862,0.999485802679459
REACTOME_ACTIVATION_OF_RAC,11,Down,0.514360874387157,0.999485802679459
VALK_AML_CLUSTER_16,16,Down,0.514419464931331,0.999485802679459
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,36,Down,0.515455782922999,0.999485802679459
BIOCARTA_IL4_PATHWAY,9,Down,0.515605018853536,0.999485802679459
MARTENS_TRETINOIN_RESPONSE_DN,603,Down,0.515800129656443,0.999485802679459
BROWN_MYELOID_CELL_DEVELOPMENT_DN,94,Up,0.515901517310174,0.999485802679459
YAGI_AML_WITH_T_9_11_TRANSLOCATION,94,Up,0.516023183270783,0.999485802679459
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,216,Down,0.516296171430818,0.999485802679459
GLINSKY_CANCER_DEATH_UP,7,Down,0.516714392225537,0.999485802679459
MARTINELLI_IMMATURE_NEUTROPHIL_UP,2,Down,0.516842570454857,0.999485802679459
REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,13,Down,0.516949264066663,0.999485802679459
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,51,Up,0.517033225784837,0.999485802679459
BIOCARTA_EIF_PATHWAY,14,Down,0.517054000112219,0.999485802679459
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,270,Up,0.517205584394017,0.999485802679459
QI_PLASMACYTOMA_DN,79,Up,0.517273627447513,0.999485802679459
LEE_BMP2_TARGETS_UP,493,Up,0.517563157585632,0.999485802679459
BIOCARTA_RHO_PATHWAY,30,Up,0.517822660380698,0.999485802679459
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,13,Up,0.517961065368269,0.999485802679459
LAU_APOPTOSIS_CDKN2A_DN,5,Down,0.517968901125737,0.999485802679459
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,21,Up,0.518307647286505,0.999485802679459
DARWICHE_PAPILLOMA_PROGRESSION_RISK,43,Down,0.518896533741321,0.999485802679459
CERVERA_SDHB_TARGETS_1_UP,75,Up,0.519311801817911,0.999485802679459
GRESHOCK_CANCER_COPY_NUMBER_UP,262,Up,0.519479437852364,0.999485802679459
DURAND_STROMA_NS_UP,117,Up,0.519963988113792,0.999485802679459
FALVELLA_SMOKERS_WITH_LUNG_CANCER,61,Down,0.520049648102443,0.999485802679459
PID_P53_REGULATION_PATHWAY,53,Up,0.52031442447546,0.999485802679459
SCHUHMACHER_MYC_TARGETS_UP,74,Up,0.520409151628688,0.999485802679459
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,256,Up,0.520726510194153,0.999485802679459
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,23,Down,0.520973692328258,0.999485802679459
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,66,Up,0.520997087677849,0.999485802679459
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,30,Up,0.521210804355738,0.999485802679459
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,146,Down,0.52137449821283,0.999485802679459
BIOCARTA_RAB_PATHWAY,11,Down,0.521994498824885,0.999485802679459
BROCKE_APOPTOSIS_REVERSED_BY_IL6,119,Up,0.522051715605806,0.999485802679459
OHASHI_AURKB_TARGETS,8,Up,0.522060764220791,0.999485802679459
RODRIGUES_NTN1_TARGETS_UP,15,Up,0.522160568423498,0.999485802679459
WENG_POR_TARGETS_GLOBAL_DN,17,Down,0.522397935046847,0.999485802679459
PID_HNF3B_PATHWAY,21,Up,0.522714402192761,0.999485802679459
MORI_MATURE_B_LYMPHOCYTE_UP,62,Down,0.522910657695011,0.999485802679459
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,86,Down,0.523384160713178,0.999485802679459
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,116,Down,0.52366972168432,0.999485802679459
OZEN_MIR125B1_TARGETS,24,Down,0.523743965720748,0.999485802679459
PID_PDGFRB_PATHWAY,116,Up,0.523778711459825,0.999485802679459
KEGG_CALCIUM_SIGNALING_PATHWAY,111,Down,0.523944649504088,0.999485802679459
BIOCARTA_EPO_PATHWAY,16,Down,0.524271693868669,0.999485802679459
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,102,Down,0.524531071440317,0.999485802679459
BIOCARTA_NEUROTRANSMITTERS_PATHWAY,1,Down,0.524537138531004,0.999485802679459
GROSS_HIF1A_TARGETS_DN,19,Down,0.524599690114893,0.999485802679459
FARMER_BREAST_CANCER_CLUSTER_4,16,Down,0.525540658927365,0.999485802679459
PHONG_TNF_TARGETS_UP,52,Up,0.525863647527132,0.999485802679459
GENTILE_UV_RESPONSE_CLUSTER_D9,26,Down,0.526088973855062,0.999485802679459
BURTON_ADIPOGENESIS_PEAK_AT_16HR,36,Down,0.526644828626058,0.999485802679459
PID_NCADHERIN_PATHWAY,30,Down,0.526819230150835,0.999485802679459
BOUDOUKHA_BOUND_BY_IGF2BP2,84,Down,0.527249316712159,0.999485802679459
GENTLES_LEUKEMIC_STEM_CELL_UP,17,Up,0.527801657307561,0.999485802679459
PYEON_HPV_POSITIVE_TUMORS_UP,66,Up,0.52782810712339,0.999485802679459
PID_ER_NONGENOMIC_PATHWAY,33,Down,0.527942057912743,0.999485802679459
KHETCHOUMIAN_TRIM24_TARGETS_UP,37,Up,0.528107835649305,0.999485802679459
VECCHI_GASTRIC_CANCER_EARLY_DN,165,Up,0.528124943292464,0.999485802679459
VISALA_AGING_LYMPHOCYTE_DN,15,Up,0.528227727574757,0.999485802679459
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,60,Up,0.528740050733686,0.999485802679459
SMIRNOV_RESPONSE_TO_IR_6HR_UP,141,Up,0.528817304089096,0.999485802679459
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP,22,Down,0.529000857815238,0.999485802679459
ONDER_CDH1_TARGETS_1_DN,133,Down,0.529138543014312,0.999485802679459
BIOCARTA_BAD_PATHWAY,21,Down,0.529810985773271,0.999485802679459
HINATA_NFKB_TARGETS_FIBROBLAST_UP,61,Up,0.529958632474046,0.999485802679459
KEGG_LONG_TERM_DEPRESSION,38,Up,0.52996055966741,0.999485802679459
AIYAR_COBRA1_TARGETS_UP,26,Down,0.530069487284525,0.999485802679459
WANG_CLIM2_TARGETS_UP,197,Up,0.530696783236788,0.999485802679459
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,95,Down,0.530752474075717,0.999485802679459
PID_HIF2PATHWAY,27,Up,0.530865142177916,0.999485802679459
LEI_HOXC8_TARGETS_UP,8,Down,0.53099551312463,0.999485802679459
SWEET_KRAS_TARGETS_UP,73,Down,0.531092714605111,0.999485802679459
MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN,4,Up,0.531185700672755,0.999485802679459
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,98,Down,0.531332271841927,0.999485802679459
WHITESIDE_CISPLATIN_RESISTANCE_UP,11,Down,0.531411824635317,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,17,Up,0.53145413475874,0.999485802679459
BROWNE_HCMV_INFECTION_2HR_UP,24,Up,0.531460935363319,0.999485802679459
SHIN_B_CELL_LYMPHOMA_CLUSTER_1,8,Up,0.531820089675444,0.999485802679459
COATES_MACROPHAGE_M1_VS_M2_DN,51,Up,0.532195949342027,0.999485802679459
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,23,Down,0.532410577726686,0.999485802679459
RASHI_NFKB1_TARGETS,17,Up,0.532575197309142,0.999485802679459
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,66,Down,0.532805355784584,0.999485802679459
BRUECKNER_TARGETS_OF_MIRLET7A3_DN,62,Down,0.532890694630396,0.999485802679459
NAKAJIMA_MAST_CELL,31,Down,0.533012405515858,0.999485802679459
REACTOME_INFLAMMASOMES,14,Up,0.533283935004795,0.999485802679459
GHANDHI_DIRECT_IRRADIATION_UP,72,Up,0.533329500534859,0.999485802679459
BIOCARTA_VIP_PATHWAY,22,Up,0.533336503994877,0.999485802679459
SENESE_HDAC1_TARGETS_UP,378,Up,0.533629315069345,0.999485802679459
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_,50,Down,0.533849639286903,0.999485802679459
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,16,Up,0.533934335201696,0.999485802679459
BIOCARTA_SHH_PATHWAY,15,Up,0.534124552193224,0.999485802679459
PID_ATF2_PATHWAY,52,Up,0.534366776742817,0.999485802679459
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,24,Down,0.53456773862323,0.999485802679459
REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS,4,Up,0.534792164812727,0.999485802679459
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,38,Down,0.534956754363052,0.999485802679459
KORKOLA_EMBRYONAL_CARCINOMA_DN,6,Up,0.535091836902554,0.999485802679459
BROWNE_HCMV_INFECTION_6HR_DN,136,Down,0.535318114988032,0.999485802679459
ZHAN_EARLY_DIFFERENTIATION_GENES_UP,5,Down,0.535449012360593,0.999485802679459
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,185,Up,0.53548797399445,0.999485802679459
REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION,12,Down,0.535541495281196,0.999485802679459
PID_P53_DOWNSTREAM_PATHWAY,117,Up,0.535563754673736,0.999485802679459
PID_BARD1_PATHWAY,28,Down,0.536059231428861,0.999485802679459
BIOCARTA_MAL_PATHWAY,15,Up,0.53623710521666,0.999485802679459
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,431,Down,0.53644756380741,0.999485802679459
REACTOME_FANCONI_ANEMIA_PATHWAY,19,Down,0.536479909400675,0.999485802679459
NAKAYAMA_FRA2_TARGETS,35,Up,0.536521407936866,0.999485802679459
MATZUK_MEIOTIC_AND_DNA_REPAIR,27,Up,0.536705298141015,0.999485802679459
BIOCARTA_FEEDER_PATHWAY,6,Down,0.536728736821252,0.999485802679459
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,22,Up,0.537573856727803,0.999485802679459
KREPPEL_CD99_TARGETS_UP,5,Down,0.537619469540875,0.999485802679459
KORKOLA_SEMINOMA_UP,32,Down,0.537626263788385,0.999485802679459
REACTOME_TCR_SIGNALING,31,Down,0.538990235733869,0.999485802679459
SMID_BREAST_CANCER_LUMINAL_B_UP,102,Down,0.539319099038824,0.999485802679459
REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION,8,Down,0.539403883020559,0.999485802679459
MITSIADES_RESPONSE_TO_APLIDIN_UP,352,Up,0.539499623954558,0.999485802679459
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,229,Down,0.539528524227124,0.999485802679459
MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP,8,Down,0.539582588739346,0.999485802679459
LU_IL4_SIGNALING,69,Up,0.539715256644834,0.999485802679459
BENPORATH_PROLIFERATION,136,Down,0.540264315827558,0.999485802679459
FERRANDO_HOX11_NEIGHBORS,17,Up,0.540470186311636,0.999485802679459
HUANG_DASATINIB_RESISTANCE_DN,55,Up,0.54052402348054,0.999485802679459
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT,24,Up,0.540657763108145,0.999485802679459
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,169,Up,0.540782309085307,0.999485802679459
OXFORD_RALB_TARGETS_UP,7,Down,0.540787798085018,0.999485802679459
BIOCARTA_RAS_PATHWAY,22,Up,0.540799629204694,0.999485802679459
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,137,Down,0.540999207540396,0.999485802679459
LOPES_METHYLATED_IN_COLON_CANCER_UP,10,Down,0.541217027611264,0.999485802679459
VERHAAK_AML_WITH_NPM1_MUTATED_DN,146,Up,0.541246694937221,0.999485802679459
DING_LUNG_CANCER_BY_MUTATION_RATE,16,Up,0.541927515607335,0.999485802679459
BIOCARTA_NUCLEARRS_PATHWAY,7,Down,0.541939779294456,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15,9,Down,0.542429760293472,0.999485802679459
GRADE_COLON_VS_RECTAL_CANCER_DN,42,Down,0.542487067832064,0.999485802679459
REACTOME_DEFENSINS,1,Down,0.542550404555095,0.999485802679459
REACTOME_BETA_DEFENSINS,1,Down,0.542550404555095,0.999485802679459
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,91,Up,0.542692391851858,0.999485802679459
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP,5,Down,0.542716046622964,0.999485802679459
IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,9,Down,0.542770060422475,0.999485802679459
YANG_BREAST_CANCER_ESR1_DN,16,Up,0.543267727013289,0.999485802679459
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,68,Down,0.543403144222495,0.999485802679459
NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON,20,Down,0.543958959315676,0.999485802679459
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,50,Down,0.544139284714315,0.999485802679459
VILIMAS_NOTCH1_TARGETS_DN,7,Up,0.544272853091724,0.999485802679459
RAMALHO_STEMNESS_UP,186,Down,0.544320462631001,0.999485802679459
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS,7,Down,0.54452333894781,0.999485802679459
MCBRYAN_TERMINAL_END_BUD_DN,5,Down,0.545042637378317,0.999485802679459
VALK_AML_CLUSTER_4,22,Up,0.545362178273184,0.999485802679459
REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN,24,Down,0.545551194133299,0.999485802679459
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,146,Down,0.545758518567203,0.999485802679459
BAFNA_MUC4_TARGETS_UP,5,Down,0.545764665129939,0.999485802679459
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,200,Down,0.545996623236779,0.999485802679459
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN,12,Up,0.546044664469481,0.999485802679459
MIKKELSEN_ES_ICP_WITH_H3K27ME3,8,Up,0.546294087752172,0.999485802679459
REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS,22,Down,0.546394397645958,0.999485802679459
LIN_MELANOMA_COPY_NUMBER_DN,35,Down,0.546474189624505,0.999485802679459
KEGG_GLUTATHIONE_METABOLISM,36,Down,0.54670467800255,0.999485802679459
WANG_CISPLATIN_RESPONSE_AND_XPC_DN,196,Up,0.54712626654368,0.999485802679459
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,35,Up,0.547207951020242,0.999485802679459
YOKOE_CANCER_TESTIS_ANTIGENS,26,Up,0.547260091132041,0.999485802679459
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,8,Down,0.547669085111434,0.999485802679459
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,394,Down,0.547757187867685,0.999485802679459
DARWICHE_PAPILLOMA_RISK_HIGH_UP,92,Down,0.547905489836617,0.999485802679459
REACTOME_SIGNALING_BY_ROBO_RECEPTOR,26,Down,0.547952910840513,0.999485802679459
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN,9,Up,0.548016340094934,0.999485802679459
MATZUK_EMBRYONIC_GERM_CELL,14,Down,0.548122933812119,0.999485802679459
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,54,Down,0.548356246667628,0.999485802679459
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,74,Down,0.548659078693236,0.999485802679459
KEGG_CELL_CYCLE,116,Down,0.548789934392719,0.999485802679459
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,15,Down,0.549252949306956,0.999485802679459
BIOCARTA_ERK5_PATHWAY,15,Down,0.549327863595144,0.999485802679459
SHIN_B_CELL_LYMPHOMA_CLUSTER_7,22,Up,0.549540047452597,0.999485802679459
MUELLER_PLURINET,261,Up,0.54957120005485,0.999485802679459
LE_EGR2_TARGETS_UP,94,Down,0.549911661263043,0.999485802679459
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP,406,Up,0.550022901444902,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,25,Up,0.550377215232924,0.999485802679459
MIKKELSEN_IPS_LCP_WITH_H3K27ME3,4,Up,0.550589696969526,0.999485802679459
MOOTHA_MITOCHONDRIA,363,Down,0.550656726157786,0.999485802679459
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE,18,Down,0.550826121331066,0.999485802679459
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,30,Up,0.550903544425187,0.999485802679459
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,110,Up,0.551016906729576,0.999485802679459
KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT,32,Down,0.551188368564361,0.999485802679459
PODAR_RESPONSE_TO_ADAPHOSTIN_DN,16,Down,0.551836315721395,0.999485802679459
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,34,Down,0.551872994044245,0.999485802679459
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,47,Up,0.551966151423119,0.999485802679459
LU_AGING_BRAIN_DN,117,Up,0.552406066026913,0.999485802679459
DAIRKEE_CANCER_PRONE_RESPONSE_BPA,45,Up,0.552668912865339,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,120,Up,0.55293546876134,0.999485802679459
PID_AJDISS_2PATHWAY,41,Up,0.553110815287852,0.999485802679459
BIOCARTA_P35ALZHEIMERS_PATHWAY,9,Up,0.553813620971844,0.999485802679459
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,299,Up,0.554224038651565,0.999485802679459
ZHU_CMV_8_HR_UP,41,Down,0.554314353802371,0.999485802679459
PID_TGFBR_PATHWAY,51,Down,0.554350239130858,0.999485802679459
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,111,Up,0.554524145852025,0.999485802679459
TERAMOTO_OPN_TARGETS_CLUSTER_5,4,Down,0.554587215930653,0.999485802679459
YANG_BREAST_CANCER_ESR1_LASER_DN,43,Down,0.555004500692468,0.999485802679459
PETROVA_PROX1_TARGETS_DN,56,Up,0.555156503659482,0.999485802679459
REACTOME_GLUCOSE_TRANSPORT,30,Down,0.555437768495039,0.999485802679459
BIOCARTA_BLYMPHOCYTE_PATHWAY,3,Down,0.555741962712723,0.999485802679459
CHASSOT_SKIN_WOUND,8,Up,0.555830192061272,0.999485802679459
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,11,Down,0.55605641487036,0.999485802679459
RICKMAN_METASTASIS_UP,268,Down,0.556650684410899,0.999485802679459
BURTON_ADIPOGENESIS_3,95,Up,0.556665104967773,0.999485802679459
ZHENG_FOXP3_TARGETS_DN,5,Down,0.556770919770202,0.999485802679459
CORRADETTI_MTOR_PATHWAY_REGULATORS_DN,6,Down,0.556881420742808,0.999485802679459
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,24,Up,0.5569534450468,0.999485802679459
WANG_BARRETTS_ESOPHAGUS_UP,30,Up,0.557038716249164,0.999485802679459
NUYTTEN_EZH2_TARGETS_UP,883,Up,0.557287628319573,0.999485802679459
CAIRO_LIVER_DEVELOPMENT_UP,125,Up,0.557290600325648,0.999485802679459
REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM,5,Down,0.557458678756686,0.999485802679459
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,30,Down,0.557514435454481,0.999485802679459
CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP,4,Down,0.557817802841774,0.999485802679459
SMID_BREAST_CANCER_LUMINAL_B_DN,288,Up,0.557883454852585,0.999485802679459
PENG_LEUCINE_DEPRIVATION_DN,169,Down,0.558210006856886,0.999485802679459
REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR,12,Down,0.558368301250306,0.999485802679459
ZUCCHI_METASTASIS_UP,38,Down,0.558685035960096,0.999485802679459
MOOTHA_HUMAN_MITODB_6_2002,354,Down,0.558730547201411,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,16,Down,0.558766858243817,0.999485802679459
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,68,Down,0.558823818188537,0.999485802679459
REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR,9,Down,0.558962300676929,0.999485802679459
LIM_MAMMARY_STEM_CELL_UP,343,Up,0.559011094059488,0.999485802679459
REACTOME_EXTENSION_OF_TELOMERES,26,Down,0.559064262452609,0.999485802679459
BRIDEAU_IMPRINTED_GENES,35,Down,0.559074105809684,0.999485802679459
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN,12,Down,0.559458943745106,0.999485802679459
REACTOME_PI_3K_CASCADE,38,Down,0.559498337271708,0.999485802679459
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,177,Up,0.559542076427347,0.999485802679459
REACTOME_AXON_GUIDANCE,194,Down,0.559721916549915,0.999485802679459
APPIERTO_RESPONSE_TO_FENRETINIDE_UP,34,Up,0.559942341138848,0.999485802679459
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,41,Up,0.560209663830374,0.999485802679459
HUMMERICH_MALIGNANT_SKIN_TUMOR_UP,11,Up,0.560560695462373,0.999485802679459
REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER,14,Down,0.560574428241688,0.999485802679459
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,14,Down,0.560947571490884,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN,4,Down,0.561012495145639,0.999485802679459
BIOCARTA_PTC1_PATHWAY,11,Down,0.561187734120676,0.999485802679459
BIOCARTA_EPHA4_PATHWAY,7,Down,0.561293612154275,0.999485802679459
PID_PI3KCI_AKT_PATHWAY,32,Down,0.561307118523025,0.999485802679459
ELLWOOD_MYC_TARGETS_DN,30,Down,0.561472067806301,0.999485802679459
GUILLAUMOND_KLF10_TARGETS_UP,35,Down,0.561683391667181,0.999485802679459
REACTOME_RNA_POL_III_CHAIN_ELONGATION,17,Down,0.561977759294219,0.999485802679459
REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS,10,Up,0.562029290372325,0.999485802679459
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,62,Down,0.562457371466897,0.999485802679459
VANLOO_SP3_TARGETS_DN,58,Down,0.562774769572684,0.999485802679459
KEGG_BASAL_TRANSCRIPTION_FACTORS,28,Down,0.563157526865962,0.999485802679459
NABA_MATRISOME,478,Down,0.563197849492408,0.999485802679459
CHOI_ATL_STAGE_PREDICTOR,34,Up,0.563253214219287,0.999485802679459
GUTIERREZ_MULTIPLE_MYELOMA_UP,31,Down,0.563504637748123,0.999485802679459
MARSON_FOXP3_TARGETS_STIMULATED_DN,8,Up,0.563514120393256,0.999485802679459
ST_WNT_CA2_CYCLIC_GMP_PATHWAY,13,Down,0.563549311149513,0.999485802679459
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,51,Down,0.563903384669381,0.999485802679459
BENPORATH_MYC_MAX_TARGETS,680,Down,0.564296400753399,0.999485802679459
REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION,19,Down,0.564500374184661,0.999485802679459
MUNSHI_MULTIPLE_MYELOMA_DN,9,Down,0.565115397025257,0.999485802679459
KRIEG_HYPOXIA_VIA_KDM3A,45,Down,0.565482610914481,0.999485802679459
BENPORATH_ES_WITH_H3K27ME3,502,Up,0.565548374239982,0.999485802679459
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,43,Up,0.565912355569416,0.999485802679459
MARKS_HDAC_TARGETS_DN,13,Up,0.566709760127865,0.999485802679459
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER,24,Down,0.56677863742749,0.999485802679459
KEGG_PRIMARY_IMMUNODEFICIENCY,16,Up,0.567062601877254,0.999485802679459
PENG_LEUCINE_DEPRIVATION_UP,105,Down,0.567389867419337,0.999485802679459
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP,11,Down,0.567461130812649,0.999485802679459
REACTOME_FRS2_MEDIATED_CASCADE,20,Down,0.56749634739202,0.999485802679459
ALCALA_APOPTOSIS,70,Up,0.567606779824107,0.999485802679459
KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,63,Down,0.567923861710816,0.999485802679459
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN,627,Up,0.567984071367276,0.999485802679459
WELCH_GATA1_TARGETS,16,Down,0.568176654910495,0.999485802679459
REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,8,Down,0.568367543005527,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,52,Up,0.568439152818449,0.999485802679459
EHRLICH_ICF_SYNDROM_DN,10,Down,0.568487111407545,0.999485802679459
MATZUK_SPERMATOZOA,70,Down,0.569200625760821,0.999485802679459
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD,8,Down,0.569293287711014,0.999485802679459
KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,7,Down,0.569544055167009,0.999485802679459
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,18,Up,0.569647553463511,0.999485802679459
KALMA_E2F1_TARGETS,11,Down,0.569773236505835,0.999485802679459
ZHU_CMV_ALL_DN,107,Up,0.569854274703495,0.999485802679459
KEGG_GLYCOLYSIS_GLUCONEOGENESIS,39,Down,0.569864033536532,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,79,Down,0.570024009791811,0.999485802679459
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,29,Down,0.570483182626845,0.999485802679459
DE_YY1_TARGETS_UP,8,Down,0.57054073695197,0.999485802679459
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,64,Up,0.57063229772795,0.999485802679459
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,16,Down,0.570799583374607,0.999485802679459
BIOCARTA_TPO_PATHWAY,20,Down,0.570851355325645,0.999485802679459
REACTOME_OLFACTORY_SIGNALING_PATHWAY,5,Down,0.570974646259059,0.999485802679459
JIANG_VHL_TARGETS,115,Down,0.571143930550784,0.999485802679459
BIOCARTA_PARKIN_PATHWAY,9,Up,0.571223114587836,0.999485802679459
DER_IFN_GAMMA_RESPONSE_DN,10,Down,0.571372729858664,0.999485802679459
DORN_ADENOVIRUS_INFECTION_48HR_DN,35,Down,0.571405391318595,0.999485802679459
TIAN_TNF_SIGNALING_VIA_NFKB,22,Down,0.571677804677797,0.999485802679459
JOHNSTONE_PARVB_TARGETS_1_UP,5,Up,0.57193903727003,0.999485802679459
CHANG_IMMORTALIZED_BY_HPV31_DN,48,Up,0.572110544331143,0.999485802679459
WU_CELL_MIGRATION,148,Up,0.57219437731768,0.999485802679459
REACTOME_TIE2_SIGNALING,12,Up,0.572352681495555,0.999485802679459
HUMMEL_BURKITTS_LYMPHOMA_UP,33,Down,0.572485212241183,0.999485802679459
REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING,20,Down,0.57303162565574,0.999485802679459
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,20,Down,0.57303162565574,0.999485802679459
GEORGANTAS_HSC_MARKERS,49,Up,0.573060175827656,0.999485802679459
GAVIN_PDE3B_TARGETS,13,Down,0.573171107380189,0.999485802679459
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN,8,Up,0.573199981005927,0.999485802679459
PID_TOLL_ENDOGENOUS_PATHWAY,19,Up,0.573294257737217,0.999485802679459
WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN,4,Up,0.574333141469298,0.999485802679459
LEIN_NEURON_MARKERS,50,Down,0.574468639185945,0.999485802679459
BIOCARTA_MONOCYTE_PATHWAY,6,Up,0.574512711903117,0.999485802679459
LEE_LIVER_CANCER_SURVIVAL_UP,96,Up,0.575081501789259,0.999485802679459
PASINI_SUZ12_TARGETS_UP,73,Down,0.575188670695717,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_HP_DN,35,Up,0.57531504082383,0.999485802679459
REACTOME_IRON_UPTAKE_AND_TRANSPORT,31,Up,0.575518326934027,0.999485802679459
TONG_INTERACT_WITH_PTTG1,44,Down,0.57567166054056,0.999485802679459
BIOCARTA_INSULIN_PATHWAY,19,Up,0.575809457508827,0.999485802679459
PID_FAK_PATHWAY,55,Down,0.576260573922599,0.999485802679459
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN,3,Down,0.576557959284467,0.999485802679459
SEMBA_FHIT_TARGETS_DN,9,Down,0.576826046398883,0.999485802679459
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,20,Up,0.576894052703914,0.999485802679459
PID_EPHA_FWDPATHWAY,20,Up,0.577384766112898,0.999485802679459
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,10,Up,0.577596778276045,0.999485802679459
REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM,10,Down,0.577598047401905,0.999485802679459
PID_ALPHA_SYNUCLEIN_PATHWAY,21,Up,0.577633757456856,0.999485802679459
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,18,Down,0.577851616414164,0.999485802679459
ELVIDGE_HIF2A_TARGETS_UP,6,Down,0.577921905699477,0.999485802679459
MARTINELLI_IMMATURE_NEUTROPHIL_DN,6,Down,0.578269130659138,0.999485802679459
PID_HIF1_TFPATHWAY,53,Down,0.578684071877682,0.999485802679459
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,70,Up,0.578878087716206,0.999485802679459
BIOCARTA_CTL_PATHWAY,3,Down,0.57897905716299,0.999485802679459
REACTOME_XENOBIOTICS,2,Down,0.579065129603332,0.999485802679459
WORSCHECH_TUMOR_REJECTION_DN,6,Down,0.579108558520407,0.999485802679459
SESTO_RESPONSE_TO_UV_C8,62,Up,0.579145406298599,0.999485802679459
REACTOME_G1_PHASE,32,Down,0.579412416571237,0.999485802679459
RODWELL_AGING_KIDNEY_DN,103,Down,0.579415817845312,0.999485802679459
BHAT_ESR1_TARGETS_VIA_AKT1_DN,66,Down,0.579466517909043,0.999485802679459
RASHI_RESPONSE_TO_IONIZING_RADIATION_3,38,Down,0.579477851732331,0.999485802679459
BIOCARTA_ECM_PATHWAY,23,Up,0.57947808006545,0.999485802679459
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,102,Up,0.580310086253071,0.999485802679459
WIKMAN_ASBESTOS_LUNG_CANCER_DN,18,Down,0.580710671444344,0.999485802679459
REACTOME_SIGNALING_BY_WNT,60,Down,0.580987030328931,0.999485802679459
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,56,Down,0.581012347868012,0.999485802679459
PID_KIT_PATHWAY,45,Down,0.581044211226904,0.999485802679459
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,78,Up,0.581172637722773,0.999485802679459
CONRAD_GERMLINE_STEM_CELL,6,Down,0.581617379583668,0.999485802679459
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP,13,Down,0.581672448359359,0.999485802679459
PIONTEK_PKD1_TARGETS_DN,11,Down,0.58172414038152,0.999485802679459
JISON_SICKLE_CELL_DISEASE_UP,144,Up,0.58194045922907,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,143,Up,0.582027577641539,0.999485802679459
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,9,Down,0.58221401222996,0.999485802679459
LUCAS_HNF4A_TARGETS_DN,6,Down,0.582296168124428,0.999485802679459
REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS,8,Down,0.582410950254445,0.999485802679459
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP,16,Up,0.582745322790616,0.999485802679459
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP,585,Up,0.583094816808407,0.999485802679459
MCLACHLAN_DENTAL_CARIES_DN,54,Down,0.583137386242674,0.999485802679459
LANDIS_ERBB2_BREAST_TUMORS_324_UP,124,Up,0.58325663130427,0.999485802679459
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,39,Down,0.583595122313669,0.999485802679459
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,38,Down,0.583741278635636,0.999485802679459
MOREIRA_RESPONSE_TO_TSA_DN,8,Down,0.583939966610427,0.999485802679459
CHICAS_RB1_TARGETS_SENESCENT,442,Down,0.584013215642095,0.999485802679459
BIDUS_METASTASIS_UP,192,Down,0.584047927676348,0.999485802679459
REACTOME_MRNA_SPLICING_MINOR_PATHWAY,39,Down,0.584080320544267,0.999485802679459
REACTOME_STRIATED_MUSCLE_CONTRACTION,17,Up,0.584103327875575,0.999485802679459
TOMIDA_METASTASIS_UP,23,Down,0.58420466887695,0.999485802679459
ZEILSTRA_CD44_TARGETS_UP,5,Up,0.584311297189118,0.999485802679459
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,90,Down,0.58436316744879,0.999485802679459
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN,19,Up,0.584419124577435,0.999485802679459
PID_FGF_PATHWAY,42,Down,0.584471867228927,0.999485802679459
NUTT_GBM_VS_AO_GLIOMA_DN,39,Down,0.584573474154784,0.999485802679459
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,18,Up,0.585373205517754,0.999485802679459
SEMBA_FHIT_TARGETS_UP,9,Down,0.585457949839318,0.999485802679459
NGUYEN_NOTCH1_TARGETS_UP,25,Up,0.585947963258874,0.999485802679459
HEIDENBLAD_AMPLICON_12P11_12_UP,26,Down,0.585996807668538,0.999485802679459
REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION,32,Up,0.586191956651787,0.999485802679459
DAZARD_UV_RESPONSE_CLUSTER_G2,20,Down,0.586641465274774,0.999485802679459
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN,6,Down,0.586869385460046,0.999485802679459
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,199,Down,0.587091815921304,0.999485802679459
BIOCARTA_HIF_PATHWAY,13,Down,0.587510083492043,0.999485802679459
HOFFMAN_CLOCK_TARGETS_DN,5,Up,0.587822588117029,0.999485802679459
JAZAG_TGFB1_SIGNALING_DN,22,Down,0.587955025521625,0.999485802679459
KERLEY_RESPONSE_TO_CISPLATIN_UP,36,Down,0.588227116093521,0.999485802679459
VANLOO_SP3_TARGETS_UP,5,Down,0.588456758898357,0.999485802679459
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,148,Up,0.588576657277628,0.999485802679459
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,27,Down,0.588602920777858,0.999485802679459
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,73,Down,0.588693863382564,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,15,Up,0.588715488147095,0.999485802679459
EHLERS_ANEUPLOIDY_UP,34,Up,0.58872342476267,0.999485802679459
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,6,Down,0.588842735341502,0.999485802679459
REACTOME_PI_METABOLISM,40,Down,0.589047547277029,0.999485802679459
REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,9,Up,0.589084362145814,0.999485802679459
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN,15,Up,0.589190866814158,0.999485802679459
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4,16,Up,0.589506226686532,0.999485802679459
OHM_EMBRYONIC_CARCINOMA_UP,3,Up,0.590253045834936,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,31,Up,0.590377672944321,0.999485802679459
DIERICK_SEROTONIN_FUNCTION_GENES,2,Down,0.590767820179475,0.999485802679459
KEGG_PRION_DISEASES,23,Down,0.590843568434388,0.999485802679459
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,123,Down,0.590924601425894,0.999485802679459
WESTON_VEGFA_TARGETS_12HR,27,Down,0.591026408281037,0.999485802679459
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN,30,Down,0.591075078362218,0.999485802679459
DORSAM_HOXA9_TARGETS_UP,30,Up,0.591273532659799,0.999485802679459
KEGG_GLIOMA,53,Down,0.591518519304912,0.999485802679459
WU_ALZHEIMER_DISEASE_UP,10,Down,0.591527421869273,0.999485802679459
PID_CXCR3_PATHWAY,35,Down,0.591574149520548,0.999485802679459
REACTOME_SHC_MEDIATED_SIGNALLING,13,Down,0.591631538645114,0.999485802679459
PID_ARF_3PATHWAY,18,Up,0.592103359736712,0.999485802679459
LANDIS_BREAST_CANCER_PROGRESSION_UP,34,Up,0.593110160982321,0.999485802679459
BIOCARTA_CARM_ER_PATHWAY,31,Up,0.59332928863991,0.999485802679459
KEGG_TASTE_TRANSDUCTION,14,Down,0.593345339776225,0.999485802679459
REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS,23,Down,0.593529482902018,0.999485802679459
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP,4,Down,0.593618949346375,0.999485802679459
SIG_BCR_SIGNALING_PATHWAY,39,Up,0.593670084107131,0.999485802679459
SHEPARD_BMYB_TARGETS,51,Down,0.594189215402039,0.999485802679459
KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN,32,Up,0.594317085276146,0.999485802679459
KEGG_LONG_TERM_POTENTIATION,51,Down,0.594364024299831,0.999485802679459
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,50,Down,0.594368038930417,0.999485802679459
PID_AURORA_B_PATHWAY,36,Up,0.594540369052029,0.999485802679459
BIOCARTA_PGC1A_PATHWAY,20,Down,0.594872290625923,0.999485802679459
ST_INTERLEUKIN_4_PATHWAY,21,Up,0.594895563228882,0.999485802679459
CAIRO_HEPATOBLASTOMA_DN,156,Down,0.594981119703652,0.999485802679459
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,33,Down,0.595340543906572,0.999485802679459
BOCHKIS_FOXA2_TARGETS,304,Down,0.596007990180638,0.999485802679459
REACTOME_PROLACTIN_RECEPTOR_SIGNALING,8,Down,0.596038845826401,0.999485802679459
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,36,Up,0.596181742259607,0.999485802679459
FRIDMAN_SENESCENCE_UP,62,Up,0.59625719825853,0.999485802679459
REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT,10,Down,0.596305570030251,0.999485802679459
PID_RET_PATHWAY,34,Down,0.596334523443997,0.999485802679459
LEE_LIVER_CANCER_MYC_TGFA_DN,30,Up,0.596363321248363,0.999485802679459
REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION,8,Down,0.596410364883444,0.999485802679459
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,196,Up,0.596626888902951,0.999485802679459
REACTOME_PHASE_II_CONJUGATION,37,Down,0.596885292643044,0.999485802679459
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP,6,Up,0.597106443635029,0.999485802679459
HOQUE_METHYLATED_IN_CANCER,36,Up,0.597184786418739,0.999485802679459
LA_MEN1_TARGETS,17,Down,0.597538865007421,0.999485802679459
DAZARD_RESPONSE_TO_UV_NHEK_DN,276,Up,0.597764034904381,0.999485802679459
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN,22,Up,0.597853795709774,0.999485802679459
PID_AURORA_A_PATHWAY,31,Down,0.597873807081227,0.999485802679459
BIOCARTA_AMI_PATHWAY,10,Down,0.598053603029685,0.999485802679459
WANG_LMO4_TARGETS_DN,292,Down,0.598192772339397,0.999485802679459
VERHAAK_AML_WITH_NPM1_MUTATED_UP,118,Down,0.598615392470756,0.999485802679459
ZHU_SKIL_TARGETS_UP,19,Up,0.599142141656815,0.999485802679459
DISTECHE_ESCAPED_FROM_X_INACTIVATION,13,Down,0.599445051613129,0.999485802679459
REACTOME_BIOLOGICAL_OXIDATIONS,55,Up,0.599539966962456,0.999485802679459
BROWNE_HCMV_INFECTION_30MIN_DN,96,Down,0.599754669430061,0.999485802679459
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,116,Down,0.599784355557123,0.999485802679459
WESTON_VEGFA_TARGETS,82,Down,0.599785201516107,0.999485802679459
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,22,Down,0.600091732201141,0.999485802679459
HAHTOLA_SEZARY_SYNDROM_UP,64,Up,0.600226121942011,0.999485802679459
KEGG_TYPE_I_DIABETES_MELLITUS,10,Up,0.600285147785107,0.999485802679459
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,65,Up,0.601333702661478,0.999485802679459
RIGGINS_TAMOXIFEN_RESISTANCE_DN,182,Up,0.601835590106863,0.999485802679459
BIOCARTA_IL17_PATHWAY,6,Up,0.60194888753525,0.999485802679459
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3,527,Down,0.602209177381248,0.999485802679459
SCHRAETS_MLL_TARGETS_UP,31,Up,0.602283370124304,0.999485802679459
SEIDEN_ONCOGENESIS_BY_MET,83,Down,0.602311301717721,0.999485802679459
LEI_HOXC8_TARGETS_DN,16,Up,0.60241147737619,0.999485802679459
PID_WNT_SIGNALING_PATHWAY,20,Down,0.602517049200083,0.999485802679459
REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS,7,Down,0.602623373517446,0.999485802679459
KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP,9,Down,0.602703407992621,0.999485802679459
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,75,Down,0.602774935853541,0.999485802679459
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,52,Down,0.602893089086673,0.999485802679459
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,195,Up,0.603131464802734,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24,10,Up,0.603541603137539,0.999485802679459
GAL_LEUKEMIC_STEM_CELL_UP,98,Down,0.60390051041448,0.999485802679459
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,21,Down,0.603925120444227,0.999485802679459
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,17,Up,0.605292319559621,0.999485802679459
WESTON_VEGFA_TARGETS_3HR,56,Down,0.605387369551349,0.999485802679459
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,9,Down,0.605524236887349,0.999485802679459
MARTINEZ_RB1_TARGETS_DN,373,Down,0.605678381437183,0.999485802679459
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN,33,Up,0.605903020545534,0.999485802679459
AZARE_STAT3_TARGETS,22,Down,0.605987322951993,0.999485802679459
COURTOIS_SENESCENCE_TRIGGERS,6,Down,0.606188777093991,0.999485802679459
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,79,Up,0.606245912518556,0.999485802679459
NAKAMURA_ADIPOGENESIS_EARLY_DN,34,Up,0.606306342553079,0.999485802679459
DER_IFN_GAMMA_RESPONSE_UP,62,Up,0.606359465887111,0.999485802679459
BYSTROEM_CORRELATED_WITH_IL5_DN,56,Up,0.606369735328476,0.999485802679459
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS,18,Down,0.606399804884986,0.999485802679459
SCHOEN_NFKB_SIGNALING,27,Up,0.60654056830721,0.999485802679459
CHESLER_BRAIN_HIGHEST_EXPRESSION,30,Up,0.606621961953699,0.999485802679459
DORN_ADENOVIRUS_INFECTION_32HR_DN,33,Down,0.606757217434842,0.999485802679459
REACTOME_TRNA_AMINOACYLATION,40,Down,0.606867681762379,0.999485802679459
REACTOME_MRNA_CAPPING,26,Down,0.606982197570484,0.999485802679459
DORN_ADENOVIRUS_INFECTION_24HR_DN,37,Down,0.607219847366882,0.999485802679459
MADAN_DPPA4_TARGETS,16,Down,0.607412679180587,0.999485802679459
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,180,Up,0.607457937420722,0.999485802679459
THUM_SYSTOLIC_HEART_FAILURE_DN,174,Up,0.607641522942097,0.999485802679459
TERAMOTO_OPN_TARGETS_CLUSTER_3,4,Down,0.607664492575166,0.999485802679459
KAAB_FAILED_HEART_ATRIUM_DN,126,Up,0.60779860725915,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,40,Down,0.608717131076391,0.999485802679459
REACTOME_NETRIN1_SIGNALING,29,Down,0.609481781491914,0.999485802679459
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT,40,Down,0.609961215795853,0.999485802679459
MARSHALL_VIRAL_INFECTION_RESPONSE_DN,22,Up,0.610058093919784,0.999485802679459
KEGG_ALPHA_LINOLENIC_ACID_METABOLISM,6,Up,0.610179193537766,0.999485802679459
KEGG_RNA_DEGRADATION,48,Down,0.610193410546168,0.999485802679459
BIOCARTA_TGFB_PATHWAY,18,Up,0.610258340201057,0.999485802679459
PID_ARF6_DOWNSTREAM_PATHWAY,14,Up,0.61030831864531,0.999485802679459
VALK_AML_CLUSTER_2,21,Down,0.610370957091106,0.999485802679459
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,205,Down,0.610597561174279,0.999485802679459
SHEN_SMARCA2_TARGETS_UP,391,Down,0.610934069642778,0.999485802679459
PID_NFAT_TFPATHWAY,26,Up,0.611224031356627,0.999485802679459
CHEN_HOXA5_TARGETS_6HR_UP,10,Up,0.611247807000796,0.999485802679459
MA_PITUITARY_FETAL_VS_ADULT_UP,22,Up,0.611321926610094,0.999485802679459
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,156,Down,0.612356946376552,0.999485802679459
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,38,Down,0.612381734269689,0.999485802679459
ZIRN_TRETINOIN_RESPONSE_UP,11,Down,0.612586530620649,0.999485802679459
MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,3,Up,0.612745650018177,0.999485802679459
NAKAYAMA_FGF2_TARGETS,19,Up,0.6127760739215,0.999485802679459
CHIBA_RESPONSE_TO_TSA_DN,23,Up,0.612787110979116,0.999485802679459
PRAMOONJAGO_SOX4_TARGETS_DN,44,Down,0.612879240594134,0.999485802679459
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN,17,Down,0.612893358308695,0.999485802679459
ALONSO_METASTASIS_UP,161,Up,0.61300843653885,0.999485802679459
VANTVEER_BREAST_CANCER_ESR1_UP,129,Up,0.613143557978842,0.999485802679459
KIM_WT1_TARGETS_DN,400,Down,0.613171671155335,0.999485802679459
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP,9,Down,0.613510958089468,0.999485802679459
LIAO_HAVE_SOX4_BINDING_SITES,38,Down,0.613623053768016,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,93,Up,0.614041084980619,0.999485802679459
CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN,8,Down,0.61431445167406,0.999485802679459
NAKAJIMA_EOSINOPHIL,13,Down,0.614343062279218,0.999485802679459
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,19,Down,0.61435561733295,0.999485802679459
BENPORATH_ES_1,304,Up,0.614490028778939,0.999485802679459
BENPORATH_MYC_TARGETS_WITH_EBOX,191,Down,0.614586579047187,0.999485802679459
REACTOME_GLUTATHIONE_CONJUGATION,16,Down,0.614626401547912,0.999485802679459
WEBER_METHYLATED_HCP_IN_SPERM_UP,7,Down,0.614644353885262,0.999485802679459
OXFORD_RALA_AND_RALB_TARGETS_DN,8,Down,0.614852492056051,0.999485802679459
SERVITJA_ISLET_HNF1A_TARGETS_DN,45,Down,0.614881699315559,0.999485802679459
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,166,Down,0.61488791303281,0.999485802679459
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,177,Up,0.615022356245171,0.999485802679459
JOHNSTONE_PARVB_TARGETS_3_UP,360,Up,0.615654037401533,0.999485802679459
MORI_MATURE_B_LYMPHOCYTE_DN,63,Down,0.616261650097531,0.999485802679459
PID_P38_MKK3_6PATHWAY,26,Down,0.616340077780276,0.999485802679459
KEGG_O_GLYCAN_BIOSYNTHESIS,20,Down,0.616722089560777,0.999485802679459
REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS,18,Down,0.616823583065018,0.999485802679459
HOEGERKORP_CD44_TARGETS_TEMPORAL_UP,8,Down,0.617026203735477,0.999485802679459
PYEON_HPV_POSITIVE_TUMORS_DN,7,Up,0.617237048168726,0.999485802679459
ITO_PTTG1_TARGETS_DN,8,Down,0.617666288945284,0.999485802679459
HOWLIN_CITED1_TARGETS_1_UP,21,Up,0.617888688711335,0.999485802679459
KEGG_HOMOLOGOUS_RECOMBINATION,25,Down,0.618043871722873,0.999485802679459
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,39,Down,0.618063712474508,0.999485802679459
BIOCARTA_BCELLSURVIVAL_PATHWAY,16,Down,0.618294405266682,0.999485802679459
KANG_CISPLATIN_RESISTANCE_UP,16,Up,0.618559100907457,0.999485802679459
CROMER_TUMORIGENESIS_DN,23,Down,0.618856390725222,0.999485802679459
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,351,Up,0.619031740499724,0.999485802679459
GAJATE_RESPONSE_TO_TRABECTEDIN_DN,16,Up,0.619125708035472,0.999485802679459
STEIN_ESRRA_TARGETS,456,Up,0.619350449508282,0.999485802679459
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,7,Up,0.619593541689757,0.999485802679459
ENGELMANN_CANCER_PROGENITORS_DN,45,Down,0.619599703530686,0.999485802679459
BIOCARTA_GLYCOLYSIS_PATHWAY,8,Down,0.619640775450557,0.999485802679459
VERNELL_RETINOBLASTOMA_PATHWAY_DN,20,Up,0.619880360935433,0.999485802679459
REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR,9,Down,0.61990007830423,0.999485802679459
BROWNE_HCMV_INFECTION_2HR_DN,42,Up,0.620401000906921,0.999485802679459
SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN,7,Down,0.620587865713435,0.999485802679459
HELLER_SILENCED_BY_METHYLATION_DN,83,Down,0.620682562597837,0.999485802679459
PID_TCR_PATHWAY,42,Down,0.620706825063757,0.999485802679459
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,28,Down,0.620953952263046,0.999485802679459
BAE_BRCA1_TARGETS_UP,67,Down,0.621141160776006,0.999485802679459
REACTOME_SIGNAL_ATTENUATION,11,Up,0.621397540880645,0.999485802679459
XU_CREBBP_TARGETS_DN,34,Up,0.622184292604553,0.999485802679459
REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS,13,Down,0.622359300803368,0.999485802679459
SA_TRKA_RECEPTOR,12,Down,0.622759816978999,0.999485802679459
AMIT_EGF_RESPONSE_40_HELA,38,Up,0.623007961003639,0.999485802679459
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,105,Down,0.623016502579514,0.999485802679459
KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION,11,Up,0.623463860694702,0.999485802679459
BIOCARTA_CTLA4_PATHWAY,6,Down,0.623822044742081,0.999485802679459
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP,57,Up,0.624065853413114,0.999485802679459
TRACEY_RESISTANCE_TO_IFNA2_UP,2,Up,0.624129439371113,0.999485802679459
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,19,Down,0.624181443721899,0.999485802679459
TAVOR_CEBPA_TARGETS_UP,37,Up,0.624291523773188,0.999485802679459
KEEN_RESPONSE_TO_ROSIGLITAZONE_UP,29,Up,0.62430749159011,0.999485802679459
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP,7,Down,0.624311381183228,0.999485802679459
BIOCARTA_LONGEVITY_PATHWAY,12,Up,0.624835080911327,0.999485802679459
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,20,Down,0.625569160197889,0.999485802679459
BIOCARTA_DREAM_PATHWAY,12,Down,0.625783622554684,0.999485802679459
GHO_ATF5_TARGETS_DN,16,Down,0.626216385234466,0.999485802679459
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3,22,Up,0.626481664266674,0.999485802679459
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,17,Up,0.626546820639924,0.999485802679459
REACTOME_PLATELET_HOMEOSTASIS,47,Down,0.626930599617249,0.999485802679459
DAUER_STAT3_TARGETS_UP,39,Up,0.628382199805317,0.999485802679459
ROY_WOUND_BLOOD_VESSEL_DN,12,Down,0.628394291740201,0.999485802679459
WEBER_METHYLATED_IN_COLON_CANCER,15,Up,0.628956702118335,0.999485802679459
CAIRO_HEPATOBLASTOMA_UP,173,Down,0.629007163933584,0.999485802679459
BROWNE_HCMV_INFECTION_6HR_UP,43,Down,0.6290192808093,0.999485802679459
BIOCARTA_ARAP_PATHWAY,16,Down,0.629198971523408,0.999485802679459
MAHADEVAN_IMATINIB_RESISTANCE_UP,14,Down,0.629206939511314,0.999485802679459
LINDVALL_IMMORTALIZED_BY_TERT_UP,64,Down,0.629226657062641,0.999485802679459
EPPERT_HSC_R,91,Up,0.629603558313601,0.999485802679459
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,160,Up,0.629779804669951,0.999485802679459
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,53,Down,0.63009319356007,0.999485802679459
REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE,11,Down,0.630114866811792,0.999485802679459
NABA_ECM_GLYCOPROTEINS,100,Up,0.630281782964176,0.999485802679459
HUANG_FOXA2_TARGETS_DN,32,Down,0.630342909723779,0.999485802679459
REACTOME_GLOBAL_GENOMIC_NER_GG_NER,30,Down,0.630613640942599,0.999485802679459
WANG_MLL_TARGETS,187,Up,0.630780246926209,0.999485802679459
TSUTSUMI_FBXW8_TARGETS,6,Up,0.630920672842482,0.999485802679459
PENG_RAPAMYCIN_RESPONSE_DN,216,Down,0.631022410421057,0.999485802679459
ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE,11,Down,0.631055245278631,0.999485802679459
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,15,Down,0.631498133678556,0.999485802679459
ENK_UV_RESPONSE_KERATINOCYTE_UP,405,Down,0.631539716713767,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,23,Up,0.632146890385378,0.999485802679459
DELYS_THYROID_CANCER_UP,318,Down,0.632467819483435,0.999485802679459
KIM_WT1_TARGETS_8HR_DN,94,Down,0.632498415763174,0.999485802679459
RADMACHER_AML_PROGNOSIS,58,Down,0.632767970402496,0.999485802679459
BENPORATH_ES_CORE_NINE,9,Down,0.632879840847518,0.999485802679459
REACTOME_HEMOSTASIS,310,Down,0.632911762118139,0.999485802679459
NADERI_BREAST_CANCER_PROGNOSIS_UP,37,Down,0.63304518395383,0.999485802679459
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,30,Down,0.633456236332545,0.999485802679459
OSADA_ASCL1_TARGETS_UP,28,Up,0.633615222313123,0.999485802679459
ITO_PTTG1_TARGETS_UP,10,Down,0.633670197669929,0.999485802679459
AGARWAL_AKT_PATHWAY_TARGETS,7,Down,0.633828623258395,0.999485802679459
REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY,7,Down,0.633828707618406,0.999485802679459
XU_GH1_AUTOCRINE_TARGETS_UP,160,Down,0.634108373179351,0.999485802679459
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,25,Up,0.634849501035246,0.999485802679459
BERENJENO_TRANSFORMED_BY_RHOA_UP,465,Down,0.634922281842307,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,19,Down,0.635032906221477,0.999485802679459
TOOKER_GEMCITABINE_RESISTANCE_DN,114,Down,0.635212128539577,0.999485802679459
VALK_AML_CLUSTER_12,18,Down,0.635371878621064,0.999485802679459
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA,9,Down,0.635596316832964,0.999485802679459
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,24,Up,0.635908120965058,0.999485802679459
KATSANOU_ELAVL1_TARGETS_DN,112,Up,0.635976095397276,0.999485802679459
BIOCARTA_TNFR2_PATHWAY,15,Down,0.636634697162668,0.999485802679459
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,15,Down,0.636813373527855,0.999485802679459
PID_UPA_UPAR_PATHWAY,29,Down,0.637003080090051,0.999485802679459
BILANGES_SERUM_SENSITIVE_VIA_TSC1,13,Down,0.637534184249202,0.999485802679459
VERRECCHIA_RESPONSE_TO_TGFB1_C6,5,Down,0.638200076796817,0.999485802679459
BIOCARTA_MITOCHONDRIA_PATHWAY,21,Up,0.638268327675761,0.999485802679459
LI_WILMS_TUMOR,15,Up,0.638391015545459,0.999485802679459
VERHAAK_GLIOBLASTOMA_PRONEURAL,127,Up,0.638585213653605,0.999485802679459
REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS,5,Up,0.638675709672817,0.999485802679459
ZHANG_RESPONSE_TO_CANTHARIDIN_DN,58,Down,0.638980500793074,0.999485802679459
ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY,33,Down,0.639488991071034,0.999485802679459
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,31,Down,0.639693131513034,0.999485802679459
WINZEN_DEGRADED_VIA_KHSRP,76,Up,0.639946209727292,0.999485802679459
BIOCARTA_VITCB_PATHWAY,9,Down,0.640145969807299,0.999485802679459
NABA_SECRETED_FACTORS,134,Down,0.640159377599603,0.999485802679459
DASU_IL6_SIGNALING_SCAR_UP,28,Down,0.640249854252272,0.999485802679459
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,51,Up,0.640414684303943,0.999485802679459
REACTOME_CGMP_EFFECTS,10,Up,0.640607860343445,0.999485802679459
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,38,Down,0.641504617433735,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,67,Up,0.641645195097569,0.999485802679459
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL,7,Down,0.641776105016593,0.999485802679459
HAEGERSTRAND_RESPONSE_TO_IMATINIB,7,Down,0.641868185338043,0.999485802679459
WU_HBX_TARGETS_2_DN,13,Up,0.641878325049278,0.999485802679459
SHIRAISHI_PLZF_TARGETS_UP,9,Up,0.641998400941155,0.999485802679459
REACTOME_G1_S_SPECIFIC_TRANSCRIPTION,17,Down,0.64208915762607,0.999485802679459
OXFORD_RALA_OR_RALB_TARGETS_DN,24,Down,0.642354261994504,0.999485802679459
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,20,Down,0.642483847016003,0.999485802679459
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,175,Down,0.642918331976865,0.999485802679459
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP,26,Up,0.643104055174156,0.999485802679459
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,313,Up,0.643260062497,0.999485802679459
LE_SKI_TARGETS_DN,8,Up,0.643421170220842,0.999485802679459
BROWNE_HCMV_INFECTION_20HR_DN,87,Up,0.643856225654496,0.999485802679459
KEGG_SMALL_CELL_LUNG_CANCER,76,Up,0.644152048085763,0.999485802679459
SEMENZA_HIF1_TARGETS,30,Down,0.644222026866181,0.999485802679459
PID_CIRCADIAN_PATHWAY,14,Down,0.644395414263617,0.999485802679459
GRADE_METASTASIS_DN,39,Down,0.64501052587458,0.999485802679459
PID_LKB1_PATHWAY,43,Up,0.645443569098903,0.999485802679459
REACTOME_ACYL_CHAIN_REMODELLING_OF_PG,6,Up,0.645903755606964,0.999485802679459
KAUFFMANN_DNA_REPLICATION_GENES,131,Down,0.645916753657189,0.999485802679459
TSENG_IRS1_TARGETS_DN,98,Down,0.646474064566095,0.999485802679459
DAZARD_UV_RESPONSE_CLUSTER_G28,10,Up,0.646786585954833,0.999485802679459
SCIBETTA_KDM5B_TARGETS_UP,16,Down,0.647396205315848,0.999485802679459
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,17,Down,0.647445513219937,0.999485802679459
BIOCARTA_EDG1_PATHWAY,24,Down,0.647902121916954,0.999485802679459
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,89,Down,0.648062378623529,0.999485802679459
GHO_ATF5_TARGETS_UP,12,Down,0.648532613238489,0.999485802679459
DELACROIX_RARG_BOUND_MEF,284,Up,0.648538187792194,0.999485802679459
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,98,Down,0.648566028986609,0.999485802679459
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON,64,Up,0.648913064055083,0.999485802679459
RAY_ALZHEIMERS_DISEASE,6,Up,0.649254962261581,0.999485802679459
ST_FAS_SIGNALING_PATHWAY,59,Up,0.649491935283506,0.999485802679459
GESERICK_TERT_TARGETS_DN,19,Up,0.649518220453208,0.999485802679459
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,93,Up,0.649606577380744,0.999485802679459
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,18,Up,0.649776382298977,0.999485802679459
NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF,8,Down,0.649916145354957,0.999485802679459
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8,12,Down,0.649920674706188,0.999485802679459
WIERENGA_STAT5A_TARGETS_UP,145,Down,0.650378775286602,0.999485802679459
ZHOU_PANCREATIC_EXOCRINE_PROGENITOR,5,Down,0.650551031944698,0.999485802679459
INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN,4,Down,0.650830912111788,0.999485802679459
GOUYER_TATI_TARGETS_UP,7,Down,0.650941594608622,0.999485802679459
BROWNE_HCMV_INFECTION_14HR_DN,239,Down,0.651441703380873,0.999485802679459
RICKMAN_HEAD_AND_NECK_CANCER_E,22,Up,0.651489194717391,0.999485802679459
JAIN_NFKB_SIGNALING,66,Down,0.65157247677742,0.999485802679459
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR,109,Down,0.651609515326698,0.999485802679459
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN,13,Down,0.651739796236217,0.999485802679459
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE,11,Up,0.651781238657268,0.999485802679459
TOMIDA_LUNG_CANCER_POOR_SURVIVAL,5,Down,0.651942629471599,0.999485802679459
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,27,Up,0.651961840476511,0.999485802679459
SANSOM_APC_MYC_TARGETS,176,Up,0.651988175924975,0.999485802679459
KIM_ALL_DISORDERS_CALB1_CORR_UP,462,Down,0.652084984208451,0.999485802679459
YANG_MUC2_TARGETS_DUODENUM_6MO_DN,12,Up,0.652964010038261,0.999485802679459
PID_DELTA_NP63_PATHWAY,38,Down,0.653123424088968,0.999485802679459
RIZKI_TUMOR_INVASIVENESS_3D_UP,151,Up,0.653213725926459,0.999485802679459
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,15,Up,0.653360029135082,0.999485802679459
PID_GMCSF_PATHWAY,31,Down,0.653607912779689,0.999485802679459
MIKKELSEN_DEDIFFERENTIATED_STATE_DN,5,Down,0.65376022810624,0.999485802679459
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,58,Up,0.653785468760461,0.999485802679459
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,36,Down,0.653843310895537,0.999485802679459
REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,13,Down,0.654441211180575,0.999485802679459
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,59,Up,0.654447154285154,0.999485802679459
BIOCARTA_ACH_PATHWAY,11,Up,0.654673270398604,0.999485802679459
POOLA_INVASIVE_BREAST_CANCER_UP,176,Up,0.655163137756841,0.999485802679459
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,112,Up,0.655432495177251,0.999485802679459
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN,3,Down,0.655575020176249,0.999485802679459
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,45,Up,0.655654867747062,0.999485802679459
LU_EZH2_TARGETS_DN,316,Down,0.655985470723969,0.999485802679459
MCCABE_HOXC6_TARGETS_DN,14,Up,0.656377807282529,0.999485802679459
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION,11,Down,0.656454049075166,0.999485802679459
OSADA_ASCL1_TARGETS_DN,18,Down,0.656733764282759,0.999485802679459
RODWELL_AGING_KIDNEY_UP,305,Up,0.657029644653368,0.999485802679459
ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS,5,Down,0.657127732757451,0.999485802679459
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,56,Down,0.65778597174752,0.999485802679459
TERAMOTO_OPN_TARGETS_CLUSTER_7,16,Up,0.65779911470193,0.999485802679459
KLEIN_TARGETS_OF_BCR_ABL1_FUSION,26,Up,0.658081837092159,0.999485802679459
BRUNO_HEMATOPOIESIS,52,Up,0.658327393888889,0.999485802679459
REACTOME_MUSCLE_CONTRACTION,33,Up,0.658401171858625,0.999485802679459
BIOCARTA_P53HYPOXIA_PATHWAY,20,Down,0.658455147458933,0.999485802679459
BIOCARTA_BARR_MAPK_PATHWAY,11,Down,0.658770836965094,0.999485802679459
REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION,4,Down,0.65903751590212,0.999485802679459
YANG_BREAST_CANCER_ESR1_UP,30,Down,0.659700407587842,0.999485802679459
DONATO_CELL_CYCLE_TRETINOIN,6,Up,0.659992497540367,0.999485802679459
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,47,Up,0.660423326670472,0.999485802679459
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,242,Down,0.660625335100083,0.999485802679459
MATZUK_EARLY_ANTRAL_FOLLICLE,6,Up,0.660687289300956,0.999485802679459
LINDSTEDT_DENDRITIC_CELL_MATURATION_D,46,Up,0.660717155197524,0.999485802679459
KYNG_NORMAL_AGING_UP,16,Down,0.661003953206931,0.999485802679459
CADWELL_ATG16L1_TARGETS_UP,39,Down,0.661245236244072,0.999485802679459
REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS,7,Down,0.661508782207923,0.999485802679459
WILLIAMS_ESR2_TARGETS_DN,10,Up,0.662052685630254,0.999485802679459
HOELZEL_NF1_TARGETS_UP,95,Up,0.662248369759655,0.999485802679459
FERRARI_RESPONSE_TO_FENRETINIDE_UP,13,Up,0.662907346518526,0.999485802679459
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP,42,Down,0.663119445812053,0.999485802679459
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,113,Up,0.663181379433656,0.999485802679459
CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL,9,Up,0.663213905404142,0.999485802679459
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,24,Down,0.6632787271385,0.999485802679459
GILDEA_METASTASIS,26,Down,0.663432534634263,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9,7,Down,0.663516197886693,0.999485802679459
SYED_ESTRADIOL_RESPONSE,17,Up,0.663543176247382,0.999485802679459
AMIT_EGF_RESPONSE_120_MCF10A,35,Up,0.663562706043493,0.999485802679459
JIANG_CORE_DUPLICON_GENES,2,Down,0.664201166354283,0.999485802679459
ONO_FOXP3_TARGETS_UP,13,Up,0.664451003956263,0.999485802679459
ST_PAC1_RECEPTOR_PATHWAY,5,Down,0.664555039235097,0.999485802679459
PID_SHP2_PATHWAY,42,Down,0.664937563275266,0.999485802679459
KEGG_ONE_CARBON_POOL_BY_FOLATE,16,Down,0.665108387765837,0.999485802679459
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,53,Up,0.665227796533759,0.999485802679459
BIOCARTA_LAIR_PATHWAY,10,Down,0.665288835564684,0.999485802679459
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN,6,Up,0.665401155304181,0.999485802679459
BECKER_TAMOXIFEN_RESISTANCE_DN,38,Up,0.665478814090459,0.999485802679459
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,86,Up,0.665532107658999,0.999485802679459
OXFORD_RALA_AND_RALB_TARGETS_UP,10,Down,0.665536795748244,0.999485802679459
PID_CD8_TCR_PATHWAY,33,Down,0.66559829712156,0.999485802679459
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP,729,Up,0.665897809289933,0.999485802679459
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP,9,Down,0.666222572929461,0.999485802679459
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,34,Up,0.666346294403066,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN,6,Down,0.666491467362398,0.999485802679459
MIKKELSEN_ES_LCP_WITH_H3K27ME3,6,Down,0.666548228138797,0.999485802679459
TAGHAVI_NEOPLASTIC_TRANSFORMATION,12,Down,0.667468102067417,0.999485802679459
DER_IFN_BETA_RESPONSE_DN,5,Down,0.667480051700301,0.999485802679459
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP,892,Up,0.667493636313426,0.999485802679459
MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED,228,Up,0.667572686230708,0.999485802679459
BIOCARTA_FCER1_PATHWAY,32,Up,0.66815292540014,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,16,Down,0.668566267687144,0.999485802679459
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,56,Up,0.668752751794828,0.999485802679459
CORRE_MULTIPLE_MYELOMA_DN,45,Down,0.668956736582961,0.999485802679459
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,145,Up,0.668970346699772,0.999485802679459
REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX,29,Down,0.669245863617343,0.999485802679459
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,43,Down,0.669402708544902,0.999485802679459
ELVIDGE_HIF1A_TARGETS_DN,75,Down,0.66969172025481,0.999485802679459
ELLWOOD_MYC_TARGETS_UP,10,Down,0.669960427243324,0.999485802679459
KEGG_DRUG_METABOLISM_OTHER_ENZYMES,22,Down,0.669978156730909,0.999485802679459
WANG_RECURRENT_LIVER_CANCER_UP,18,Up,0.669994408899132,0.999485802679459
JIANG_AGING_HYPOTHALAMUS_UP,40,Down,0.670224218793315,0.999485802679459
HAHTOLA_MYCOSIS_FUNGOIDES_DN,8,Down,0.670233446214498,0.999485802679459
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,56,Down,0.670504242924812,0.999485802679459
PID_ERBB1_INTERNALIZATION_PATHWAY,40,Down,0.670712033252128,0.999485802679459
BIOCARTA_P27_PATHWAY,13,Down,0.670718637105915,0.999485802679459
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,49,Down,0.670918355723576,0.999485802679459
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP,8,Down,0.671490516913248,0.999485802679459
HAMAI_APOPTOSIS_VIA_TRAIL_UP,499,Up,0.671591664338168,0.999485802679459
NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS,4,Down,0.671807628138028,0.999485802679459
GRADE_COLON_CANCER_DN,23,Up,0.671901209293797,0.999485802679459
KEGG_TYPE_II_DIABETES_MELLITUS,32,Up,0.6720256080836,0.999485802679459
CHENG_IMPRINTED_BY_ESTRADIOL,79,Down,0.672217459767588,0.999485802679459
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,45,Down,0.67232248253191,0.999485802679459
BIOCARTA_IL6_PATHWAY,21,Down,0.672364210122401,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13,4,Up,0.672741508954201,0.999485802679459
LIU_PROSTATE_CANCER_DN,329,Up,0.672796387173108,0.999485802679459
HELLER_HDAC_TARGETS_DN,220,Up,0.672828725038571,0.999485802679459
GREENBAUM_E2A_TARGETS_UP,27,Up,0.672921396438959,0.999485802679459
WHITESIDE_CISPLATIN_RESISTANCE_DN,12,Up,0.673403197374009,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,34,Down,0.673683653229802,0.999485802679459
REACTOME_P38MAPK_EVENTS,12,Down,0.673708192874911,0.999485802679459
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN,686,Down,0.674238896501623,0.999485802679459
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,123,Down,0.674267590621286,0.999485802679459
HOSHIDA_LIVER_CANCER_SUBCLASS_S2,103,Up,0.674519510647945,0.999485802679459
REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_,36,Down,0.674902131414604,0.999485802679459
JONES_TCOF1_TARGETS,5,Up,0.675015274592133,0.999485802679459
DEN_INTERACT_WITH_LCA5,21,Down,0.675787791432229,0.999485802679459
MEISSNER_BRAIN_HCP_WITH_H3K27ME3,101,Up,0.675885135360307,0.999485802679459
REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY,3,Down,0.676454577545033,0.999485802679459
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,96,Up,0.676480932537669,0.999485802679459
KENNY_CTNNB1_TARGETS_UP,41,Down,0.676548933568217,0.999485802679459
PID_AR_PATHWAY,53,Down,0.67705076284898,0.999485802679459
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,214,Up,0.677081179779585,0.999485802679459
HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER,4,Down,0.677394655614607,0.999485802679459
KANG_FLUOROURACIL_RESISTANCE_DN,14,Up,0.677414265174485,0.999485802679459
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN,3,Up,0.677484400943919,0.999485802679459
REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS,7,Down,0.677487863297303,0.999485802679459
ROZANOV_MMP14_TARGETS_DN,26,Down,0.677547384404318,0.999485802679459
PID_HEDGEHOG_GLI_PATHWAY,46,Down,0.677988311158947,0.999485802679459
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,114,Up,0.678079075766702,0.999485802679459
SIMBULAN_PARP1_TARGETS_DN,16,Down,0.678183704542815,0.999485802679459
KAAB_FAILED_HEART_VENTRICLE_DN,31,Up,0.678191302891366,0.999485802679459
REACTOME_SIGNALING_BY_NOTCH4,10,Up,0.678227922920218,0.999485802679459
ST_GRANULE_CELL_SURVIVAL_PATHWAY,24,Down,0.678257070055112,0.999485802679459
FRASOR_RESPONSE_TO_ESTRADIOL_UP,25,Down,0.678351367747174,0.999485802679459
REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,14,Up,0.678451108112232,0.999485802679459
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA,23,Down,0.678626732092688,0.999485802679459
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2,5,Down,0.678808505662307,0.999485802679459
GHANDHI_BYSTANDER_IRRADIATION_UP,52,Up,0.678822522222141,0.999485802679459
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN,637,Down,0.678860306079399,0.999485802679459
DAZARD_UV_RESPONSE_CLUSTER_G4,19,Up,0.679126138893716,0.999485802679459
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER,31,Up,0.679130890755992,0.999485802679459
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,17,Up,0.679247496987835,0.999485802679459
REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,13,Up,0.679447969801067,0.999485802679459
BENPORATH_SUZ12_TARGETS,467,Up,0.679449645636242,0.999485802679459
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,31,Down,0.68002496123562,0.999485802679459
MAEKAWA_ATF2_TARGETS,13,Up,0.680318405252533,0.999485802679459
HOEBEKE_LYMPHOID_STEM_CELL_UP,68,Down,0.680389882464456,0.999485802679459
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,78,Up,0.680825177699872,0.999485802679459
WENDT_COHESIN_TARGETS_UP,31,Up,0.681265930414247,0.999485802679459
KEGG_GNRH_SIGNALING_PATHWAY,71,Up,0.681422910801581,0.999485802679459
BIOCARTA_EXTRINSIC_PATHWAY,5,Up,0.682251441486905,0.999485802679459
VANTVEER_BREAST_CANCER_BRCA1_DN,31,Up,0.682540762927255,0.999485802679459
WANG_RESPONSE_TO_FORSKOLIN_DN,7,Up,0.682573766964766,0.999485802679459
SPIRA_SMOKERS_LUNG_CANCER_UP,30,Down,0.682635940479812,0.999485802679459
MATZUK_STEROIDOGENESIS,4,Down,0.682793306521906,0.999485802679459
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP,11,Up,0.683003613199228,0.999485802679459
DASU_IL6_SIGNALING_SCAR_DN,14,Down,0.683613955016646,0.999485802679459
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,168,Down,0.683698695425316,0.999485802679459
DOANE_BREAST_CANCER_CLASSES_UP,42,Down,0.683792480387187,0.999485802679459
LIU_TOPBP1_TARGETS,10,Down,0.68403680074346,0.999485802679459
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,19,Up,0.684152004577187,0.999485802679459
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP,4,Down,0.68516309883037,0.999485802679459
SUNG_METASTASIS_STROMA_DN,43,Up,0.685373584009993,0.999485802679459
WILCOX_RESPONSE_TO_PROGESTERONE_UP,122,Down,0.685829586478842,0.999485802679459
PID_S1P_META_PATHWAY,18,Down,0.685835859017412,0.999485802679459
BIOCARTA_RAC1_PATHWAY,23,Down,0.686014368878081,0.999485802679459
ROVERSI_GLIOMA_COPY_NUMBER_UP,74,Down,0.686080334363791,0.999485802679459
CUI_TCF21_TARGETS_DN,19,Up,0.686083938837592,0.999485802679459
HALMOS_CEBPA_TARGETS_UP,39,Down,0.686088303672099,0.999485802679459
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,51,Down,0.686095812204221,0.999485802679459
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP,44,Up,0.686176545422886,0.999485802679459
XU_GH1_EXOGENOUS_TARGETS_UP,45,Down,0.686349668410386,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN,4,Down,0.687276147576275,0.999485802679459
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,253,Down,0.687397285404367,0.999485802679459
HASLINGER_B_CLL_WITH_11Q23_DELETION,17,Up,0.687754338542956,0.999485802679459
HEIDENBLAD_AMPLICON_12P11_12_DN,22,Down,0.688142034575284,0.999485802679459
BIOCARTA_PROTEASOME_PATHWAY,27,Down,0.688576380152408,0.999485802679459
HONMA_DOCETAXEL_RESISTANCE,29,Up,0.68876310826789,0.999485802679459
PID_CONE_PATHWAY,5,Down,0.68888056508371,0.999485802679459
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,206,Up,0.688917387141551,0.999485802679459
CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,12,Down,0.68898033932988,0.999485802679459
SERVITJA_LIVER_HNF1A_TARGETS_UP,100,Up,0.689078276269059,0.999485802679459
SU_PLACENTA,12,Up,0.689193802162543,0.999485802679459
REACTOME_BOTULINUM_NEUROTOXICITY,14,Down,0.689212591553102,0.999485802679459
LY_AGING_PREMATURE_DN,27,Down,0.689766195464365,0.999485802679459
LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED,13,Up,0.689901849567625,0.999485802679459
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,22,Down,0.690125735407124,0.999485802679459
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN,20,Up,0.690490025942434,0.999485802679459
NEWMAN_ERCC6_TARGETS_DN,30,Up,0.690570519005223,0.999485802679459
JIANG_HYPOXIA_NORMAL,268,Down,0.691192455854718,0.999485802679459
SENGUPTA_EBNA1_ANTICORRELATED,93,Up,0.691251294566769,0.999485802679459
BIOCARTA_BARRESTIN_SRC_PATHWAY,12,Down,0.691260926715589,0.999485802679459
GEORGES_CELL_CYCLE_MIR192_TARGETS,56,Up,0.691410309623471,0.999485802679459
DORN_ADENOVIRUS_INFECTION_12HR_UP,23,Down,0.691457057112871,0.999485802679459
PID_IFNG_PATHWAY,39,Up,0.691631022330783,0.999485802679459
MAINA_HYPOXIA_VHL_TARGETS_UP,5,Up,0.691951336824422,0.999485802679459
REACTOME_GLYCOPROTEIN_HORMONES,4,Down,0.692168980875624,0.999485802679459
REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS,4,Down,0.692168980875624,0.999485802679459
LIEN_BREAST_CARCINOMA_METAPLASTIC,26,Down,0.692253250594467,0.999485802679459
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,246,Up,0.692411319989776,0.999485802679459
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,71,Up,0.692760214575876,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25,7,Down,0.692826680280979,0.999485802679459
SMIRNOV_RESPONSE_TO_IR_2HR_DN,42,Down,0.693000807509078,0.999485802679459
OUILLETTE_CLL_13Q14_DELETION_DN,44,Up,0.693276111829946,0.999485802679459
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,163,Up,0.69358571652105,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30,4,Down,0.694348597326633,0.999485802679459
LIAO_METASTASIS,427,Down,0.694426832022118,0.999485802679459
SUBTIL_PROGESTIN_TARGETS,34,Down,0.694476915143308,0.999485802679459
KORKOLA_SEMINOMA_DN,5,Down,0.694864625693788,0.999485802679459
ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF,367,Up,0.695514953852987,0.999485802679459
BROWNE_HCMV_INFECTION_48HR_UP,142,Down,0.695972737061056,0.999485802679459
SMIRNOV_RESPONSE_TO_IR_6HR_DN,83,Up,0.696185457806117,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4,9,Down,0.696260039372036,0.999485802679459
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,66,Down,0.696422773519896,0.999485802679459
BRUNEAU_SEPTATION_VENTRICULAR,8,Up,0.696437202627185,0.999485802679459
BIOCARTA_CXCR4_PATHWAY,19,Down,0.69651017393106,0.999485802679459
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,25,Down,0.696700397138562,0.999485802679459
BIOCARTA_THELPER_PATHWAY,3,Down,0.696782754702159,0.999485802679459
DARWICHE_PAPILLOMA_RISK_HIGH_DN,110,Up,0.696985459862382,0.999485802679459
GENTILE_UV_RESPONSE_CLUSTER_D2,38,Down,0.697121430374172,0.999485802679459
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN,473,Up,0.697233303800157,0.999485802679459
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,23,Down,0.697545396959006,0.999485802679459
MALIK_REPRESSED_BY_ESTROGEN,10,Up,0.697583179664381,0.999485802679459
KEGG_INOSITOL_PHOSPHATE_METABOLISM,45,Down,0.697631388597099,0.999485802679459
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY,17,Down,0.69766301754141,0.999485802679459
STANELLE_E2F1_TARGETS,25,Down,0.698109190685249,0.999485802679459
BIOCARTA_ASBCELL_PATHWAY,2,Down,0.698183908620261,0.999485802679459
GREENBAUM_E2A_TARGETS_DN,14,Down,0.698485468851763,0.999485802679459
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,60,Up,0.69861139039396,0.999485802679459
WONG_ENDMETRIUM_CANCER_UP,12,Up,0.698642247093917,0.999485802679459
JI_METASTASIS_REPRESSED_BY_STK11,18,Down,0.698685394176492,0.999485802679459
ROSS_AML_WITH_PML_RARA_FUSION,56,Down,0.698773582933885,0.999485802679459
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,29,Up,0.698990222250441,0.999485802679459
BAELDE_DIABETIC_NEPHROPATHY_DN,377,Up,0.698998224362016,0.999485802679459
VALK_AML_WITH_11Q23_REARRANGED,10,Down,0.699012086239052,0.999485802679459
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP,617,Down,0.699098518333871,0.999485802679459
PID_ECADHERIN_NASCENT_AJ_PATHWAY,34,Down,0.699279709590382,0.999485802679459
FUKUSHIMA_TNFSF11_TARGETS,11,Up,0.699413382103336,0.999485802679459
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,22,Down,0.699413537919324,0.999485802679459
REACTOME_CD28_DEPENDENT_VAV1_PATHWAY,7,Down,0.699543103381237,0.999485802679459
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,24,Down,0.699584773615911,0.999485802679459
DELACROIX_RAR_BOUND_ES,316,Down,0.699620260094185,0.999485802679459
BIOCARTA_IL2_PATHWAY,15,Up,0.700056293169617,0.999485802679459
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,177,Down,0.700239395339019,0.999485802679459
BIOCARTA_TCAPOPTOSIS_PATHWAY,1,Down,0.700385735636644,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21,6,Up,0.700769475175013,0.999485802679459
BIOCARTA_IL7_PATHWAY,15,Up,0.701073242416695,0.999485802679459
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,82,Down,0.701243250762114,0.999485802679459
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,189,Down,0.701503137891966,0.999485802679459
REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS,26,Down,0.701670961103012,0.999485802679459
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,46,Down,0.701941944540782,0.999485802679459
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN,74,Up,0.702021045439828,0.999485802679459
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,253,Up,0.702094684539753,0.999485802679459
ONO_AML1_TARGETS_UP,12,Up,0.702125276057634,0.999485802679459
BAFNA_MUC4_TARGETS_DN,4,Down,0.702871683368012,0.999485802679459
ENK_UV_RESPONSE_EPIDERMIS_DN,404,Up,0.703826337818838,0.999485802679459
PID_EPHA2_FWD_PATHWAY,18,Down,0.704324450238038,0.999485802679459
TIEN_INTESTINE_PROBIOTICS_6HR_DN,147,Up,0.704431605779079,0.999485802679459
WEBER_METHYLATED_ICP_IN_SPERM_UP,1,Up,0.704501856271274,0.999485802679459
LIU_CDX2_TARGETS_UP,16,Up,0.705254391433795,0.999485802679459
MILI_PSEUDOPODIA_HAPTOTAXIS_UP,427,Down,0.705439910906297,0.999485802679459
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,54,Up,0.705489658509368,0.999485802679459
CHESLER_BRAIN_D6MIT150_QTL_TRANS,4,Up,0.705596825925333,0.999485802679459
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,75,Down,0.705666948514423,0.999485802679459
GOLUB_ALL_VS_AML_UP,22,Down,0.706012989483976,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3,5,Down,0.706529421685212,0.999485802679459
DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4,4,Down,0.706572762299641,0.999485802679459
SESTO_RESPONSE_TO_UV_C4,17,Up,0.706816941926995,0.999485802679459
KEGG_PHENYLALANINE_METABOLISM,9,Down,0.707116401931696,0.999485802679459
NIELSEN_LEIOMYOSARCOMA_CNN1_DN,18,Up,0.707727775145149,0.999485802679459
AMIT_SERUM_RESPONSE_60_MCF10A,48,Down,0.707788032327618,0.999485802679459
BIOCARTA_CHEMICAL_PATHWAY,21,Up,0.707865444393515,0.999485802679459
TSENG_ADIPOGENIC_POTENTIAL_UP,22,Down,0.707893812903911,0.999485802679459
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,17,Down,0.708579677821268,0.999485802679459
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN,10,Down,0.708908503591577,0.999485802679459
PID_P75_NTR_PATHWAY,57,Up,0.709169580957119,0.999485802679459
NAGY_PCAF_COMPONENTS_HUMAN,8,Up,0.709344467603648,0.999485802679459
REACTOME_SYNTHESIS_OF_PA,15,Up,0.709375836774545,0.999485802679459
BENPORATH_ES_2,23,Down,0.70953104934814,0.999485802679459
PID_PTP1B_PATHWAY,40,Up,0.709762763892585,0.999485802679459
REACTOME_UNFOLDED_PROTEIN_RESPONSE,70,Up,0.710025002678633,0.999485802679459
HAHTOLA_CTCL_CUTANEOUS,14,Down,0.710215656196935,0.999485802679459
HUMMERICH_BENIGN_SKIN_TUMOR_UP,12,Up,0.710310486524957,0.999485802679459
WELCSH_BRCA1_TARGETS_DN,126,Down,0.711354199840311,0.999485802679459
REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI,14,Down,0.711562009488673,0.999485802679459
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,285,Down,0.711643088157163,0.999485802679459
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,68,Up,0.711700422926505,0.999485802679459
NADELLA_PRKAR1A_TARGETS_UP,6,Up,0.711760140933326,0.999485802679459
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,245,Down,0.711771989031264,0.999485802679459
NICK_RESPONSE_TO_PROC_TREATMENT_UP,3,Down,0.711799642803379,0.999485802679459
REACTOME_TRYPTOPHAN_CATABOLISM,5,Up,0.712252488481159,0.999485802679459
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,202,Up,0.712536865861835,0.999485802679459
REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT,97,Down,0.712956346822471,0.999485802679459
ABBUD_LIF_SIGNALING_1_DN,20,Up,0.713384283711918,0.999485802679459
GRANDVAUX_IRF3_TARGETS_DN,17,Up,0.713735112014528,0.999485802679459
BOYLAN_MULTIPLE_MYELOMA_D_DN,54,Down,0.713758228705527,0.999485802679459
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP,12,Down,0.714153251214546,0.999485802679459
ZHENG_GLIOBLASTOMA_PLASTICITY_DN,40,Up,0.714224374691312,0.999485802679459
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,48,Up,0.714560604681731,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,38,Up,0.714923274616535,0.999485802679459
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,224,Up,0.715064020671887,0.999485802679459
RIGGI_EWING_SARCOMA_PROGENITOR_DN,140,Down,0.715571834104747,0.999485802679459
DARWICHE_SKIN_TUMOR_PROMOTER_UP,95,Down,0.715583537799964,0.999485802679459
PUJANA_BRCA_CENTERED_NETWORK,110,Up,0.715753279088468,0.999485802679459
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,132,Down,0.715935252778658,0.999485802679459
LI_WILMS_TUMOR_ANAPLASTIC_UP,18,Down,0.716215013461937,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,28,Down,0.716266847978089,0.999485802679459
MARKEY_RB1_ACUTE_LOF_UP,202,Up,0.716452196277588,0.999485802679459
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN,7,Down,0.716566493437154,0.999485802679459
MIKKELSEN_PLURIPOTENT_STATE_DN,7,Down,0.71658429018032,0.999485802679459
KEGG_PROSTATE_CANCER,78,Up,0.716622111389193,0.999485802679459
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP,3,Down,0.716647178465997,0.999485802679459
DAZARD_UV_RESPONSE_CLUSTER_G3,12,Down,0.716895393485605,0.999485802679459
MORI_PLASMA_CELL_UP,40,Down,0.71716323978232,0.999485802679459
GUO_HEX_TARGETS_DN,44,Up,0.71728538029155,0.999485802679459
PID_FOXO_PATHWAY,46,Down,0.717416655478853,0.999485802679459
KRISHNAN_FURIN_TARGETS_DN,10,Down,0.717604040135582,0.999485802679459
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,165,Down,0.717692864971342,0.999485802679459
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,78,Down,0.717705822772937,0.999485802679459
BROWNE_HCMV_INFECTION_4HR_UP,41,Up,0.717755054200893,0.999485802679459
KEGG_VIRAL_MYOCARDITIS,31,Up,0.718213970392508,0.999485802679459
REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION,13,Down,0.718270115764083,0.999485802679459
STARK_HYPPOCAMPUS_22Q11_DELETION_UP,43,Down,0.718563000900488,0.999485802679459
BASSO_HAIRY_CELL_LEUKEMIA_DN,67,Up,0.718687036289774,0.999485802679459
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS,651,Down,0.718695800252309,0.999485802679459
TAVAZOIE_METASTASIS,68,Down,0.718760078691089,0.999485802679459
MAINA_VHL_TARGETS_UP,7,Down,0.719010361786719,0.999485802679459
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,59,Up,0.719290861681063,0.999485802679459
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN,526,Down,0.719409654659439,0.999485802679459
KEGG_SULFUR_METABOLISM,8,Up,0.7200428854685,0.999485802679459
REACTOME_SIGNALING_BY_NOTCH2,11,Up,0.720089253880634,0.999485802679459
REACTOME_SOS_MEDIATED_SIGNALLING,13,Up,0.720114862605874,0.999485802679459
OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN,2,Up,0.720177407861701,0.999485802679459
KEGG_FOLATE_BIOSYNTHESIS,7,Down,0.720188440635135,0.999485802679459
AMIT_EGF_RESPONSE_240_MCF10A,18,Down,0.720210785768478,0.999485802679459
BHAT_ESR1_TARGETS_VIA_AKT1_UP,214,Down,0.720414675567057,0.999485802679459
OHM_METHYLATED_IN_ADULT_CANCERS,19,Up,0.72078213315958,0.999485802679459
BILANGES_SERUM_SENSITIVE_GENES,62,Up,0.720818634852919,0.999485802679459
PID_P38_GAMMA_DELTA_PATHWAY,9,Up,0.720940810256892,0.999485802679459
GEISS_RESPONSE_TO_DSRNA_UP,35,Up,0.721250634096617,0.999485802679459
RIZKI_TUMOR_INVASIVENESS_2D_UP,56,Down,0.72127840077181,0.999485802679459
WANG_TUMOR_INVASIVENESS_DN,177,Up,0.721319814487137,0.999485802679459
BENPORATH_PRC2_TARGETS,273,Up,0.72153609236582,0.999485802679459
HORTON_SREBF_TARGETS,23,Down,0.72199474594411,0.999485802679459
ST_INTERFERON_GAMMA_PATHWAY,7,Up,0.722133149134295,0.999485802679459
PID_TCPTP_PATHWAY,40,Up,0.722212191305589,0.999485802679459
PATTERSON_DOCETAXEL_RESISTANCE,25,Up,0.722223208704223,0.999485802679459
SHEPARD_BMYB_MORPHOLINO_UP,152,Up,0.722243582369511,0.999485802679459
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP,7,Up,0.722364342542836,0.999485802679459
PEDRIOLI_MIR31_TARGETS_DN,279,Up,0.723005902935497,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,64,Down,0.723111088769431,0.999485802679459
MCLACHLAN_DENTAL_CARIES_UP,131,Up,0.723742148413889,0.999485802679459
ROVERSI_GLIOMA_LOH_REGIONS,26,Down,0.723950542395454,0.999485802679459
MCCABE_HOXC6_TARGETS_CANCER_UP,18,Up,0.72402163365983,0.999485802679459
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,23,Down,0.724039778669497,0.999485802679459
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,23,Down,0.724389736809421,0.999485802679459
SENESE_HDAC3_TARGETS_DN,408,Down,0.724548697201627,0.999485802679459
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,44,Down,0.724682364248258,0.999485802679459
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,28,Up,0.725046446419306,0.999485802679459
REACTOME_SHC_RELATED_EVENTS,14,Down,0.725061585322844,0.999485802679459
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,134,Down,0.72516530483215,0.999485802679459
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,185,Up,0.725183413453506,0.999485802679459
KEGG_HEDGEHOG_SIGNALING_PATHWAY,37,Down,0.725471522441547,0.999485802679459
AMIT_DELAYED_EARLY_GENES,18,Down,0.725622201790137,0.999485802679459
HAHTOLA_SEZARY_SYNDROM_DN,17,Up,0.725665137942915,0.999485802679459
REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES,18,Down,0.726146451101321,0.999485802679459
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA,5,Up,0.726497861750912,0.999485802679459
HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER,9,Down,0.726554388225796,0.999485802679459
BIOCARTA_HER2_PATHWAY,20,Up,0.726777916747881,0.999485802679459
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,16,Up,0.727049738746017,0.999485802679459
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE,8,Down,0.727142517684381,0.999485802679459
TOMLINS_PROSTATE_CANCER_DN,36,Up,0.727186590692345,0.999485802679459
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,16,Down,0.72730416208218,0.999485802679459
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,256,Up,0.728086292767289,0.999485802679459
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP,4,Down,0.728636671901081,0.999485802679459
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,31,Down,0.728701739356257,0.999485802679459
FAELT_B_CLL_WITH_VH3_21_DN,45,Up,0.728726903311554,0.999485802679459
GAVIN_FOXP3_TARGETS_CLUSTER_P7,62,Down,0.728729272691029,0.999485802679459
LANG_MYB_FAMILY_TARGETS,27,Up,0.728819934006055,0.999485802679459
PID_INTEGRIN_A9B1_PATHWAY,20,Down,0.72890974449838,0.999485802679459
MIKI_COEXPRESSED_WITH_CYP19A1,5,Up,0.728936846707438,0.999485802679459
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,51,Up,0.728944239130223,0.999485802679459
REACTOME_ION_CHANNEL_TRANSPORT,27,Down,0.729146210249988,0.999485802679459
LINSLEY_MIR16_TARGETS,180,Down,0.729235228787289,0.999485802679459
GNATENKO_PLATELET_SIGNATURE,34,Down,0.729257890372221,0.999485802679459
WARTERS_RESPONSE_TO_IR_SKIN,58,Up,0.729417697507348,0.999485802679459
YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP,9,Down,0.729481010586307,0.999485802679459
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,33,Down,0.729528906085108,0.999485802679459
REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA,11,Down,0.729557105625151,0.999485802679459
LEE_AGING_NEOCORTEX_UP,69,Up,0.729718937895621,0.999485802679459
CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL,1,Up,0.730161938803105,0.999485802679459
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,29,Down,0.730302206380935,0.999485802679459
HOWLIN_CITED1_TARGETS_2_DN,9,Down,0.730452986830639,0.999485802679459
RHODES_UNDIFFERENTIATED_CANCER,65,Up,0.730671214191189,0.999485802679459
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,47,Up,0.73106846281102,0.999485802679459
SU_SALIVARY_GLAND,6,Down,0.731123047874414,0.999485802679459
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,29,Down,0.731869214328658,0.999485802679459
GU_PDEF_TARGETS_DN,26,Up,0.731963071481114,0.999485802679459
ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS,10,Up,0.73214495456669,0.999485802679459
BIOCARTA_NDKDYNAMIN_PATHWAY,18,Up,0.732420311543441,0.999485802679459
PARK_TRETINOIN_RESPONSE,6,Up,0.732824205937976,0.999485802679459
YANG_MUC2_TARGETS_DUODENUM_6MO_UP,2,Up,0.733039140847357,0.999485802679459
REACTOME_SIGNALING_BY_NOTCH3,11,Up,0.733172120845952,0.999485802679459
REACTOME_MYOGENESIS,20,Up,0.733775511321643,0.999485802679459
REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,8,Up,0.734333999529704,0.999485802679459
REACTOME_TOLL_RECEPTOR_CASCADES,97,Down,0.734374258119741,0.999485802679459
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS,9,Down,0.734770543353305,0.999485802679459
MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP,11,Up,0.735231602461444,0.999485802679459
REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP,16,Down,0.735377791323709,0.999485802679459
REACTOME_IL_7_SIGNALING,9,Down,0.735518340189784,0.999485802679459
LI_LUNG_CANCER,34,Down,0.735593678916456,0.999485802679459
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,49,Up,0.735920797279589,0.999485802679459
PIEPOLI_LGI1_TARGETS_DN,8,Up,0.736079697940573,0.999485802679459
MURAKAMI_UV_RESPONSE_1HR_UP,13,Up,0.736595418359464,0.999485802679459
BARIS_THYROID_CANCER_DN,49,Up,0.736678634588221,0.999485802679459
REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS,30,Down,0.736832740528384,0.999485802679459
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,14,Up,0.736930338967493,0.999485802679459
BAUS_TFF2_TARGETS_DN,7,Up,0.73729278951814,0.999485802679459
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS,28,Up,0.737409159023206,0.999485802679459
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN,6,Down,0.737431923186837,0.999485802679459
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,140,Down,0.737444932058324,0.999485802679459
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,20,Up,0.737495910368775,0.999485802679459
WALLACE_PROSTATE_CANCER_DN,5,Up,0.737640862766223,0.999485802679459
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,21,Down,0.738038731687151,0.999485802679459
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,121,Up,0.738120521122812,0.999485802679459
BLALOCK_ALZHEIMERS_DISEASE_UP,1374,Up,0.73819661343819,0.999485802679459
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN,15,Up,0.738250901738421,0.999485802679459
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,35,Up,0.738492632136253,0.999485802679459
HAN_SATB1_TARGETS_UP,314,Up,0.738760489586685,0.999485802679459
GERHOLD_ADIPOGENESIS_DN,53,Down,0.739167734853529,0.999485802679459
NIELSEN_LEIOMYOSARCOMA_CNN1_UP,14,Down,0.73934110084672,0.999485802679459
GHANDHI_BYSTANDER_IRRADIATION_DN,7,Up,0.739353311794663,0.999485802679459
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,64,Up,0.739868916101828,0.999485802679459
IM_SREBF1A_TARGETS,5,Down,0.739946031507931,0.999485802679459
SHI_SPARC_TARGETS_DN,10,Up,0.740165625826382,0.999485802679459
MCCLUNG_COCAINE_REWARD_5D,59,Down,0.740276428291185,0.999485802679459
MIKKELSEN_ES_ICP_WITH_H3K4ME3,419,Down,0.740463876700488,0.999485802679459
KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN,10,Up,0.740475336818052,0.999485802679459
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,219,Down,0.740532759597246,0.999485802679459
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,61,Up,0.740990940489988,0.999485802679459
SANCHEZ_MDM2_TARGETS,12,Down,0.741100928606542,0.999485802679459
REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING,15,Up,0.741272684037677,0.999485802679459
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,55,Up,0.74152764790675,0.999485802679459
LEE_SP4_THYMOCYTE,11,Up,0.74160530084596,0.999485802679459
KINNEY_DNMT1_METHYLATION_TARGETS,2,Up,0.741665034302332,0.999485802679459
BENPORATH_SOX2_TARGETS,593,Up,0.741966849354168,0.999485802679459
NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON,12,Up,0.742064247763353,0.999485802679459
KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,14,Down,0.742110664570683,0.999485802679459
ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE,12,Up,0.742268733972589,0.999485802679459
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN,4,Down,0.742452837287232,0.999485802679459
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,35,Up,0.742536773392989,0.999485802679459
CASTELLANO_HRAS_TARGETS_DN,3,Up,0.742905330522985,0.999485802679459
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,273,Down,0.743121251305053,0.999485802679459
BRACHAT_RESPONSE_TO_METHOTREXATE_UP,17,Up,0.743541738912926,0.999485802679459
CHANDRAN_METASTASIS_TOP50_DN,35,Down,0.743709531945791,0.999485802679459
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,46,Up,0.743729150435061,0.999485802679459
KEGG_ENDOCYTOSIS,142,Down,0.743861100987957,0.999485802679459
LEE_RECENT_THYMIC_EMIGRANT,169,Down,0.74391668114608,0.999485802679459
BROWNE_HCMV_INFECTION_14HR_UP,135,Down,0.744226810690745,0.999485802679459
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN,11,Down,0.744245691073704,0.999485802679459
ZHENG_FOXP3_TARGETS_UP,16,Up,0.74487900722107,0.999485802679459
SCHLOSSER_SERUM_RESPONSE_DN,600,Down,0.74515775173713,0.999485802679459
PEREZ_TP63_TARGETS,232,Up,0.74530385735772,0.999485802679459
WALLACE_PROSTATE_CANCER_RACE_DN,62,Down,0.745715981400545,0.999485802679459
BIOCARTA_EIF2_PATHWAY,11,Down,0.746044889458109,0.999485802679459
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,84,Up,0.746121742256349,0.999485802679459
MATZUK_LUTEAL_GENES,6,Down,0.74618198051441,0.999485802679459
PID_S1P_S1P2_PATHWAY,22,Down,0.746306461214289,0.999485802679459
DIRMEIER_LMP1_RESPONSE_EARLY,50,Up,0.746357525845356,0.999485802679459
REACTOME_PROSTANOID_LIGAND_RECEPTORS,4,Up,0.746460835143223,0.999485802679459
SOUCEK_MYC_TARGETS,2,Down,0.746643742300205,0.999485802679459
FURUKAWA_DUSP6_TARGETS_PCI35_DN,65,Down,0.746776276330048,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,121,Down,0.746881624615725,0.999485802679459
LEE_AGING_MUSCLE_UP,37,Down,0.747143820670198,0.999485802679459
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN,18,Up,0.74733335391162,0.999485802679459
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,18,Down,0.747344195428585,0.999485802679459
COLLIS_PRKDC_REGULATORS,14,Up,0.748212603625604,0.999485802679459
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,69,Down,0.748531444972015,0.999485802679459
REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS,8,Up,0.748552569045013,0.999485802679459
MIKKELSEN_DEDIFFERENTIATED_STATE_UP,6,Up,0.749017879163873,0.999485802679459
JIANG_AGING_CEREBRAL_CORTEX_DN,47,Down,0.74911371215581,0.999485802679459
REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS,14,Down,0.749734034270855,0.999485802679459
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,41,Up,0.749775360502747,0.999485802679459
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN,10,Up,0.749850923964393,0.999485802679459
HOLLEMAN_DAUNORUBICIN_B_ALL_UP,9,Down,0.749999993814388,0.999485802679459
REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT,22,Down,0.750848038172026,0.999485802679459
MARSON_FOXP3_TARGETS_STIMULATED_UP,16,Up,0.751194582737981,0.999485802679459
KOBAYASHI_EGFR_SIGNALING_6HR_DN,15,Down,0.75123596948261,0.999485802679459
FIRESTEIN_CTNNB1_PATHWAY,32,Down,0.751452605374645,0.999485802679459
GENTILE_UV_LOW_DOSE_UP,22,Down,0.751939394406255,0.999485802679459
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,26,Up,0.752033036467131,0.999485802679459
DARWICHE_PAPILLOMA_RISK_LOW_UP,98,Down,0.752328580616426,0.999485802679459
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER,11,Down,0.752342897564661,0.999485802679459
REACTOME_CELL_CELL_COMMUNICATION,78,Down,0.752726901560441,0.999485802679459
STEINER_ERYTHROCYTE_MEMBRANE_GENES,12,Down,0.75297181184725,0.999485802679459
RAHMAN_TP53_TARGETS_PHOSPHORYLATED,20,Down,0.753040186516283,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,27,Down,0.753106303998616,0.999485802679459
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,32,Down,0.753346610284744,0.999485802679459
KEGG_NON_HOMOLOGOUS_END_JOINING,11,Down,0.753451626958201,0.999485802679459
HAN_JNK_SINGALING_DN,24,Up,0.753627818317921,0.999485802679459
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN,11,Up,0.754058097658868,0.999485802679459
KEGG_ALLOGRAFT_REJECTION,3,Down,0.754192496582103,0.999485802679459
BIOCARTA_IGF1_PATHWAY,19,Up,0.754211098246097,0.999485802679459
ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY,606,Up,0.754843309283122,0.999485802679459
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1,8,Up,0.755029547715947,0.999485802679459
MEDINA_SMARCA4_TARGETS,37,Down,0.75521224959376,0.999485802679459
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,28,Down,0.755295445276949,0.999485802679459
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,95,Down,0.755337804577652,0.999485802679459
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,22,Down,0.755445732411722,0.999485802679459
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,67,Up,0.75552189473413,0.999485802679459
JU_AGING_TERC_TARGETS_DN,3,Down,0.755744013750355,0.999485802679459
TESAR_ALK_TARGETS_EPISC_4D_UP,5,Down,0.755896545744863,0.999485802679459
INAMURA_LUNG_CANCER_SCC_UP,8,Down,0.756025003710769,0.999485802679459
ZHENG_IL22_SIGNALING_DN,27,Up,0.756293036469628,0.999485802679459
WANG_RESPONSE_TO_BEXAROTENE_UP,22,Down,0.75641730401838,0.999485802679459
LEE_LIVER_CANCER_MYC_E2F1_DN,30,Up,0.756473747051307,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6,4,Up,0.756520654330753,0.999485802679459
REACTOME_DNA_REPAIR,97,Down,0.757295683655729,0.999485802679459
HOOI_ST7_TARGETS_UP,69,Down,0.757382596033325,0.999485802679459
SERVITJA_LIVER_HNF1A_TARGETS_DN,78,Up,0.757725338167489,0.999485802679459
PALOMERO_GSI_SENSITIVITY_DN,3,Down,0.758142912116731,0.999485802679459
VANASSE_BCL2_TARGETS_DN,48,Up,0.758414369875312,0.999485802679459
LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP,6,Down,0.758610032424576,0.999485802679459
WANG_THOC1_TARGETS_DN,12,Up,0.758612696867855,0.999485802679459
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,19,Up,0.759408318703972,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN,6,Up,0.75958788242819,0.999485802679459
BIOCARTA_P53_PATHWAY,16,Down,0.759696470530877,0.999485802679459
KANG_AR_TARGETS_DN,13,Down,0.760046856720059,0.999485802679459
OHGUCHI_LIVER_HNF4A_TARGETS_DN,63,Down,0.760144732659851,0.999485802679459
LOPEZ_MESOTHELIOMA_SURVIVAL_DN,10,Down,0.760211386322453,0.999485802679459
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,145,Down,0.76031905246108,0.999485802679459
YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,12,Up,0.760403780319063,0.999485802679459
YANG_BREAST_CANCER_ESR1_BULK_UP,23,Down,0.760846402114442,0.999485802679459
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_,10,Down,0.761044746875148,0.999485802679459
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,153,Up,0.7610704214706,0.999485802679459
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,58,Up,0.761153845149207,0.999485802679459
WANG_RECURRENT_LIVER_CANCER_DN,12,Down,0.76150807722201,0.999485802679459
BRUNEAU_SEPTATION_ATRIAL,2,Up,0.76210305218279,0.999485802679459
STANHILL_HRAS_TRANSFROMATION_UP,6,Up,0.76230097944767,0.999485802679459
IVANOV_MUTATED_IN_COLON_CANCER,10,Down,0.762568830150292,0.999485802679459
MATZUK_MALE_REPRODUCTION_SERTOLI,20,Up,0.762673919486949,0.999485802679459
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,32,Down,0.762949976407056,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,70,Up,0.763021333568871,0.999485802679459
KEGG_SELENOAMINO_ACID_METABOLISM,21,Up,0.7630793762362,0.999485802679459
KEGG_ETHER_LIPID_METABOLISM,15,Down,0.763228025166512,0.999485802679459
REACTOME_INTEGRATION_OF_PROVIRUS,8,Down,0.763250804758474,0.999485802679459
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,34,Down,0.763447435205478,0.999485802679459
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,85,Down,0.763681670317105,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,31,Down,0.763711456942092,0.999485802679459
BIOCARTA_SPPA_PATHWAY,15,Down,0.763919239295703,0.999485802679459
AMIT_SERUM_RESPONSE_20_MCF10A,17,Down,0.76408590863311,0.999485802679459
WALLACE_JAK2_TARGETS_UP,20,Down,0.764144709670408,0.999485802679459
MIZUKAMI_HYPOXIA_UP,10,Down,0.764778621161954,0.999485802679459
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,35,Down,0.765064984767789,0.999485802679459
NGO_MALIGNANT_GLIOMA_1P_LOH,16,Down,0.765258321824371,0.999485802679459
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,174,Down,0.765292967372226,0.999485802679459
REACTOME_IMMUNE_SYSTEM,650,Up,0.765832171282069,0.999485802679459
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,51,Down,0.766230365461753,0.999485802679459
REACTOME_RAF_MAP_KINASE_CASCADE,9,Down,0.766333510903258,0.999485802679459
BILD_SRC_ONCOGENIC_SIGNATURE,55,Down,0.766849959902906,0.999485802679459
BORLAK_LIVER_CANCER_EGF_UP,45,Up,0.767024649752746,0.999485802679459
FUJIWARA_PARK2_IN_LIVER_CANCER_UP,6,Down,0.767155150389264,0.999485802679459
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,72,Up,0.767176589406541,0.999485802679459
WONG_MITOCHONDRIA_GENE_MODULE,186,Down,0.767189876255132,0.999485802679459
BIOCARTA_SPRY_PATHWAY,16,Down,0.767379317432856,0.999485802679459
STEIN_ESRRA_TARGETS_UP,332,Up,0.76743984765307,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,42,Down,0.767508854863607,0.999485802679459
KAPOSI_LIVER_CANCER_MET_DN,5,Up,0.767627772900964,0.999485802679459
CAMPS_COLON_CANCER_COPY_NUMBER_UP,57,Down,0.767881598644445,0.999485802679459
CHEN_LUNG_CANCER_SURVIVAL,21,Up,0.7682099839442,0.999485802679459
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP,25,Up,0.768265446022317,0.999485802679459
HWANG_PROSTATE_CANCER_MARKERS,21,Down,0.768405973648543,0.999485802679459
SCHRAETS_MLL_TARGETS_DN,24,Down,0.768488539205107,0.999485802679459
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN,774,Down,0.76870455347178,0.999485802679459
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN,6,Up,0.7689688226492,0.999485802679459
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,36,Down,0.769039666657204,0.999485802679459
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,104,Up,0.769169800775051,0.999485802679459
ZERBINI_RESPONSE_TO_SULINDAC_UP,8,Down,0.769577745525995,0.999485802679459
SA_CASPASE_CASCADE,16,Down,0.769689390241807,0.999485802679459
UEDA_PERIFERAL_CLOCK,138,Down,0.769718603618001,0.999485802679459
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,18,Down,0.769817923346927,0.999485802679459
REACTOME_COMMON_PATHWAY,3,Down,0.77003490666032,0.999485802679459
CUI_TCF21_TARGETS_2_DN,641,Up,0.770373166215135,0.999485802679459
FARMER_BREAST_CANCER_CLUSTER_7,16,Up,0.770375766472632,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN,8,Down,0.77088156836727,0.999485802679459
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,52,Up,0.771055125357961,0.999485802679459
GALE_APL_WITH_FLT3_MUTATED_UP,49,Down,0.771801785167491,0.999485802679459
WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN,4,Up,0.771871855458118,0.999485802679459
SHIN_B_CELL_LYMPHOMA_CLUSTER_8,26,Down,0.772926654235075,0.999485802679459
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN,813,Down,0.773111692692394,0.999485802679459
REACTOME_THE_NLRP3_INFLAMMASOME,10,Up,0.773355538841157,0.999485802679459
NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,6,Down,0.773646852230554,0.999485802679459
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,56,Up,0.773768015169212,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,57,Up,0.773903776736289,0.999485802679459
KIM_MYCL1_AMPLIFICATION_TARGETS_UP,9,Up,0.773922405574425,0.999485802679459
KORKOLA_CHORIOCARCINOMA,1,Up,0.774197533573716,0.999485802679459
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,305,Up,0.774203137628358,0.999485802679459
THUM_MIR21_TARGETS_HEART_DISEASE_UP,12,Up,0.774254008685308,0.999485802679459
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,7,Down,0.77428827717585,0.999485802679459
LIU_PROSTATE_CANCER_UP,73,Down,0.774394871537697,0.999485802679459
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,65,Up,0.774454256315864,0.999485802679459
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP,1258,Down,0.774619072522811,0.999485802679459
WANG_HCP_PROSTATE_CANCER,92,Up,0.774765263074505,0.999485802679459
REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION,7,Down,0.774835783143444,0.999485802679459
REACTOME_GLUCONEOGENESIS,24,Down,0.774987748018672,0.999485802679459
REACTOME_GLUCURONIDATION,3,Down,0.775045942985038,0.999485802679459
REACTOME_HDL_MEDIATED_LIPID_TRANSPORT,8,Down,0.775497023467168,0.999485802679459
PID_PDGFRA_PATHWAY,19,Down,0.775541823849343,0.999485802679459
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,62,Down,0.775611079335253,0.999485802679459
PID_ANTHRAX_PATHWAY,15,Up,0.775685537472461,0.999485802679459
SMIRNOV_RESPONSE_TO_IR_2HR_UP,44,Up,0.775948581063102,0.999485802679459
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,13,Up,0.776028348165256,0.999485802679459
KEGG_PYRUVATE_METABOLISM,33,Down,0.776132395336288,0.999485802679459
BURTON_ADIPOGENESIS_PEAK_AT_24HR,37,Down,0.776156680942495,0.999485802679459
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,57,Up,0.776392085420244,0.999485802679459
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,200,Down,0.776412871566509,0.999485802679459
LEIN_OLIGODENDROCYTE_MARKERS,45,Up,0.776735826424547,0.999485802679459
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP,729,Up,0.776801299872028,0.999485802679459
BASSO_HAIRY_CELL_LEUKEMIA_UP,3,Down,0.776962906148619,0.999485802679459
WONG_IFNA2_RESISTANCE_UP,13,Up,0.776999775125714,0.999485802679459
OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP,21,Down,0.777243478532578,0.999485802679459
AFFAR_YY1_TARGETS_UP,140,Down,0.777377220722345,0.999485802679459
REACTOME_P75NTR_SIGNALS_VIA_NFKB,11,Down,0.777392496169055,0.999485802679459
WONG_ENDOMETRIAL_CANCER_LATE,3,Down,0.778038494642195,0.999485802679459
WORSCHECH_TUMOR_REJECTION_UP,26,Up,0.778272281196293,0.999485802679459
REACTOME_SIGNALING_BY_BMP,18,Down,0.778508372245518,0.999485802679459
LENAOUR_DENDRITIC_CELL_MATURATION_DN,90,Up,0.778816233222834,0.999485802679459
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,432,Up,0.778979399014525,0.999485802679459
KIM_PTEN_TARGETS_DN,3,Up,0.779123199867647,0.999485802679459
DOUGLAS_BMI1_TARGETS_DN,274,Up,0.779211034194918,0.999485802679459
DASU_IL6_SIGNALING_UP,51,Up,0.779213250453668,0.999485802679459
REACTOME_DEVELOPMENTAL_BIOLOGY,294,Down,0.779415216546124,0.999485802679459
PALOMERO_GSI_SENSITIVITY_UP,6,Down,0.779440158621208,0.999485802679459
YANAGIHARA_ESX1_TARGETS,24,Down,0.77954845194132,0.999485802679459
TSENG_ADIPOGENIC_POTENTIAL_DN,32,Down,0.779953058290878,0.999485802679459
MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN,9,Up,0.780246725023707,0.999485802679459
YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN,3,Up,0.780369746686462,0.999485802679459
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,54,Up,0.780648085275472,0.999485802679459
KENNY_CTNNB1_TARGETS_DN,44,Up,0.780923210532718,0.999485802679459
MARKEY_RB1_CHRONIC_LOF_DN,77,Up,0.780933078036471,0.999485802679459
RICKMAN_METASTASIS_DN,194,Up,0.781019485008181,0.999485802679459
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,83,Down,0.781064896982182,0.999485802679459
REACTOME_METABOLISM_OF_PORPHYRINS,11,Up,0.781111587612269,0.999485802679459
REACTOME_BASE_EXCISION_REPAIR,19,Down,0.781170895200548,0.999485802679459
NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON,8,Down,0.78127206636423,0.999485802679459
REACTOME_SHC_MEDIATED_CASCADE,12,Down,0.78129286195758,0.999485802679459
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR,386,Up,0.781339898293664,0.999485802679459
KEGG_ALZHEIMERS_DISEASE,119,Down,0.78176424759165,0.999485802679459
LUI_THYROID_CANCER_PAX8_PPARG_DN,41,Down,0.781896991408811,0.999485802679459
LI_CISPLATIN_RESISTANCE_UP,19,Up,0.781898994813957,0.999485802679459
TANG_SENESCENCE_TP53_TARGETS_UP,20,Down,0.782463462356769,0.999485802679459
REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION,24,Up,0.782926094772428,0.999485802679459
SHEPARD_CRUSH_AND_BURN_MUTANT_UP,152,Up,0.78423291142043,0.999485802679459
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS,95,Up,0.784427252182286,0.999485802679459
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,11,Down,0.784643201808744,0.999485802679459
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP,474,Up,0.785027785121712,0.999485802679459
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,7,Up,0.785048192075907,0.999485802679459
REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,103,Down,0.785123835617664,0.999485802679459
WANG_METASTASIS_OF_BREAST_CANCER,9,Down,0.785247442515662,0.999485802679459
MATTIOLI_MGUS_VS_PCL,84,Down,0.785449002667329,0.999485802679459
NUYTTEN_NIPP1_TARGETS_UP,608,Up,0.785492726379721,0.999485802679459
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,59,Up,0.786750745965366,0.999485802679459
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,17,Down,0.78686790577854,0.999485802679459
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,10,Down,0.786991313987422,0.999485802679459
REACTOME_APOPTOTIC_EXECUTION_PHASE,40,Up,0.787152453338631,0.999485802679459
MURAKAMI_UV_RESPONSE_6HR_UP,32,Down,0.78721063067455,0.999485802679459
NABA_CORE_MATRISOME,145,Down,0.787311492144436,0.999485802679459
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,15,Up,0.787470439022736,0.999485802679459
ODONNELL_METASTASIS_DN,13,Down,0.787498393506353,0.999485802679459
LIN_NPAS4_TARGETS_DN,43,Up,0.787753144772745,0.999485802679459
CASTELLANO_NRAS_TARGETS_DN,12,Up,0.78788546137039,0.999485802679459
KANG_CISPLATIN_RESISTANCE_DN,8,Down,0.787958754573754,0.999485802679459
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,84,Down,0.788010179091137,0.999485802679459
FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION,8,Up,0.788461306014268,0.999485802679459
CHEN_PDGF_TARGETS,16,Down,0.788748550292511,0.999485802679459
CROMER_METASTASIS_DN,68,Down,0.789053754514099,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_MS_DN,34,Down,0.789150678148988,0.999485802679459
BIOCARTA_D4GDI_PATHWAY,11,Up,0.789286608948783,0.999485802679459
NADLER_OBESITY_DN,31,Down,0.789367042176357,0.999485802679459
REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION,8,Down,0.789552873290423,0.999485802679459
SABATES_COLORECTAL_ADENOMA_SIZE_UP,12,Down,0.789584184962961,0.999485802679459
CROONQUIST_IL6_DEPRIVATION_UP,14,Down,0.790125313926104,0.999485802679459
NAKAMURA_ADIPOGENESIS_LATE_DN,33,Down,0.790146980170952,0.999485802679459
COLLER_MYC_TARGETS_UP,21,Down,0.790288069206405,0.999485802679459
SIMBULAN_PARP1_TARGETS_UP,25,Down,0.790308857647724,0.999485802679459
BROWNE_HCMV_INFECTION_10HR_DN,49,Up,0.790522829479859,0.999485802679459
REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA,12,Down,0.790689752687185,0.999485802679459
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,195,Up,0.790869520203995,0.999485802679459
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,14,Down,0.790893615871189,0.999485802679459
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,59,Down,0.790906422276764,0.999485802679459
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,19,Down,0.791161544686885,0.999485802679459
KAUFFMANN_MELANOMA_RELAPSE_UP,59,Down,0.791479043601403,0.999485802679459
TESAR_ALK_TARGETS_EPISC_3D_UP,5,Down,0.791941482647579,0.999485802679459
TOMLINS_METASTASIS_UP,10,Down,0.792015292658637,0.999485802679459
KANG_GIST_WITH_PDGFRA_DN,4,Down,0.792257607556092,0.999485802679459
RODRIGUES_THYROID_CARCINOMA_UP,11,Down,0.792305651178615,0.999485802679459
HOLLMANN_APOPTOSIS_VIA_CD40_UP,156,Up,0.792539642899547,0.999485802679459
XU_RESPONSE_TO_TRETINOIN_UP,13,Down,0.792697383288698,0.999485802679459
KEGG_SPHINGOLIPID_METABOLISM,24,Down,0.792721915154905,0.999485802679459
NOUSHMEHR_GBM_GERMLINE_MUTATED,3,Down,0.792767200165032,0.999485802679459
REACTOME_SIGNALING_BY_ILS,85,Up,0.792933920021011,0.999485802679459
WANG_SMARCE1_TARGETS_DN,303,Down,0.792944662661045,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,314,Down,0.793240328505071,0.999485802679459
GENTILE_UV_LOW_DOSE_DN,57,Down,0.793259781406297,0.999485802679459
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN,2,Up,0.793429183387939,0.999485802679459
REACTOME_APOPTOSIS,123,Up,0.793482523076997,0.999485802679459
YAMASHITA_LIVER_CANCER_STEM_CELL_DN,33,Up,0.793519680749484,0.999485802679459
REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES,7,Up,0.79383948804505,0.999485802679459
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,50,Up,0.794375081129358,0.999485802679459
REACTOME_PERK_REGULATED_GENE_EXPRESSION,24,Down,0.794447162027292,0.999485802679459
ZHU_CMV_24_HR_UP,83,Up,0.794660227889761,0.999485802679459
BILD_MYC_ONCOGENIC_SIGNATURE,158,Down,0.79488620530039,0.999485802679459
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION,11,Up,0.795653286923007,0.999485802679459
TESAR_ALK_TARGETS_HUMAN_ES_5D_UP,4,Down,0.795879686468288,0.999485802679459
SWEET_LUNG_CANCER_KRAS_UP,355,Up,0.796413936303336,0.999485802679459
PID_REELIN_PATHWAY,26,Down,0.796582604021241,0.999485802679459
REACTOME_G_ALPHA1213_SIGNALLING_EVENTS,61,Up,0.797267058716202,0.999485802679459
REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION,8,Down,0.797272592367825,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,109,Down,0.797273796717325,0.999485802679459
CROONQUIST_NRAS_SIGNALING_UP,18,Down,0.797790475120563,0.999485802679459
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,55,Up,0.79782205333891,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,18,Down,0.797973806556332,0.999485802679459
MENSSEN_MYC_TARGETS,51,Up,0.798021028798373,0.999485802679459
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,7,Down,0.798031893369454,0.999485802679459
REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,5,Down,0.798045344608986,0.999485802679459
BROWNE_HCMV_INFECTION_24HR_DN,126,Down,0.798072637372563,0.999485802679459
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,106,Down,0.798127783117745,0.999485802679459
JIANG_HYPOXIA_CANCER,70,Down,0.798166996425542,0.999485802679459
KEGG_PANCREATIC_CANCER,66,Up,0.798234859005085,0.999485802679459
MMS_MOUSE_LYMPH_HIGH_4HRS_UP,31,Up,0.798399946141695,0.999485802679459
BEIER_GLIOMA_STEM_CELL_UP,21,Up,0.79843548785304,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,59,Up,0.798802471142684,0.999485802679459
WU_ALZHEIMER_DISEASE_DN,14,Down,0.798899822806622,0.999485802679459
ZHANG_BREAST_CANCER_PROGENITORS_DN,118,Down,0.799423519956026,0.999485802679459
JEPSEN_SMRT_TARGETS,21,Down,0.799568125484438,0.999485802679459
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,18,Up,0.799598835396354,0.999485802679459
ZHAN_V2_LATE_DIFFERENTIATION_GENES,40,Up,0.799670511204442,0.999485802679459
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP,53,Up,0.799787984649083,0.999485802679459
JI_RESPONSE_TO_FSH_UP,63,Down,0.799809153096972,0.999485802679459
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN,64,Down,0.799888260183649,0.999485802679459
BILD_CTNNB1_ONCOGENIC_SIGNATURE,71,Up,0.800668272106402,0.999485802679459
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED,25,Down,0.80073263464085,0.999485802679459
OSMAN_BLADDER_CANCER_UP,342,Up,0.800941024725853,0.999485802679459
ABE_VEGFA_TARGETS,10,Down,0.800995951473822,0.999485802679459
SUNG_METASTASIS_STROMA_UP,96,Down,0.801338072294995,0.999485802679459
GOLDRATH_ANTIGEN_RESPONSE,267,Up,0.801373338236789,0.999485802679459
CAFFAREL_RESPONSE_TO_THC_8HR_5_UP,15,Up,0.801700826568551,0.999485802679459
ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE,11,Up,0.802039598951424,0.999485802679459
ZHANG_RESPONSE_TO_CANTHARIDIN_UP,16,Up,0.80234827468379,0.999485802679459
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,52,Down,0.802655415651449,0.999485802679459
REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE,16,Down,0.802936958447468,0.999485802679459
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN,43,Up,0.803263012074466,0.999485802679459
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,110,Up,0.803288468513988,0.999485802679459
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,137,Up,0.803684022012108,0.999485802679459
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3,14,Up,0.804008841636708,0.999485802679459
REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION,20,Down,0.804159688292289,0.999485802679459
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,113,Down,0.804217711139124,0.999485802679459
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,24,Down,0.804502047753576,0.999485802679459
REACTOME_GLYCOLYSIS,22,Up,0.805028024776197,0.999485802679459
PID_NFKAPPAB_ATYPICAL_PATHWAY,13,Down,0.805067114900248,0.999485802679459
BENPORATH_NANOG_TARGETS,801,Down,0.805146379522264,0.999485802679459
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,73,Up,0.805248679342014,0.999485802679459
REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,18,Down,0.805250596803887,0.999485802679459
WOO_LIVER_CANCER_RECURRENCE_DN,55,Down,0.80655672541422,0.999485802679459
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,119,Down,0.806761522583388,0.999485802679459
LANDIS_ERBB2_BREAST_TUMORS_65_DN,29,Down,0.806801095449431,0.999485802679459
RICKMAN_HEAD_AND_NECK_CANCER_C,46,Up,0.807044282336446,0.999485802679459
SHIRAISHI_PLZF_TARGETS_DN,6,Down,0.807343854841258,0.999485802679459
YAGI_AML_FAB_MARKERS,152,Up,0.807661047024841,0.999485802679459
CAFFAREL_RESPONSE_TO_THC_8HR_3_UP,5,Down,0.807680923103654,0.999485802679459
AMIT_EGF_RESPONSE_60_MCF10A,33,Down,0.807971171350324,0.999485802679459
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP,13,Down,0.808192967608156,0.999485802679459
KRIGE_AMINO_ACID_DEPRIVATION,25,Up,0.808397256448621,0.999485802679459
REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION,10,Up,0.808849556299255,0.999485802679459
PHESSE_TARGETS_OF_APC_AND_MBD2_UP,5,Down,0.80890536087947,0.999485802679459
KIM_MYCN_AMPLIFICATION_TARGETS_UP,61,Up,0.809566599833671,0.999485802679459
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5,10,Up,0.809605918511622,0.999485802679459
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,101,Up,0.809674899206819,0.999485802679459
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,59,Down,0.809716097775523,0.999485802679459
RAMASWAMY_METASTASIS_UP,58,Down,0.809945482646559,0.999485802679459
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,15,Up,0.811217317919062,0.999485802679459
REACTOME_SIGNALING_BY_GPCR,273,Down,0.81141193794138,0.999485802679459
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,19,Up,0.811754229554717,0.999485802679459
CHEBOTAEV_GR_TARGETS_UP,52,Up,0.811853161649287,0.999485802679459
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,24,Down,0.812197042867603,0.999485802679459
BROWNE_HCMV_INFECTION_20HR_UP,193,Down,0.81221893308416,0.999485802679459
BROWNE_HCMV_INFECTION_1HR_DN,160,Down,0.812260617141538,0.999485802679459
GOUYER_TUMOR_INVASIVENESS,8,Up,0.812343513250741,0.999485802679459
FORTSCHEGGER_PHF8_TARGETS_UP,205,Up,0.812399295422352,0.999485802679459
IKEDA_MIR133_TARGETS_UP,39,Up,0.812746005581941,0.999485802679459
MAYBURD_RESPONSE_TO_L663536_DN,44,Up,0.812747916605128,0.999485802679459
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN,7,Up,0.812911918316769,0.999485802679459
REACTOME_KERATAN_SULFATE_DEGRADATION,5,Down,0.81309773427518,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,265,Up,0.813277771363823,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,11,Up,0.813436530636339,0.999485802679459
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,61,Down,0.813535391913855,0.999485802679459
KYNG_RESPONSE_TO_H2O2,56,Down,0.814833386944067,0.999485802679459
BIOCARTA_AGPCR_PATHWAY,10,Down,0.814881153959697,0.999485802679459
KANG_IMMORTALIZED_BY_TERT_DN,58,Down,0.815189114695155,0.999485802679459
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII,12,Down,0.815703137036102,0.999485802679459
FREDERICK_PRKCI_TARGETS,5,Up,0.816402924715589,0.999485802679459
ONKEN_UVEAL_MELANOMA_UP,655,Up,0.816720010768551,0.999485802679459
CHICAS_RB1_TARGETS_GROWING,201,Down,0.816828941156868,0.999485802679459
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL,12,Down,0.816938876890279,0.999485802679459
REACTOME_ACTIVATED_TLR4_SIGNALLING,82,Up,0.817104036221281,0.999485802679459
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,19,Up,0.817521746636485,0.999485802679459
REACTOME_AMINE_DERIVED_HORMONES,1,Down,0.817553012839606,0.999485802679459
PID_TCR_JNK_PATHWAY,10,Down,0.818132369642593,0.999485802679459
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,42,Down,0.818320610333775,0.999485802679459
HU_ANGIOGENESIS_DN,31,Up,0.818450244757988,0.999485802679459
KANNAN_TP53_TARGETS_UP,48,Down,0.818933678675621,0.999485802679459
YAGI_AML_WITH_11Q23_REARRANGED,265,Down,0.819143817014092,0.999485802679459
REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION,9,Up,0.819165133970006,0.999485802679459
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN,21,Up,0.819350415343502,0.999485802679459
VALK_AML_CLUSTER_7,17,Down,0.819948871527717,0.999485802679459
SCHUHMACHER_MYC_TARGETS_DN,4,Up,0.81999147573494,0.999485802679459
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,174,Down,0.820111394647275,0.999485802679459
NOUZOVA_METHYLATED_IN_APL,44,Up,0.820153701223848,0.999485802679459
FUJIWARA_PARK2_IN_LIVER_CANCER_DN,2,Up,0.820572253234436,0.999485802679459
MARKS_ACETYLATED_NON_HISTONE_PROTEINS,12,Down,0.820920940257879,0.999485802679459
REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE,3,Up,0.821039227438467,0.999485802679459
AMIT_EGF_RESPONSE_480_MCF10A,35,Up,0.821288684579545,0.999485802679459
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,22,Up,0.821488158732327,0.999485802679459
KEGG_P53_SIGNALING_PATHWAY,60,Up,0.82151880140562,0.999485802679459
BIOCARTA_G1_PATHWAY,26,Down,0.821835615575653,0.999485802679459
BIOCARTA_CDK5_PATHWAY,8,Down,0.821874341781207,0.999485802679459
BIOCARTA_SKP2E2F_PATHWAY,10,Down,0.822264971760569,0.999485802679459
SAGIV_CD24_TARGETS_UP,13,Down,0.8223458083,0.999485802679459
PIONTEK_PKD1_TARGETS_UP,26,Up,0.822542490638986,0.999485802679459
AFFAR_YY1_TARGETS_DN,167,Down,0.822763977610512,0.999485802679459
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,48,Up,0.822766471669367,0.999485802679459
GENTILE_UV_HIGH_DOSE_UP,21,Down,0.822947882741483,0.999485802679459
ZHANG_TLX_TARGETS_60HR_UP,241,Up,0.822979026558736,0.999485802679459
BIOCARTA_ETC_PATHWAY,9,Down,0.823422962656246,0.999485802679459
FOSTER_KDM1A_TARGETS_UP,127,Down,0.823464767049725,0.999485802679459
FRIDMAN_IMMORTALIZATION_DN,25,Up,0.823594301083004,0.999485802679459
PID_EPO_PATHWAY,29,Up,0.823816807014909,0.999485802679459
HUMMERICH_BENIGN_SKIN_TUMOR_DN,7,Down,0.824096601905118,0.999485802679459
PID_FANCONI_PATHWAY,40,Up,0.824152056955234,0.999485802679459
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,180,Up,0.824232751536941,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_CD2_UP,29,Down,0.824281762562092,0.999485802679459
LEIN_CHOROID_PLEXUS_MARKERS,61,Up,0.824473577968573,0.999485802679459
REACTOME_IL_2_SIGNALING,27,Down,0.825024605744178,0.999485802679459
KIM_MYCL1_AMPLIFICATION_TARGETS_DN,16,Down,0.825113670438535,0.999485802679459
NIELSEN_SCHWANNOMA_DN,14,Up,0.825131264229858,0.999485802679459
REACTOME_ZINC_TRANSPORTERS,9,Down,0.825139207420475,0.999485802679459
SABATES_COLORECTAL_ADENOMA_UP,68,Up,0.825171496354094,0.999485802679459
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP,10,Up,0.82538905218782,0.999485802679459
BIOCARTA_IL3_PATHWAY,10,Down,0.825491461589995,0.999485802679459
KORKOLA_CHORIOCARCINOMA_UP,5,Down,0.8255409656421,0.999485802679459
RODRIGUES_NTN1_AND_DCC_TARGETS,24,Down,0.825766493189705,0.999485802679459
GERHOLD_RESPONSE_TO_TZD_DN,10,Down,0.825832063285608,0.999485802679459
ST_JNK_MAPK_PATHWAY,36,Up,0.825998896964991,0.999485802679459
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,74,Up,0.826077234375825,0.999485802679459
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,41,Down,0.826203271007068,0.999485802679459
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,486,Down,0.826224169739167,0.999485802679459
REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION,89,Down,0.826453995178681,0.999485802679459
REACTOME_BASIGIN_INTERACTIONS,20,Up,0.827759104547452,0.999485802679459
IGLESIAS_E2F_TARGETS_UP,123,Up,0.827791128835235,0.999485802679459
APRELIKOVA_BRCA1_TARGETS,39,Down,0.827969495980057,0.999485802679459
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,91,Down,0.828014330340853,0.999485802679459
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,41,Up,0.828737391085479,0.999485802679459
INGRAM_SHH_TARGETS_UP,88,Down,0.828926726215355,0.999485802679459
REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS,16,Down,0.828959912468608,0.999485802679459
MCDOWELL_ACUTE_LUNG_INJURY_DN,29,Down,0.829002825399037,0.999485802679459
KEGG_DRUG_METABOLISM_CYTOCHROME_P450,22,Up,0.829043098124334,0.999485802679459
OZANNE_AP1_TARGETS_UP,14,Down,0.829215229064774,0.999485802679459
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,52,Up,0.829568044376965,0.999485802679459
REACTOME_RNA_POL_III_TRANSCRIPTION,33,Up,0.829624094250181,0.999485802679459
MARTINEZ_RB1_AND_TP53_TARGETS_DN,413,Up,0.830529771297611,0.999485802679459
GROSS_ELK3_TARGETS_UP,21,Down,0.831314215029595,0.999485802679459
BRUINS_UVC_RESPONSE_EARLY_LATE,246,Down,0.831605799287714,0.999485802679459
FIRESTEIN_PROLIFERATION,137,Up,0.83205143678213,0.999485802679459
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,14,Down,0.832319788991491,0.999485802679459
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN,18,Down,0.832609862678699,0.999485802679459
REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS,3,Up,0.832743582292244,0.999485802679459
SHEN_SMARCA2_TARGETS_DN,142,Up,0.833052329012162,0.999485802679459
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,276,Down,0.833122461698462,0.999485802679459
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,48,Up,0.833209353012485,0.999485802679459
RIZ_ERYTHROID_DIFFERENTIATION,71,Down,0.833428266049148,0.999485802679459
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN,9,Up,0.833615957798971,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,7,Down,0.833799583803702,0.999485802679459
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,54,Down,0.83401320283537,0.999485802679459
PARK_HSC_AND_MULTIPOTENT_PROGENITORS,45,Down,0.83419603529906,0.999485802679459
BIOCARTA_GH_PATHWAY,21,Up,0.834410162720683,0.999485802679459
WANG_CLIM2_TARGETS_DN,158,Down,0.835014574180935,0.999485802679459
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN,15,Up,0.835017343242913,0.999485802679459
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,254,Down,0.835131374988315,0.999485802679459
OUYANG_PROSTATE_CANCER_MARKERS,16,Up,0.835161324884517,0.999485802679459
LU_AGING_BRAIN_UP,207,Up,0.835722844745467,0.999485802679459
ST_T_CELL_SIGNAL_TRANSDUCTION,35,Down,0.836016363103623,0.999485802679459
IWANAGA_CARCINOGENESIS_BY_KRAS_UP,117,Up,0.83625581978353,0.999485802679459
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP,16,Down,0.836429822230166,0.999485802679459
DIRMEIER_LMP1_RESPONSE_LATE_UP,44,Up,0.836503368595849,0.999485802679459
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,18,Up,0.836726529048265,0.999485802679459
MULLIGHAN_NPM1_SIGNATURE_3_DN,117,Down,0.837022632765169,0.999485802679459
WIERENGA_STAT5A_TARGETS_GROUP2,41,Down,0.837142903648352,0.999485802679459
REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS,11,Down,0.837554656457404,0.999485802679459
KOMMAGANI_TP63_GAMMA_TARGETS,9,Down,0.83774727517359,0.999485802679459
WHITFIELD_CELL_CYCLE_M_G1,124,Down,0.838330192195675,0.999485802679459
LABBE_WNT3A_TARGETS_DN,55,Up,0.839051363349952,0.999485802679459
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,20,Up,0.839731903487472,0.999485802679459
IVANOVSKA_MIR106B_TARGETS,74,Down,0.839941142973059,0.999485802679459
DAZARD_RESPONSE_TO_UV_SCC_UP,99,Down,0.8400360669063,0.999485802679459
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,21,Up,0.840179475756171,0.999485802679459
TERAMOTO_OPN_TARGETS_CLUSTER_1,8,Up,0.840288658252909,0.999485802679459
SMID_BREAST_CANCER_LUMINAL_A_DN,16,Down,0.840298493166895,0.999485802679459
KAUFFMANN_DNA_REPAIR_GENES,206,Up,0.840348815318784,0.999485802679459
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,16,Down,0.840481411283329,0.999485802679459
REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION,5,Up,0.840579648752595,0.999485802679459
REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER,41,Up,0.840585947450247,0.999485802679459
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,11,Down,0.840913809207913,0.999485802679459
REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS,12,Down,0.841160770635231,0.999485802679459
NAKAMURA_METASTASIS,31,Down,0.841290700098735,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,437,Up,0.841327155345534,0.999485802679459
WOOD_EBV_EBNA1_TARGETS_DN,41,Up,0.841475833550272,0.999485802679459
KYNG_DNA_DAMAGE_UP,166,Up,0.842238891827696,0.999485802679459
BIOCARTA_CALCINEURIN_PATHWAY,16,Up,0.842258524077725,0.999485802679459
FUJII_YBX1_TARGETS_UP,31,Up,0.842378022357302,0.999485802679459
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP,15,Down,0.842411487675791,0.999485802679459
REACTOME_IL1_SIGNALING,34,Up,0.843434774557714,0.999485802679459
AIYAR_COBRA1_TARGETS_DN,28,Down,0.843465391361223,0.999485802679459
CHEN_ETV5_TARGETS_TESTIS,15,Down,0.843723083486274,0.999485802679459
YAGUE_PRETUMOR_DRUG_RESISTANCE_UP,5,Down,0.843860898308337,0.999485802679459
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN,9,Up,0.844129098333415,0.999485802679459
PARENT_MTOR_SIGNALING_DN,32,Down,0.844386672537329,0.999485802679459
PID_AVB3_INTEGRIN_PATHWAY,65,Down,0.845016000844527,0.999485802679459
ZIRN_TRETINOIN_RESPONSE_WT1_UP,19,Up,0.845076504155749,0.999485802679459
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,71,Up,0.845360750791246,0.999485802679459
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR,7,Up,0.845508149969766,0.999485802679459
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,34,Down,0.845610869203638,0.999485802679459
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,92,Down,0.845703173436515,0.999485802679459
KIM_MYC_AMPLIFICATION_TARGETS_UP,159,Down,0.845714899773261,0.999485802679459
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,69,Down,0.846025315616391,0.999485802679459
GERHOLD_ADIPOGENESIS_UP,37,Down,0.846219322920002,0.999485802679459
DARWICHE_SKIN_TUMOR_PROMOTER_DN,107,Up,0.846230338254613,0.999485802679459
ZWANG_EGF_INTERVAL_UP,43,Down,0.846535795680187,0.999485802679459
NIELSEN_LEIOMYOSARCOMA_DN,14,Down,0.846551527505293,0.999485802679459
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,156,Up,0.846603125861141,0.999485802679459
RAMALHO_STEMNESS_DN,49,Up,0.847629159651213,0.999485802679459
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,44,Up,0.848131396082497,0.999485802679459
NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON,25,Down,0.848247367839881,0.999485802679459
VICENT_METASTASIS_UP,9,Up,0.84856741689478,0.999485802679459
BIOCARTA_HDAC_PATHWAY,24,Down,0.848578769507608,0.999485802679459
WANG_NFKB_TARGETS,12,Up,0.848617335020382,0.999485802679459
HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2,146,Up,0.848691257523071,0.999485802679459
TIAN_BHLHA15_TARGETS,12,Down,0.84878977573999,0.999485802679459
HUPER_BREAST_BASAL_VS_LUMINAL_UP,32,Up,0.848873240109028,0.999485802679459
ZHANG_GATA6_TARGETS_DN,45,Up,0.848933430526779,0.999485802679459
NUTT_GBM_VS_AO_GLIOMA_UP,39,Down,0.849031764590799,0.999485802679459
BAKKER_FOXO3_TARGETS_UP,49,Up,0.849246178822445,0.999485802679459
KEGG_VEGF_SIGNALING_PATHWAY,49,Down,0.849827707137864,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,138,Up,0.849890425170559,0.999485802679459
LY_AGING_MIDDLE_DN,14,Down,0.850053598661217,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11,3,Down,0.850436480609975,0.999485802679459
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3,7,Down,0.8504730833567,0.999485802679459
AMIT_EGF_RESPONSE_40_MCF10A,17,Up,0.850635459249626,0.999485802679459
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,7,Up,0.850712448329272,0.999485802679459
KRISHNAN_FURIN_TARGETS_UP,9,Down,0.850731850284151,0.999485802679459
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,37,Up,0.851060993749653,0.999485802679459
MARTINEZ_RB1_TARGETS_UP,480,Down,0.851624140743489,0.999485802679459
SIG_CD40PATHWAYMAP,34,Up,0.85201226438098,0.999485802679459
GAVIN_FOXP3_TARGETS_CLUSTER_P3,116,Down,0.852145889622458,0.999485802679459
OLSSON_E2F3_TARGETS_UP,16,Down,0.852278797121638,0.999485802679459
KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,19,Up,0.852566596357076,0.999485802679459
BIOCARTA_NGF_PATHWAY,15,Down,0.852574180779783,0.999485802679459
ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE,12,Down,0.852647814882583,0.999485802679459
DELACROIX_RAR_TARGETS_DN,16,Up,0.852661260132446,0.999485802679459
BIOCARTA_FAS_PATHWAY,28,Down,0.852864805309185,0.999485802679459
REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,7,Down,0.853276775037424,0.999485802679459
KEGG_CHEMOKINE_SIGNALING_PATHWAY,110,Up,0.853294341562275,0.999485802679459
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN,10,Up,0.8535245953337,0.999485802679459
BALDWIN_PRKCI_TARGETS_UP,27,Down,0.853904384084921,0.999485802679459
KEGG_PATHWAYS_IN_CANCER,261,Up,0.853989998180188,0.999485802679459
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,28,Down,0.854007365710484,0.999485802679459
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN,36,Up,0.85415024373402,0.999485802679459
REACTOME_SIGNALING_BY_SCF_KIT,65,Down,0.854370879245702,0.999485802679459
BIOCARTA_VDR_PATHWAY,12,Up,0.854847446757141,0.999485802679459
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,104,Down,0.855225005291341,0.999485802679459
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,50,Down,0.855259343395605,0.999485802679459
MCCABE_HOXC6_TARGETS_CANCER_DN,18,Down,0.85541568799073,0.999485802679459
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,121,Down,0.856374601708047,0.999485802679459
BURTON_ADIPOGENESIS_8,76,Down,0.85638960089408,0.999485802679459
BIOCARTA_BIOPEPTIDES_PATHWAY,35,Up,0.856625959822527,0.999485802679459
BIOCARTA_FREE_PATHWAY,8,Up,0.856640016066831,0.999485802679459
BYSTRYKH_SCP2_QTL,3,Down,0.857718613676495,0.999485802679459
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS,10,Up,0.857918697443463,0.999485802679459
ZHAN_MULTIPLE_MYELOMA_HP_UP,33,Down,0.858105903533731,0.999485802679459
PID_REG_GR_PATHWAY,60,Up,0.858167776692235,0.999485802679459
PID_RAC1_PATHWAY,47,Up,0.858663111089302,0.999485802679459
ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN,10,Up,0.859341487519657,0.999485802679459
NADELLA_PRKAR1A_TARGETS_DN,8,Up,0.859696346678962,0.999485802679459
REACTOME_GAB1_SIGNALOSOME,35,Up,0.860471947941321,0.999485802679459
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,103,Up,0.860520242569041,0.999485802679459
LEE_AGING_CEREBELLUM_UP,57,Down,0.860540715689565,0.999485802679459
PID_INTEGRIN_CS_PATHWAY,21,Down,0.860572386234163,0.999485802679459
KORKOLA_YOLK_SAC_TUMOR,41,Up,0.860664416109015,0.999485802679459
CHUNG_BLISTER_CYTOTOXICITY_DN,32,Up,0.860838678860439,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,49,Down,0.861167997484282,0.999485802679459
REACTOME_SMOOTH_MUSCLE_CONTRACTION,20,Up,0.861263828731065,0.999485802679459
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,355,Down,0.861307872394594,0.999485802679459
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,183,Down,0.861586521223154,0.999485802679459
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,19,Up,0.86186594446662,0.999485802679459
REACTOME_DIABETES_PATHWAYS,102,Up,0.862339370867762,0.999485802679459
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN,3,Down,0.862414541244523,0.999485802679459
KONDO_COLON_CANCER_HCP_WITH_H3K27ME3,1,Down,0.862428014226008,0.999485802679459
REACTOME_ELONGATION_ARREST_AND_RECOVERY,27,Down,0.862472482551427,0.999485802679459
CAFFAREL_RESPONSE_TO_THC_24HR_3_UP,7,Down,0.862525880669183,0.999485802679459
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,17,Down,0.862546492474054,0.999485802679459
BARIS_THYROID_CANCER_UP,21,Down,0.8628198651139,0.999485802679459
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON,39,Up,0.862945337434092,0.999485802679459
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,13,Up,0.863100864869305,0.999485802679459
MASSARWEH_TAMOXIFEN_RESISTANCE_UP,446,Down,0.863438080169127,0.999485802679459
NAKAMURA_CANCER_MICROENVIRONMENT_DN,39,Up,0.863517917389996,0.999485802679459
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN,13,Down,0.864064391089182,0.999485802679459
IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM,5,Up,0.864459615930587,0.999485802679459
IGARASHI_ATF4_TARGETS_DN,71,Down,0.864460898113814,0.999485802679459
PID_ERBB1_DOWNSTREAM_PATHWAY,99,Up,0.864962810456827,0.999485802679459
PID_IGF1_PATHWAY,26,Down,0.865323764784659,0.999485802679459
TSUNODA_CISPLATIN_RESISTANCE_UP,9,Down,0.865466679002009,0.999485802679459
TESAR_JAK_TARGETS_MOUSE_ES_D3_DN,2,Down,0.865799445522172,0.999485802679459
MAINA_VHL_TARGETS_DN,16,Up,0.865967524182826,0.999485802679459
MATZUK_SPERMATOCYTE,50,Up,0.866517996039509,0.999485802679459
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN,7,Up,0.866572771946346,0.999485802679459
KEGG_MELANOMA,49,Up,0.867239208983313,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN,9,Up,0.867281861508585,0.999485802679459
ROSS_AML_WITH_CBFB_MYH11_FUSION,36,Down,0.867334101802598,0.999485802679459
INGRAM_SHH_TARGETS_DN,41,Down,0.86736565358743,0.999485802679459
SHIPP_DLBCL_CURED_VS_FATAL_UP,18,Down,0.867384491240786,0.999485802679459
GERHOLD_RESPONSE_TO_TZD_UP,2,Down,0.867513566423868,0.999485802679459
VANDESLUIS_NORMAL_EMBRYOS_UP,3,Down,0.867523760925017,0.999485802679459
DAZARD_UV_RESPONSE_CLUSTER_G6,131,Up,0.867723708856779,0.999485802679459
KEGG_ASTHMA,1,Down,0.867917690110764,0.999485802679459
KASLER_HDAC7_TARGETS_1_UP,144,Up,0.867986172224981,0.999485802679459
HOUSTIS_ROS,28,Down,0.868857521494862,0.999485802679459
POOLA_INVASIVE_BREAST_CANCER_DN,95,Up,0.869133228933525,0.999485802679459
ZHENG_IL22_SIGNALING_UP,30,Down,0.869142544785095,0.999485802679459
PLASARI_TGFB1_TARGETS_1HR_UP,29,Up,0.869361345820403,0.999485802679459
BIOCARTA_GATA3_PATHWAY,12,Down,0.869557914734568,0.999485802679459
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,11,Up,0.869860641690729,0.999485802679459
WARTERS_IR_RESPONSE_5GY,32,Down,0.870019381044132,0.999485802679459
PAL_PRMT5_TARGETS_DN,18,Down,0.870444045629481,0.999485802679459
LEE_METASTASIS_AND_RNA_PROCESSING_UP,16,Up,0.8704787311918,0.999485802679459
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,24,Up,0.87048260158411,0.999485802679459
HAMAI_APOPTOSIS_VIA_TRAIL_DN,121,Down,0.870507719873787,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2,4,Up,0.870691407737795,0.999485802679459
KEGG_ERBB_SIGNALING_PATHWAY,73,Down,0.870782636634507,0.999485802679459
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,369,Down,0.870849850287583,0.999485802679459
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP,10,Down,0.870999124809967,0.999485802679459
SCHEIDEREIT_IKK_INTERACTING_PROTEINS,51,Down,0.871204807099166,0.999485802679459
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,128,Down,0.871394315440248,0.999485802679459
MATZUK_CENTRAL_FOR_FEMALE_FERTILITY,16,Down,0.871442903036049,0.999485802679459
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,30,Down,0.871597100335147,0.999485802679459
HO_LIVER_CANCER_VASCULAR_INVASION,9,Down,0.872121401958242,0.999485802679459
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,19,Up,0.872610728677623,0.999485802679459
BUSA_SAM68_TARGETS_DN,4,Up,0.872896768361085,0.999485802679459
REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE,73,Up,0.873007881122903,0.999485802679459
DOANE_BREAST_CANCER_ESR1_UP,74,Down,0.873081454521826,0.999485802679459
YANG_BCL3_TARGETS_DN,5,Down,0.873135301348711,0.999485802679459
DARWICHE_PAPILLOMA_RISK_LOW_DN,104,Up,0.873396323931001,0.999485802679459
PID_MYC_ACTIV_PATHWAY,70,Down,0.873703979624472,0.999485802679459
REACTOME_OPSINS,1,Down,0.873742798196481,0.999485802679459
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,10,Up,0.873865386902201,0.999485802679459
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,31,Up,0.874166022118957,0.999485802679459
ROPERO_HDAC2_TARGETS,65,Down,0.874190269223884,0.999485802679459
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,137,Up,0.874762241322655,0.999485802679459
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,35,Down,0.874769024741456,0.999485802679459
KORKOLA_EMBRYONAL_CARCINOMA,6,Up,0.874872071566526,0.999485802679459
MENSE_HYPOXIA_UP,84,Down,0.874999797616287,0.999485802679459
WENG_POR_TARGETS_GLOBAL_UP,13,Up,0.8750478954293,0.999485802679459
ODONNELL_TFRC_TARGETS_UP,255,Down,0.87544696643065,0.999485802679459
REACTOME_IL_3_5_AND_GM_CSF_SIGNALING,29,Up,0.87548593420857,0.999485802679459
LOPEZ_MBD_TARGETS,771,Up,0.875636270497868,0.999485802679459
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,97,Up,0.875829744757889,0.999485802679459
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,36,Up,0.875922850277464,0.999485802679459
TAKAO_RESPONSE_TO_UVB_RADIATION_DN,86,Up,0.875952133852326,0.999485802679459
RODWELL_AGING_KIDNEY_NO_BLOOD_DN,110,Down,0.876179970204296,0.999485802679459
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,23,Down,0.876214649778713,0.999485802679459
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,67,Down,0.87653764800915,0.999485802679459
REACTOME_PIP3_ACTIVATES_AKT_SIGNALING,26,Down,0.876800745747649,0.999485802679459
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,32,Up,0.876961944982247,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18,4,Down,0.877569841657449,0.999485802679459
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,19,Up,0.877740428894072,0.999485802679459
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN,8,Down,0.877863650975664,0.999485802679459
ST_G_ALPHA_S_PATHWAY,11,Up,0.877878732571152,0.999485802679459
MATZUK_MATERNAL_EFFECT,4,Down,0.878914682764675,0.999485802679459
CASTELLANO_HRAS_TARGETS_UP,1,Down,0.878994364904121,0.999485802679459
ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE,51,Down,0.879220036559523,0.999485802679459
NAGY_TFTC_COMPONENTS_HUMAN,16,Up,0.87923023316154,0.999485802679459
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,30,Down,0.879414625096597,0.999485802679459
PAL_PRMT5_TARGETS_UP,180,Up,0.879528894030385,0.999485802679459
GOZGIT_ESR1_TARGETS_DN,521,Up,0.879564932858499,0.999485802679459
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,22,Up,0.880250217348913,0.999485802679459
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY,12,Up,0.8806262630162,0.999485802679459
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,132,Up,0.880635218661378,0.999485802679459
GUO_TARGETS_OF_IRS1_AND_IRS2,79,Up,0.880830837111008,0.999485802679459
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,214,Up,0.880891448120548,0.999485802679459
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,52,Down,0.881006819716414,0.999485802679459
WOOD_EBV_EBNA1_TARGETS_UP,100,Up,0.881030269357598,0.999485802679459
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN,4,Up,0.881174623897821,0.999485802679459
REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS,2,Down,0.881333010655316,0.999485802679459
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN,14,Up,0.881495232243988,0.999485802679459
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,108,Down,0.881569433426043,0.999485802679459
REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,8,Down,0.881645854689992,0.999485802679459
AMIT_EGF_RESPONSE_60_HELA,39,Down,0.88175305799058,0.999485802679459
KEGG_AUTOIMMUNE_THYROID_DISEASE,3,Down,0.882169798805626,0.999485802679459
BIOCARTA_MCALPAIN_PATHWAY,20,Up,0.882563134256786,0.999485802679459
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER,23,Up,0.882792474771964,0.999485802679459
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,43,Up,0.883205531047228,0.999485802679459
ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR,4,Down,0.883427741333255,0.999485802679459
REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX,11,Down,0.883470260958988,0.999485802679459
PID_GLYPICAN_1PATHWAY,20,Down,0.88348778268153,0.999485802679459
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,46,Up,0.883569763106399,0.999485802679459
BIOCARTA_KREB_PATHWAY,8,Up,0.883689786536987,0.999485802679459
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,62,Down,0.88373460935556,0.999485802679459
KEGG_ARACHIDONIC_ACID_METABOLISM,19,Down,0.884040298788316,0.999485802679459
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,119,Down,0.8841154833283,0.999485802679459
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN,19,Down,0.88447571083316,0.999485802679459
YEGNASUBRAMANIAN_PROSTATE_CANCER,76,Down,0.884695537483854,0.999485802679459
LUCAS_HNF4A_TARGETS_UP,46,Down,0.885016080465746,0.999485802679459
WATANABE_COLON_CANCER_MSI_VS_MSS_UP,21,Up,0.885124425803775,0.999485802679459
SHEPARD_CRUSH_AND_BURN_MUTANT_DN,135,Up,0.885203933746387,0.999485802679459
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,18,Down,0.885342918902712,0.999485802679459
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN,9,Up,0.88615072104065,0.999485802679459
REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1,4,Down,0.886164194093847,0.999485802679459
REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION,4,Down,0.886164194093847,0.999485802679459
NIKOLSKY_BREAST_CANCER_20P13_AMPLICON,2,Down,0.886626503242855,0.999485802679459
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,25,Down,0.88678838435005,0.999485802679459
AMIT_SERUM_RESPONSE_120_MCF10A,59,Down,0.886804170562695,0.999485802679459
WEIGEL_OXIDATIVE_STRESS_RESPONSE,34,Up,0.886926732217577,0.999485802679459
AMIT_SERUM_RESPONSE_240_MCF10A,47,Up,0.887003033262034,0.999485802679459
RODRIGUES_NTN1_TARGETS_DN,121,Down,0.88724978858599,0.999485802679459
RODRIGUES_DCC_TARGETS_UP,5,Up,0.887643109021332,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,21,Up,0.887684696698935,0.999485802679459
HOLLEMAN_DAUNORUBICIN_B_ALL_DN,10,Up,0.88803640609179,0.999485802679459
KATSANOU_ELAVL1_TARGETS_UP,115,Down,0.888203852854972,0.999485802679459
PID_SYNDECAN_3_PATHWAY,14,Up,0.88846317467702,0.999485802679459
PID_LYSOPHOSPHOLIPID_PATHWAY,57,Down,0.888865624805592,0.999485802679459
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN,9,Up,0.888936829338663,0.999485802679459
BERENJENO_TRANSFORMED_BY_RHOA_DN,329,Down,0.889148629189283,0.999485802679459
PASTURAL_RIZ1_TARGETS_DN,1,Down,0.889610260766423,0.999485802679459
TIEN_INTESTINE_PROBIOTICS_2HR_DN,77,Up,0.889645069096391,0.999485802679459
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,15,Up,0.890260839014256,0.999485802679459
MCCABE_BOUND_BY_HOXC6,254,Up,0.890352504350531,0.999485802679459
SHIN_B_CELL_LYMPHOMA_CLUSTER_5,11,Down,0.890484111463405,0.999485802679459
SMID_BREAST_CANCER_BASAL_DN,450,Down,0.890519646921793,0.999485802679459
CHESLER_BRAIN_QTL_CIS,53,Up,0.890550750188973,0.999485802679459
JIANG_TIP30_TARGETS_UP,39,Up,0.890688213390215,0.999485802679459
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,31,Up,0.891066629994003,0.999485802679459
KARLSSON_TGFB1_TARGETS_DN,171,Down,0.891164934445853,0.999485802679459
REACTOME_NCAM1_INTERACTIONS,27,Up,0.89126860933528,0.999485802679459
REACTOME_G2_M_CHECKPOINTS,39,Down,0.891282104746894,0.999485802679459
KEGG_CIRCADIAN_RHYTHM_MAMMAL,12,Down,0.891547489851999,0.999485802679459
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,108,Up,0.891761425390304,0.999485802679459
MARSHALL_VIRAL_INFECTION_RESPONSE_UP,6,Up,0.892066092380072,0.999485802679459
WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP,4,Up,0.89206706640458,0.999485802679459
GOLDRATH_HOMEOSTATIC_PROLIFERATION,145,Down,0.892494899510081,0.999485802679459
KAYO_CALORIE_RESTRICTION_MUSCLE_UP,72,Down,0.89254879170598,0.999485802679459
REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS,3,Up,0.892607215733865,0.999485802679459
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,233,Down,0.89344435271169,0.999485802679459
BIOCARTA_ARENRF2_PATHWAY,11,Down,0.893585776648944,0.999485802679459
LEE_LIVER_CANCER_HEPATOBLAST,14,Down,0.893658497972931,0.999485802679459
VALK_AML_CLUSTER_8,18,Up,0.893935587493608,0.999485802679459
ELVIDGE_HYPOXIA_BY_DMOG_UP,116,Down,0.894039858450854,0.999485802679459
CROMER_TUMORIGENESIS_UP,50,Up,0.894156652395905,0.999485802679459
PID_FRA_PATHWAY,31,Up,0.894194427290279,0.999485802679459
DAIRKEE_TERT_TARGETS_UP,288,Down,0.894286511019752,0.999485802679459
KYNG_DNA_DAMAGE_DN,161,Down,0.894343272659345,0.999485802679459
WU_HBX_TARGETS_1_UP,12,Up,0.894386031335545,0.999485802679459
PID_IL8_CXCR1_PATHWAY,19,Down,0.894556195868556,0.999485802679459
BARRIER_COLON_CANCER_RECURRENCE_DN,18,Up,0.894784720288098,0.999485802679459
YANG_BREAST_CANCER_ESR1_BULK_DN,17,Down,0.895099153001511,0.999485802679459
MATZUK_SPERMATOGONIA,15,Down,0.895121512582411,0.999485802679459
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM,13,Up,0.895493342666713,0.999485802679459
REACTOME_METABOLISM_OF_NON_CODING_RNA,44,Down,0.89553577395751,0.999485802679459
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN,3,Down,0.895718774432511,0.999485802679459
LU_TUMOR_ANGIOGENESIS_UP,22,Down,0.896445233316857,0.999485802679459
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,35,Up,0.896491028195624,0.999485802679459
LIU_IL13_MEMORY_MODEL_UP,12,Up,0.896500512962287,0.999485802679459
SMID_BREAST_CANCER_ERBB2_UP,92,Up,0.896680293331948,0.999485802679459
IKEDA_MIR30_TARGETS_DN,22,Up,0.896778540235309,0.999485802679459
SANA_RESPONSE_TO_IFNG_DN,76,Up,0.896958906282795,0.999485802679459
STEGER_ADIPOGENESIS_DN,18,Up,0.896963247519192,0.999485802679459
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3,48,Down,0.897337669789846,0.999485802679459
OZANNE_AP1_TARGETS_DN,5,Down,0.897441555693929,0.999485802679459
VARELA_ZMPSTE24_TARGETS_DN,18,Down,0.897678689452954,0.999485802679459
PRAMOONJAGO_SOX4_TARGETS_UP,49,Up,0.897995644473929,0.999485802679459
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN,177,Down,0.898272972472032,0.999485802679459
SA_FAS_SIGNALING,7,Down,0.898443633218329,0.999485802679459
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP,20,Down,0.898586741794991,0.999485802679459
REACTOME_GABA_A_RECEPTOR_ACTIVATION,3,Up,0.89858733000373,0.999485802679459
KEGG_PROTEIN_EXPORT,22,Up,0.898774715631103,0.999485802679459
BROWNE_HCMV_INFECTION_4HR_DN,199,Up,0.899141243170115,0.999485802679459
LOPEZ_MESOTHELIOMA_SURVIVAL_UP,6,Down,0.89964015576103,0.999485802679459
GRABARCZYK_BCL11B_TARGETS_DN,35,Down,0.899650454790871,0.999485802679459
KORKOLA_YOLK_SAC_TUMOR_UP,17,Down,0.899727212386651,0.999485802679459
HEDENFALK_BREAST_CANCER_BRACX_UP,16,Down,0.900090721089278,0.999485802679459
GROSS_HYPOXIA_VIA_HIF1A_UP,70,Up,0.900209804336868,0.999485802679459
MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED,9,Down,0.900280443227511,0.999485802679459
FEVR_CTNNB1_TARGETS_DN,471,Down,0.900329762769976,0.999485802679459
FORTSCHEGGER_PHF8_TARGETS_DN,643,Up,0.9003478252637,0.999485802679459
FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN,6,Up,0.900425023733677,0.999485802679459
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,17,Down,0.900542402823824,0.999485802679459
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,106,Down,0.900930689819049,0.999485802679459
HAN_SATB1_TARGETS_DN,361,Up,0.900985643435024,0.999485802679459
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,45,Up,0.901197164889348,0.999485802679459
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,21,Up,0.902067677727595,0.999485802679459
RODRIGUES_THYROID_CARCINOMA_DN,69,Up,0.902296848174059,0.999485802679459
JIANG_HYPOXIA_VIA_VHL,30,Up,0.902671248473993,0.999485802679459
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,40,Up,0.902722845919396,0.999485802679459
REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON,12,Up,0.902805310667184,0.999485802679459
TSUNODA_CISPLATIN_RESISTANCE_DN,36,Up,0.902832337955613,0.999485802679459
MARKEY_RB1_CHRONIC_LOF_UP,95,Down,0.902877438988658,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,63,Up,0.902986375752709,0.999485802679459
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,19,Up,0.903346896870791,0.999485802679459
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D,679,Down,0.903567116646107,0.999485802679459
CASTELLANO_HRAS_AND_NRAS_TARGETS_DN,8,Down,0.903966165968187,0.999485802679459
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL,3,Up,0.903969120464263,0.999485802679459
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,47,Up,0.904172784350596,0.999485802679459
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,14,Down,0.90417720287173,0.999485802679459
CADWELL_ATG16L1_TARGETS_DN,48,Up,0.90511065436226,0.999485802679459
REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR,16,Down,0.905118255073588,0.999485802679459
JACKSON_DNMT1_TARGETS_DN,18,Up,0.905220728682297,0.999485802679459
REACTOME_ENOS_ACTIVATION_AND_REGULATION,15,Down,0.905333507294246,0.999485802679459
PECE_MAMMARY_STEM_CELL_DN,117,Up,0.905438746772669,0.999485802679459
REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS,14,Up,0.905548050524747,0.999485802679459
LU_TUMOR_ENDOTHELIAL_MARKERS_UP,17,Down,0.906668555969368,0.999485802679459
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,129,Up,0.907287762936031,0.999485802679459
HEIDENBLAD_AMPLICON_8Q24_UP,30,Up,0.907302916918596,0.999485802679459
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,27,Down,0.90792309212804,0.999485802679459
REACTOME_DSCAM_INTERACTIONS,8,Down,0.908331883462705,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP,5,Down,0.908409040104489,0.999485802679459
REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2,4,Down,0.908624362750513,0.999485802679459
REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION,4,Down,0.908624362750513,0.999485802679459
HUI_MAPK14_TARGETS_UP,10,Down,0.90874897776295,0.999485802679459
BIOCARTA_TOB1_PATHWAY,10,Up,0.909000720770537,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_2_DN,5,Up,0.909437669745727,0.999485802679459
SCHURINGA_STAT5A_TARGETS_DN,6,Down,0.909738106582401,0.999485802679459
KEGG_RIBOFLAVIN_METABOLISM,11,Up,0.909862527691784,0.999485802679459
KIM_ALL_DISORDERS_DURATION_CORR_UP,7,Up,0.909930528618843,0.999485802679459
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN,26,Up,0.910137923311926,0.999485802679459
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,62,Down,0.910149623382585,0.999485802679459
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G,143,Down,0.910399164682556,0.999485802679459
REACTOME_CHOLESTEROL_BIOSYNTHESIS,21,Up,0.910463040921013,0.999485802679459
ZIRN_TRETINOIN_RESPONSE_WT1_DN,5,Down,0.910781823163208,0.999485802679459
MELLMAN_TUT1_TARGETS_UP,18,Up,0.910838122057406,0.999485802679459
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,12,Down,0.910847593072316,0.999485802679459
BURTON_ADIPOGENESIS_PEAK_AT_8HR,36,Down,0.910923917389548,0.999485802679459
DOANE_RESPONSE_TO_ANDROGEN_UP,132,Down,0.911006426139308,0.999485802679459
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,13,Up,0.911130124092059,0.999485802679459
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,162,Down,0.911254783608636,0.999485802679459
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN,7,Down,0.911304877021138,0.999485802679459
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,61,Down,0.911553263991033,0.999485802679459
REACTOME_METAL_ION_SLC_TRANSPORTERS,15,Up,0.91166799708393,0.999485802679459
BIOCARTA_MET_PATHWAY,33,Down,0.911849579525095,0.999485802679459
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN,1500,Down,0.911929961746954,0.999485802679459
REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS,12,Down,0.911956720015975,0.999485802679459
MOOTHA_GLUCONEOGENESIS,25,Up,0.912137020948101,0.999485802679459
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,75,Down,0.912354552970091,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,10,Up,0.912717045201414,0.999485802679459
BIOCARTA_PTDINS_PATHWAY,23,Down,0.912858974142126,0.999485802679459
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP,3,Down,0.912875710576404,0.999485802679459
YANG_MUC2_TARGETS_DUODENUM_3MO_DN,15,Down,0.913310393422948,0.999485802679459
LINDGREN_BLADDER_CANCER_CLUSTER_2B,268,Down,0.913365294284497,0.999485802679459
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,15,Up,0.913394607266473,0.999485802679459
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,147,Down,0.913925660388233,0.999485802679459
LEIN_MEDULLA_MARKERS,53,Up,0.91403969256779,0.999485802679459
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,45,Up,0.914230723892691,0.999485802679459
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,28,Down,0.91526722183101,0.999485802679459
BIOCARTA_MTA3_PATHWAY,15,Up,0.915374757599845,0.999485802679459
ONGUSAHA_BRCA1_TARGETS_DN,12,Down,0.915532303677966,0.999485802679459
VALK_AML_CLUSTER_6,25,Up,0.915557787309816,0.999485802679459
FOURNIER_ACINAR_DEVELOPMENT_LATE_UP,7,Down,0.915806804683855,0.999485802679459
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,30,Down,0.915847483604197,0.999485802679459
FERNANDEZ_BOUND_BY_MYC,150,Down,0.917168668362264,0.999485802679459
KESHELAVA_MULTIPLE_DRUG_RESISTANCE,61,Up,0.917296523917938,0.999485802679459
KAYO_AGING_MUSCLE_UP,164,Down,0.917405772276834,0.999485802679459
ROME_INSULIN_TARGETS_IN_MUSCLE_DN,113,Down,0.917412204387523,0.999485802679459
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP,17,Up,0.917474463152839,0.999485802679459
PID_MAPK_TRK_PATHWAY,32,Up,0.917505386322228,0.999485802679459
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,238,Down,0.917564209726327,0.999485802679459
BIOCARTA_RNA_PATHWAY,10,Up,0.917596639011299,0.999485802679459
BILBAN_B_CLL_LPL_UP,48,Down,0.918178521519532,0.999485802679459
LIU_NASOPHARYNGEAL_CARCINOMA,52,Up,0.918261070390658,0.999485802679459
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,82,Down,0.918308406085748,0.999485802679459
ST_P38_MAPK_PATHWAY,37,Up,0.91957387928523,0.999485802679459
KHETCHOUMIAN_TRIM24_TARGETS_DN,3,Up,0.919602096586045,0.999485802679459
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,12,Down,0.91974515025269,0.999485802679459
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,28,Up,0.919794584121973,0.999485802679459
LEE_CALORIE_RESTRICTION_MUSCLE_DN,37,Up,0.920148979541674,0.999485802679459
BIOCARTA_RACCYCD_PATHWAY,25,Up,0.920197358453925,0.999485802679459
HOSHIDA_LIVER_CANCER_SURVIVAL_DN,75,Up,0.920430037573658,0.999485802679459
REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING,10,Up,0.920520909277916,0.999485802679459
ROSS_LEUKEMIA_WITH_MLL_FUSIONS,59,Up,0.920584784239431,0.999485802679459
KEGG_CELL_ADHESION_MOLECULES_CAMS,64,Down,0.920595858297889,0.999485802679459
SHANK_TAL1_TARGETS_DN,5,Up,0.920905425119992,0.999485802679459
MANTOVANI_NFKB_TARGETS_DN,8,Up,0.920932732678263,0.999485802679459
UDAYAKUMAR_MED1_TARGETS_UP,117,Up,0.921030177746903,0.999485802679459
NADLER_HYPERGLYCEMIA_AT_OBESITY,42,Up,0.921520108933865,0.999485802679459
SASSON_FSH_RESPONSE,8,Down,0.921551727550777,0.999485802679459
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP,5,Down,0.921649460487506,0.999485802679459
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,39,Up,0.921826374319102,0.999485802679459
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,13,Down,0.922178370373619,0.999485802679459
HUANG_FOXA2_TARGETS_UP,37,Up,0.922316305590171,0.999485802679459
VISALA_AGING_LYMPHOCYTE_UP,8,Down,0.922334110792448,0.999485802679459
WIKMAN_ASBESTOS_LUNG_CANCER_UP,13,Up,0.922382375245865,0.999485802679459
BIOCARTA_TALL1_PATHWAY,12,Down,0.922539010445395,0.999485802679459
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,55,Up,0.922897336357684,0.999485802679459
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,20,Down,0.923262501802261,0.999485802679459
YAN_ESCAPE_FROM_ANOIKIS,17,Up,0.923404765152525,0.999485802679459
GENTILE_UV_HIGH_DOSE_DN,286,Up,0.923571721049967,0.999485802679459
WINTER_HYPOXIA_METAGENE,195,Up,0.923618927391544,0.999485802679459
NIKOLSKY_BREAST_CANCER_7P15_AMPLICON,8,Down,0.923643010148474,0.999485802679459
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,103,Up,0.923667419346317,0.999485802679459
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,124,Down,0.923792577630188,0.999485802679459
FINAK_BREAST_CANCER_SDPP_SIGNATURE,10,Up,0.923972546093102,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,31,Down,0.924164030402584,0.999485802679459
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP,41,Down,0.924292953262929,0.999485802679459
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,56,Up,0.924298075543848,0.999485802679459
PID_P38_MK2_PATHWAY,19,Up,0.92435173115252,0.999485802679459
CHANGOLKAR_H2AFY_TARGETS_UP,31,Down,0.924403712809462,0.999485802679459
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,15,Up,0.925053541689629,0.999485802679459
YANG_BCL3_TARGETS_UP,262,Down,0.925124966743634,0.999485802679459
REACTOME_ARMS_MEDIATED_ACTIVATION,14,Down,0.925728534415158,0.999485802679459
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,19,Down,0.925894452490711,0.999485802679459
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,38,Down,0.925983097599231,0.999485802679459
KEGG_STARCH_AND_SUCROSE_METABOLISM,18,Up,0.926719164175037,0.999485802679459
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,119,Up,0.926815003809093,0.999485802679459
XU_AKT1_TARGETS_48HR,8,Down,0.927014892655246,0.999485802679459
GAUTSCHI_SRC_SIGNALING,8,Up,0.927071149883286,0.999485802679459
DIRMEIER_LMP1_RESPONSE_LATE_DN,21,Down,0.927306667784787,0.999485802679459
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,15,Up,0.927416911002074,0.999485802679459
REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA,23,Up,0.927591634791482,0.999485802679459
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1,410,Up,0.92764742945272,0.999485802679459
KAAB_FAILED_HEART_ATRIUM_UP,26,Up,0.927731247397679,0.999485802679459
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,37,Up,0.928375751739194,0.999485802679459
DER_IFN_ALPHA_RESPONSE_DN,4,Up,0.92839443004704,0.999485802679459
SA_PTEN_PATHWAY,16,Down,0.928408758136132,0.999485802679459
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1,5,Down,0.928418524464466,0.999485802679459
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN,6,Up,0.928509304558937,0.999485802679459
GRADE_COLON_AND_RECTAL_CANCER_DN,74,Up,0.928711969267315,0.999485802679459
REACTOME_GPCR_DOWNSTREAM_SIGNALING,206,Down,0.928779034926857,0.999485802679459
MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3,1,Down,0.929305992185171,0.999485802679459
ST_MYOCYTE_AD_PATHWAY,18,Down,0.930189566493629,0.999485802679459
CHEN_HOXA5_TARGETS_6HR_DN,5,Down,0.930277569398982,0.999485802679459
BURTON_ADIPOGENESIS_12,32,Down,0.930314605004827,0.999485802679459
HE_PTEN_TARGETS_UP,15,Up,0.930354745646425,0.999485802679459
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,269,Up,0.93035827614653,0.999485802679459
ST_GA12_PATHWAY,19,Down,0.93041001582781,0.999485802679459
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP,28,Up,0.930551271817162,0.999485802679459
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,231,Up,0.930820766173375,0.999485802679459
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN,417,Down,0.930949966979058,0.999485802679459
MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3,2,Up,0.931006963488294,0.999485802679459
GAVIN_FOXP3_TARGETS_CLUSTER_T7,86,Down,0.931171222554762,0.999485802679459
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN,8,Down,0.931228734224875,0.999485802679459
MARTINEZ_TP53_TARGETS_DN,413,Up,0.931312448804952,0.999485802679459
ZHU_CMV_ALL_UP,106,Down,0.93207583777224,0.999485802679459
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,191,Down,0.932338108344741,0.999485802679459
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN,20,Down,0.93271267108699,0.999485802679459
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,76,Down,0.932812442251737,0.999485802679459
ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE,15,Down,0.932833021282637,0.999485802679459
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,11,Down,0.932860277578919,0.999485802679459
PID_INTEGRIN3_PATHWAY,33,Up,0.933069269564824,0.999485802679459
MARCHINI_TRABECTEDIN_RESISTANCE_UP,17,Up,0.933121524207277,0.999485802679459
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B,11,Down,0.933265104389713,0.999485802679459
LAIHO_COLORECTAL_CANCER_SERRATED_UP,101,Up,0.93330982957057,0.999485802679459
PID_BCR_5PATHWAY,54,Up,0.93340825474871,0.999485802679459
LEONARD_HYPOXIA,43,Down,0.933425710353811,0.999485802679459
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,26,Up,0.933471957592519,0.999485802679459
MIKKELSEN_MEF_LCP_WITH_H3K27ME3,20,Up,0.933568275795929,0.999485802679459
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,189,Down,0.933785250866834,0.999485802679459
BASSO_CD40_SIGNALING_DN,41,Up,0.93381073581737,0.999485802679459
KIM_GERMINAL_CENTER_T_HELPER_UP,49,Down,0.933812388402602,0.999485802679459
BIOCARTA_FMLP_PATHWAY,29,Up,0.933815422377295,0.999485802679459
REACTOME_SULFUR_AMINO_ACID_METABOLISM,19,Up,0.934023838556819,0.999485802679459
BAUS_TFF2_TARGETS_UP,16,Up,0.93411304856271,0.999485802679459
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,22,Down,0.934119575879312,0.999485802679459
NAKAMURA_METASTASIS_MODEL_UP,32,Down,0.934660330734619,0.999485802679459
BIOCARTA_PYK2_PATHWAY,26,Down,0.9348336083549,0.999485802679459
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,50,Down,0.935164629234957,0.999485802679459
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,15,Up,0.935382714272357,0.999485802679459
LIM_MAMMARY_LUMINAL_MATURE_UP,80,Up,0.935573474806762,0.999485802679459
GENTILE_RESPONSE_CLUSTER_D3,56,Down,0.935824461570497,0.999485802679459
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,55,Down,0.9358248776223,0.999485802679459
VALK_AML_WITH_T_8_21_TRANSLOCATION,1,Down,0.93592260718162,0.999485802679459
PID_IL5_PATHWAY,11,Up,0.936504110139244,0.999485802679459
OHASHI_AURKA_TARGETS,5,Up,0.936765495938004,0.999485802679459
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,13,Down,0.936765594202699,0.999485802679459
REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS,1,Down,0.936819520039775,0.999485802679459
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,110,Up,0.938184431260794,0.999485802679459
FINETTI_BREAST_CANCERS_KINOME_GRAY,15,Up,0.938519374753322,0.999485802679459
GRUETZMANN_PANCREATIC_CANCER_UP,301,Down,0.938520432570581,0.999485802679459
THILLAINADESAN_ZNF217_TARGETS_UP,38,Down,0.938634380180969,0.999485802679459
RUNNE_GENDER_EFFECT_UP,8,Up,0.938640786372565,0.999485802679459
REN_MIF_TARGETS_DN,4,Down,0.93892082401541,0.999485802679459
LEE_LIVER_CANCER_E2F1_DN,33,Up,0.939116906035694,0.999485802679459
REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS,23,Up,0.939401116025924,0.999485802679459
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP,9,Up,0.939547510836496,0.999485802679459
SU_TESTIS,50,Down,0.940089274708547,0.999485802679459
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION,66,Up,0.940274451414493,0.999485802679459
MIKKELSEN_NPC_LCP_WITH_H3K4ME3,36,Up,0.940387254522046,0.999485802679459
DELPUECH_FOXO3_TARGETS_UP,59,Down,0.940409284628363,0.999485802679459
KEGG_NON_SMALL_CELL_LUNG_CANCER,45,Up,0.940536874778009,0.999485802679459
REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS,1,Up,0.940591500985984,0.999485802679459
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,94,Up,0.940597559042097,0.999485802679459
DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY,18,Down,0.94074507769153,0.999485802679459
FARMER_BREAST_CANCER_CLUSTER_8,5,Down,0.940813723679347,0.999485802679459
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,29,Up,0.940936441654375,0.999485802679459
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,265,Up,0.94155001820892,0.999485802679459
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,72,Down,0.941764194548884,0.999485802679459
REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE,65,Down,0.94212459001689,0.999485802679459
BILD_HRAS_ONCOGENIC_SIGNATURE,200,Down,0.942323023616884,0.999485802679459
CHYLA_CBFA2T3_TARGETS_DN,143,Up,0.942519435169242,0.999485802679459
PEREZ_TP53_AND_TP63_TARGETS,138,Down,0.942590197228232,0.999485802679459
CHENG_TAF7L_TARGETS,3,Up,0.942885976515132,0.999485802679459
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,318,Up,0.942957326916305,0.999485802679459
REACTOME_CS_DS_DEGRADATION,10,Up,0.942996279730434,0.999485802679459
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,27,Down,0.94303142975482,0.999485802679459
VIETOR_IFRD1_TARGETS,17,Up,0.94321828949362,0.999485802679459
LIANG_SILENCED_BY_METHYLATION_UP,23,Down,0.943245881615517,0.999485802679459
PLASARI_TGFB1_TARGETS_10HR_UP,147,Down,0.943585053234852,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1,1,Up,0.944264288479462,0.999485802679459
REACTOME_SIGNALING_BY_FGFR3_MUTANTS,5,Down,0.944654168710985,0.999485802679459
ONDER_CDH1_TARGETS_2_UP,218,Down,0.944723331109114,0.999485802679459
BASAKI_YBX1_TARGETS_DN,303,Up,0.944896239546028,0.999485802679459
HASEGAWA_TUMORIGENESIS_BY_RET_C634R,7,Down,0.945049941310213,0.999485802679459
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,280,Up,0.945102195137599,0.999485802679459
REACTOME_TIGHT_JUNCTION_INTERACTIONS,11,Down,0.945379333695573,0.999485802679459
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,158,Down,0.945568811992003,0.999485802679459
HATADA_METHYLATED_IN_LUNG_CANCER_UP,191,Up,0.946165282492916,0.999485802679459
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN,67,Up,0.946236923752049,0.999485802679459
BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION,7,Down,0.946341516591378,0.999485802679459
PENG_GLUTAMINE_DEPRIVATION_UP,32,Down,0.946349014695584,0.999485802679459
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,17,Up,0.946704898047431,0.999485802679459
BIOCARTA_AGR_PATHWAY,29,Up,0.947269984571895,0.999485802679459
NAKAMURA_LUNG_CANCER,5,Down,0.94752280981629,0.999485802679459
FOSTER_KDM1A_TARGETS_DN,161,Down,0.947555450415574,0.999485802679459
PID_EPHRINB_REV_PATHWAY,21,Down,0.947625544889196,0.999485802679459
BARRIER_COLON_CANCER_RECURRENCE_UP,34,Down,0.947719065687461,0.999485802679459
REACTOME_GPCR_LIGAND_BINDING,120,Down,0.948301050944112,0.999485802679459
LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES,12,Up,0.948338878436928,0.999485802679459
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN,648,Up,0.948408541073585,0.999485802679459
SAGIV_CD24_TARGETS_DN,39,Up,0.948504231518501,0.999485802679459
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,146,Up,0.948714868824909,0.999485802679459
XU_RESPONSE_TO_TRETINOIN_DN,11,Up,0.948743279837511,0.999485802679459
BENPORATH_EED_TARGETS,526,Down,0.949529823875766,0.999485802679459
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,20,Down,0.950372040364562,0.999485802679459
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,93,Down,0.950440784147513,0.999485802679459
GABRIELY_MIR21_TARGETS,260,Down,0.951157672474127,0.999485802679459
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,24,Down,0.951357207490557,0.999485802679459
TSAI_RESPONSE_TO_IONIZING_RADIATION,117,Down,0.951390092217488,0.999485802679459
RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2,17,Down,0.95142232063619,0.999485802679459
GOLDRATH_IMMUNE_MEMORY,52,Up,0.951610287257753,0.999485802679459
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,40,Down,0.952269917475273,0.999485802679459
HUTTMANN_B_CLL_POOR_SURVIVAL_DN,44,Down,0.952391968156019,0.999485802679459
HASLINGER_B_CLL_WITH_13Q14_DELETION,20,Down,0.952652595393934,0.999485802679459
REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX,13,Up,0.952687526350403,0.999485802679459
EPPERT_LSC_R,31,Down,0.952843282879385,0.999485802679459
ACEVEDO_LIVER_CANCER_DN,378,Down,0.953003096558144,0.999485802679459
KAUFFMANN_MELANOMA_RELAPSE_DN,6,Down,0.953107430756853,0.999485802679459
REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE,48,Down,0.953481953518229,0.999485802679459
PID_ARF6_PATHWAY,28,Down,0.953773847993435,0.999485802679459
REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR,9,Up,0.95379894664768,0.999485802679459
NADERI_BREAST_CANCER_PROGNOSIS_DN,15,Up,0.953887699650495,0.999485802679459
STONER_ESOPHAGEAL_CARCINOGENESIS_UP,31,Down,0.953895569720179,0.999485802679459
PID_PI3KCI_PATHWAY,38,Down,0.953981165501059,0.999485802679459
HARRIS_HYPOXIA,65,Down,0.954240971730516,0.999485802679459
HEDVAT_ELF4_TARGETS_UP,7,Down,0.95458289816781,0.999485802679459
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,25,Up,0.954710744437173,0.999485802679459
WILCOX_RESPONSE_TO_PROGESTERONE_DN,43,Down,0.954723806140458,0.999485802679459
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,65,Up,0.954754256938891,0.999485802679459
BIOCARTA_MEF2D_PATHWAY,16,Down,0.954756343789827,0.999485802679459
REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS,16,Up,0.955064933303152,0.999485802679459
ONDER_CDH1_TARGETS_1_UP,112,Down,0.955704198272309,0.999485802679459
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,91,Down,0.955906942975086,0.999485802679459
ZWANG_EGF_INTERVAL_DN,143,Up,0.955937704033423,0.999485802679459
CLAUS_PGR_POSITIVE_MENINGIOMA_DN,10,Down,0.956106270359698,0.999485802679459
SU_LIVER,18,Down,0.956181719571575,0.999485802679459
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS,53,Up,0.956232988303648,0.999485802679459
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,174,Down,0.956250960807078,0.999485802679459
NABA_ECM_AFFILIATED,72,Down,0.956296420341236,0.999485802679459
REACTOME_CTLA4_INHIBITORY_SIGNALING,16,Down,0.956623989127736,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,8,Down,0.956769803174453,0.999485802679459
PID_TAP63_PATHWAY,46,Up,0.957047549214307,0.999485802679459
SIMBULAN_UV_RESPONSE_NORMAL_UP,5,Up,0.95724116823306,0.999485802679459
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,25,Down,0.957445034610949,0.999485802679459
FINETTI_BREAST_CANCER_KINOME_GREEN,7,Up,0.957562101876316,0.999485802679459
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,44,Up,0.958018653838443,0.999485802679459
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN,7,Down,0.958118161732833,0.999485802679459
MCCLUNG_CREB1_TARGETS_DN,42,Down,0.958350405982371,0.999485802679459
REACTOME_HYALURONAN_METABOLISM,10,Down,0.958549210810696,0.999485802679459
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS,11,Up,0.958662180772802,0.999485802679459
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,93,Up,0.958681638110315,0.999485802679459
REACTOME_ANDROGEN_BIOSYNTHESIS,1,Down,0.959045903865836,0.999485802679459
REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS,74,Up,0.95908575623094,0.999485802679459
YU_MYC_TARGETS_DN,34,Up,0.959219627167689,0.999485802679459
REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS,5,Up,0.959788162101208,0.999485802679459
YOSHIMURA_MAPK8_TARGETS_UP,700,Up,0.960241354788361,0.999485802679459
GRUETZMANN_PANCREATIC_CANCER_DN,153,Up,0.96025658320468,0.999485802679459
REACTOME_G0_AND_EARLY_G1,23,Up,0.960283666922759,0.999485802679459
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5,3,Down,0.96028972357276,0.999485802679459
CAIRO_LIVER_DEVELOPMENT_DN,125,Up,0.960302563242599,0.999485802679459
REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,43,Down,0.9603282193503,0.999485802679459
REACTOME_TRIF_MEDIATED_TLR3_SIGNALING,67,Up,0.960405836774486,0.999485802679459
JAZAG_TGFB1_SIGNALING_UP,72,Down,0.96048254309702,0.999485802679459
MCCLUNG_DELTA_FOSB_TARGETS_2WK,28,Down,0.960782544982778,0.999485802679459
ZHANG_PROLIFERATING_VS_QUIESCENT,42,Up,0.96083489747745,0.999485802679459
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,31,Up,0.960846980744764,0.999485802679459
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,20,Down,0.960885186778196,0.999485802679459
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,28,Up,0.960919827954029,0.999485802679459
CROSBY_E2F4_TARGETS,6,Up,0.961198372238401,0.999485802679459
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,86,Up,0.961459855494352,0.999485802679459
VERRECCHIA_RESPONSE_TO_TGFB1_C4,13,Down,0.961794346055366,0.999485802679459
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,10,Up,0.961980357671765,0.999485802679459
DAIRKEE_TERT_TARGETS_DN,86,Up,0.961998663391156,0.999485802679459
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,25,Up,0.962107761917441,0.999485802679459
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP,10,Up,0.964067048386299,0.999485802679459
ELVIDGE_HYPOXIA_BY_DMOG_DN,50,Down,0.96468160735296,0.999485802679459
BURTON_ADIPOGENESIS_11,53,Down,0.964860367192555,0.999485802679459
IVANOVA_HEMATOPOIESIS_MATURE_CELL,208,Down,0.965372359968629,0.999485802679459
RIZKI_TUMOR_INVASIVENESS_2D_DN,40,Up,0.965386929452917,0.999485802679459
ZEILSTRA_CD44_TARGETS_DN,4,Down,0.965520536562363,0.999485802679459
PID_DNA_PK_PATHWAY,14,Down,0.965590602426939,0.999485802679459
REACTOME_DEADENYLATION_OF_MRNA,15,Down,0.965798860701251,0.999485802679459
ST_ADRENERGIC,28,Up,0.966337331092697,0.999485802679459
BROWNE_HCMV_INFECTION_1HR_UP,35,Up,0.966453578154201,0.999485802679459
REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY,10,Up,0.96659404380926,0.999485802679459
SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP,6,Down,0.966607126853475,0.999485802679459
PID_ALK2_PATHWAY,10,Down,0.967039103721805,0.999485802679459
TOMLINS_METASTASIS_DN,13,Down,0.967156092429968,0.999485802679459
MULLIGHAN_MLL_SIGNATURE_1_UP,295,Down,0.967273667157693,0.999485802679459
KEGG_BASE_EXCISION_REPAIR,31,Down,0.967340058004608,0.999485802679459
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP,17,Down,0.967737634352409,0.999485802679459
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,67,Up,0.96805744615576,0.999485802679459
CHENG_RESPONSE_TO_NICKEL_ACETATE,34,Up,0.968200290618895,0.999485802679459
KREPPEL_CD99_TARGETS_DN,6,Down,0.968435824987214,0.999485802679459
MUNSHI_MULTIPLE_MYELOMA_UP,73,Down,0.96865808562021,0.999485802679459
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,19,Down,0.96869161272873,0.999485802679459
REACTOME_GAP_JUNCTION_ASSEMBLY,3,Down,0.968775317618259,0.999485802679459
BURTON_ADIPOGENESIS_9,74,Up,0.969102368694639,0.999485802679459
ZERBINI_RESPONSE_TO_SULINDAC_DN,6,Down,0.969136513954477,0.999485802679459
PROVENZANI_METASTASIS_DN,114,Down,0.969342072884829,0.999485802679459
KAYO_AGING_MUSCLE_DN,102,Down,0.969642578447408,0.999485802679459
LEE_LIVER_CANCER_ACOX1_UP,48,Down,0.969770420642337,0.999485802679459
BIOCARTA_TCR_PATHWAY,34,Up,0.96991610515864,0.999485802679459
WANG_TARGETS_OF_MLL_CBP_FUSION_UP,34,Up,0.970096426964246,0.999485802679459
ROSS_AML_OF_FAB_M7_TYPE,45,Down,0.970420079781468,0.999485802679459
DEMAGALHAES_AGING_UP,39,Up,0.970541235827709,0.999485802679459
KIM_WT1_TARGETS_12HR_DN,182,Up,0.9706155564265,0.999485802679459
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,90,Up,0.970742400406793,0.999485802679459
DODD_NASOPHARYNGEAL_CARCINOMA_UP,926,Up,0.970900455689207,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN,10,Down,0.971597174938988,0.999485802679459
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,94,Up,0.971676740759195,0.999485802679459
KEGG_TYROSINE_METABOLISM,21,Up,0.972116131070634,0.999485802679459
REACTOME_PLATELET_SENSITIZATION_BY_LDL,12,Up,0.972175166292258,0.999485802679459
MIKKELSEN_MEF_HCP_WITH_H3K27ME3,166,Up,0.97222290902526,0.999485802679459
KANG_AR_TARGETS_UP,12,Up,0.972323372161263,0.999485802679459
REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS,11,Down,0.972346220907069,0.999485802679459
REACTOME_SEMAPHORIN_INTERACTIONS,57,Down,0.972728530303703,0.999485802679459
WHITFIELD_CELL_CYCLE_G2,139,Down,0.97348274359176,0.999485802679459
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,123,Down,0.973648683985063,0.999485802679459
PETRETTO_CARDIAC_HYPERTROPHY,31,Down,0.974097728900057,0.999485802679459
LY_AGING_OLD_UP,2,Down,0.974634473545273,0.999485802679459
PILON_KLF1_TARGETS_UP,343,Up,0.974908500388254,0.999485802679459
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,67,Up,0.974988817013676,0.999485802679459
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,31,Up,0.975214724051363,0.999485802679459
MCCLUNG_CREB1_TARGETS_UP,72,Up,0.975733453759015,0.999485802679459
STREICHER_LSM1_TARGETS_DN,15,Up,0.976137887386377,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,94,Down,0.976187444623795,0.999485802679459
SHEPARD_BMYB_MORPHOLINO_DN,142,Up,0.976893938986602,0.999485802679459
CHEN_METABOLIC_SYNDROM_NETWORK,826,Down,0.976962422996215,0.999485802679459
ELVIDGE_HYPOXIA_UP,147,Up,0.977131217271725,0.999485802679459
REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION,26,Up,0.977251629809232,0.999485802679459
SUZUKI_CTCFL_TARGETS_UP,7,Down,0.977795816961892,0.999485802679459
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS,21,Up,0.97808396359158,0.999485802679459
EHRLICH_ICF_SYNDROM_UP,7,Down,0.978285898986938,0.999485802679459
OKUMURA_INFLAMMATORY_RESPONSE_LPS,144,Down,0.978756298663657,0.999485802679459
ZHENG_RESPONSE_TO_ARSENITE_UP,12,Down,0.978968095444924,0.999485802679459
KARAKAS_TGFB1_SIGNALING,15,Up,0.979026364080877,0.999485802679459
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP,23,Down,0.97925394812196,0.999485802679459
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,20,Down,0.979284788470505,0.999485802679459
PID_MTOR_4PATHWAY,62,Down,0.979337828667332,0.999485802679459
BRACHAT_RESPONSE_TO_METHOTREXATE_DN,23,Up,0.979776117776054,0.999485802679459
LIN_APC_TARGETS,63,Down,0.979807134760268,0.999485802679459
REACTOME_REGULATION_OF_SIGNALING_BY_CBL,16,Up,0.979828148795556,0.999485802679459
REACTOME_IL_6_SIGNALING,10,Up,0.980001717809927,0.999485802679459
REACTOME_DOWNSTREAM_TCR_SIGNALING,19,Up,0.980351090597594,0.999485802679459
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN,13,Down,0.980459484924575,0.999485802679459
REACTOME_NEPHRIN_INTERACTIONS,17,Down,0.980529519312587,0.999485802679459
SCHRAMM_INHBA_TARGETS_UP,7,Up,0.980824077051047,0.999485802679459
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN,7,Down,0.980955857076833,0.999485802679459
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,46,Up,0.981013588873895,0.999485802679459
KOINUMA_COLON_CANCER_MSI_DN,8,Up,0.981563771523412,0.999485802679459
OSAWA_TNF_TARGETS,9,Up,0.982115857305094,0.999485802679459
JOHNSTONE_PARVB_TARGETS_1_DN,54,Up,0.982231598568729,0.999485802679459
THUM_SYSTOLIC_HEART_FAILURE_UP,302,Down,0.982452133168164,0.999485802679459
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,138,Down,0.982490524275516,0.999485802679459
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER,26,Up,0.982763063221418,0.999485802679459
RUTELLA_RESPONSE_TO_HGF_UP,332,Up,0.98284124791249,0.999485802679459
IIZUKA_LIVER_CANCER_EARLY_RECURRENCE,9,Down,0.983020759300297,0.999485802679459
BIOCARTA_BCR_PATHWAY,28,Up,0.983080682078849,0.999485802679459
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,253,Down,0.983095869772917,0.999485802679459
SENESE_HDAC1_TARGETS_DN,199,Up,0.983234672004327,0.999485802679459
PID_FCER1_PATHWAY,50,Down,0.98342499839327,0.999485802679459
SHIPP_DLBCL_CURED_VS_FATAL_DN,36,Up,0.983539615201491,0.999485802679459
JOHNSTONE_PARVB_TARGETS_2_DN,290,Down,0.983598249645072,0.999485802679459
REACTOME_NUCLEOTIDE_EXCISION_REPAIR,46,Up,0.983631446290248,0.999485802679459
PARENT_MTOR_SIGNALING_UP,458,Down,0.983953232684192,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,50,Down,0.983960024816199,0.999485802679459
ZHOU_PANCREATIC_BETA_CELL,4,Down,0.984005281156442,0.999485802679459
WOO_LIVER_CANCER_RECURRENCE_UP,89,Down,0.984124709221056,0.999485802679459
RIZ_ERYTHROID_DIFFERENTIATION_12HR,30,Up,0.984406259941759,0.999485802679459
REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT,4,Up,0.984479391327469,0.999485802679459
SANSOM_APC_TARGETS_UP,92,Up,0.984570774112824,0.999485802679459
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,75,Down,0.984729882017379,0.999485802679459
KAYO_CALORIE_RESTRICTION_MUSCLE_DN,66,Up,0.984965262015157,0.999485802679459
BIOCARTA_ERYTH_PATHWAY,8,Down,0.985117968822924,0.999485802679459
VALK_AML_CLUSTER_10,22,Up,0.985206241157985,0.999485802679459
YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN,7,Up,0.985246386109474,0.999485802679459
TCGA_GLIOBLASTOMA_MUTATED,8,Up,0.985514352669619,0.999485802679459
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,56,Up,0.985515731997485,0.999485802679459
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY,66,Down,0.985913829005204,0.999485802679459
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,51,Up,0.985920610840844,0.999485802679459
SANDERSON_PPARA_TARGETS,9,Down,0.985924926758197,0.999485802679459
LE_NEURONAL_DIFFERENTIATION_DN,18,Up,0.986128110112472,0.999485802679459
CHOW_RASSF1_TARGETS_UP,22,Up,0.986426868466757,0.999485802679459
ONDER_CDH1_TARGETS_3_UP,15,Up,0.986486683542086,0.999485802679459
REACTOME_PI3K_AKT_ACTIVATION,33,Down,0.986680713111178,0.999485802679459
HOEGERKORP_CD44_TARGETS_DIRECT_DN,9,Up,0.986692823213908,0.999485802679459
PID_EPHB_FWD_PATHWAY,35,Down,0.986922042927115,0.999485802679459
MIKKELSEN_NPC_HCP_WITH_H3K27ME3,127,Up,0.987394835171179,0.999485802679459
WOTTON_RUNX_TARGETS_DN,23,Down,0.9875180580039,0.999485802679459
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS,7,Down,0.987679177352176,0.999485802679459
THEODOROU_MAMMARY_TUMORIGENESIS,14,Up,0.987739908094668,0.999485802679459
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,14,Up,0.987856374086581,0.999485802679459
MCBRYAN_TERMINAL_END_BUD_UP,7,Down,0.98794692309192,0.999485802679459
TESAR_JAK_TARGETS_MOUSE_ES_D3_UP,3,Down,0.988411265783423,0.999485802679459
DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN,18,Down,0.988426517563106,0.999485802679459
LIM_MAMMARY_STEM_CELL_DN,322,Up,0.988459795470106,0.999485802679459
BIOCARTA_NKCELLS_PATHWAY,12,Up,0.988470163224831,0.999485802679459
YOSHIMURA_MAPK8_TARGETS_DN,301,Down,0.988713795986635,0.999485802679459
KUWANO_RNA_STABILIZED_BY_NO,6,Up,0.988855914735609,0.999485802679459
PID_ATR_PATHWAY,37,Up,0.988926550504301,0.999485802679459
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP,6,Up,0.989179706191888,0.999485802679459
UEDA_CENTRAL_CLOCK,70,Up,0.989235859469983,0.999485802679459
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,41,Down,0.989391103016458,0.999485802679459
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,21,Down,0.989965781978779,0.999485802679459
REACTOME_ACTIVATION_OF_GENES_BY_ATF4,21,Down,0.99003126069942,0.999485802679459
WAGSCHAL_EHMT2_TARGETS_UP,2,Down,0.990108204335394,0.999485802679459
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,11,Down,0.99027894912947,0.999485802679459
BIOCARTA_LYM_PATHWAY,8,Up,0.990348891855428,0.999485802679459
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,88,Down,0.990675260292994,0.999485802679459
CHANG_POU5F1_TARGETS_UP,12,Up,0.990784845239917,0.999485802679459
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,89,Down,0.990962927142673,0.999485802679459
VERNOCHET_ADIPOGENESIS,9,Up,0.991247377020395,0.999485802679459
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5,19,Down,0.991383517098428,0.999485802679459
REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS,13,Down,0.991428116132143,0.999485802679459
BIOCARTA_AHSP_PATHWAY,9,Down,0.991661709296277,0.999485802679459
REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS,1,Up,0.991985926355072,0.999485802679459
REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,1,Up,0.991985926355072,0.999485802679459
REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,1,Up,0.991985926355072,0.999485802679459
BIOCARTA_CD40_PATHWAY,13,Up,0.992143457339024,0.999485802679459
PID_ALK1_PATHWAY,24,Up,0.992397603462021,0.999485802679459
PID_CDC42_PATHWAY,67,Down,0.99248898896082,0.999485802679459
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,19,Down,0.992885152866631,0.999485802679459
RAO_BOUND_BY_SALL4_ISOFORM_A,104,Down,0.992900992182707,0.999485802679459
INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP,12,Up,0.99296341617785,0.999485802679459
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,55,Down,0.992989797419581,0.999485802679459
ALONSO_METASTASIS_NEURAL_UP,15,Down,0.99301697526673,0.999485802679459
PLASARI_NFIC_TARGETS_BASAL_DN,10,Down,0.993193614887765,0.999485802679459
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,30,Down,0.993785536733462,0.999485802679459
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,24,Up,0.993821304707686,0.999485802679459
REACTOME_REGULATION_OF_KIT_SIGNALING,14,Up,0.993889370095264,0.999485802679459
REACTOME_DOUBLE_STRAND_BREAK_REPAIR,20,Up,0.993963995152873,0.999485802679459
HOLLEMAN_DAUNORUBICIN_ALL_UP,5,Down,0.994037326396507,0.999485802679459
MACLACHLAN_BRCA1_TARGETS_UP,20,Up,0.994139095804979,0.999485802679459
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,341,Up,0.994186133921771,0.999485802679459
WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53,8,Up,0.994252008052545,0.999485802679459
KOYAMA_SEMA3B_TARGETS_UP,218,Up,0.994275650420511,0.999485802679459
HOEGERKORP_CD44_TARGETS_DIRECT_UP,19,Down,0.994526898768935,0.999485802679459
KEGG_VIBRIO_CHOLERAE_INFECTION,45,Down,0.995120449582711,0.999485802679459
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,49,Down,0.995224114167212,0.999485802679459
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,33,Down,0.995448036772112,0.999485802679459
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,16,Down,0.995748519657029,0.999485802679459
GARY_CD5_TARGETS_UP,380,Up,0.99576155540325,0.999485802679459
SENESE_HDAC3_TARGETS_UP,421,Down,0.99585014349622,0.999485802679459
LEE_LIVER_CANCER_DENA_DN,33,Down,0.995923176598182,0.999485802679459
DING_LUNG_CANCER_MUTATED_FREQUENTLY,11,Up,0.99617216083972,0.999485802679459
BIOCARTA_EPONFKB_PATHWAY,9,Up,0.996473324585406,0.999485802679459
OHM_EMBRYONIC_CARCINOMA_DN,5,Down,0.996529396272049,0.999485802679459
MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA,15,Down,0.996640188160323,0.999485802679459
PID_HDAC_CLASSII_PATHWAY,31,Down,0.996736105978754,0.999485802679459
JI_RESPONSE_TO_FSH_DN,57,Up,0.996938691155529,0.999485802679459
PID_IL8_CXCR2_PATHWAY,26,Down,0.997096190248734,0.999485802679459
AMUNDSON_RESPONSE_TO_ARSENITE,185,Down,0.997159560303934,0.999485802679459
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,57,Down,0.997565388587705,0.999485802679459
FURUKAWA_DUSP6_TARGETS_PCI35_UP,48,Down,0.997631494161436,0.999485802679459
KEGG_MELANOGENESIS,73,Down,0.997687614902268,0.999485802679459
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,303,Down,0.997782504614842,0.999485802679459
WANG_THOC1_TARGETS_UP,3,Up,0.998169032190928,0.999485802679459
LE_EGR2_TARGETS_DN,81,Down,0.998342408666097,0.999485802679459
HU_ANGIOGENESIS_UP,19,Up,0.998517928187436,0.999485802679459
WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN,33,Down,0.998631048424444,0.999485802679459
KIM_ALL_DISORDERS_DURATION_CORR_DN,116,Up,0.998856482578249,0.999485802679459
GUILLAUMOND_KLF10_TARGETS_DN,23,Down,0.999048839044455,0.999485802679459
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP,2,Down,0.999408957923333,0.999485802679459
REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN,11,Up,0.999451348577049,0.999485802679459
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,35,Up,0.999485802679459,0.999485802679459
KEGG_FOCAL_ADHESION,166,Up,NA,NA
BIOCARTA_INTEGRIN_PATHWAY,34,Up,NA,NA
ST_INTEGRIN_SIGNALING_PATHWAY,71,Up,NA,NA
PID_ILK_PATHWAY,42,Up,NA,NA
PID_ECADHERIN_KERATINOCYTE_PATHWAY,18,Up,NA,NA
PID_ECADHERIN_STABILIZATION_PATHWAY,34,Up,NA,NA
PID_THROMBIN_PAR1_PATHWAY,34,Up,NA,NA
REACTOME_CELL_CYCLE,358,Up,NA,NA
REACTOME_CELL_CYCLE_MITOTIC,285,Up,NA,NA
REACTOME_MITOTIC_M_M_G1_PHASES,153,Up,NA,NA
REACTOME_DNA_REPLICATION,173,Up,NA,NA
REACTOME_MITOTIC_PROMETAPHASE,77,Up,NA,NA
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,19,Up,NA,NA
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,243,Up,NA,NA
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP,137,Up,NA,NA
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP,448,Up,NA,NA
GARY_CD5_TARGETS_DN,374,Up,NA,NA
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN,571,Up,NA,NA
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,206,Up,NA,NA
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,286,Up,NA,NA
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,284,Up,NA,NA
ROY_WOUND_BLOOD_VESSEL_UP,42,Up,NA,NA
GAL_LEUKEMIC_STEM_CELL_DN,152,Up,NA,NA
BASAKI_YBX1_TARGETS_UP,252,Up,NA,NA
WANG_LMO4_TARGETS_UP,288,Up,NA,NA
VECCHI_GASTRIC_CANCER_EARLY_UP,336,Up,NA,NA
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,70,Up,NA,NA
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,177,Up,NA,NA
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,323,Up,NA,NA
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,110,Up,NA,NA
MULLIGHAN_NPM1_SIGNATURE_3_UP,262,Up,NA,NA
UDAYAKUMAR_MED1_TARGETS_DN,206,Up,NA,NA
TIEN_INTESTINE_PROBIOTICS_24HR_UP,501,Up,NA,NA
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,185,Up,NA,NA
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP,1052,Up,NA,NA
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,256,Up,NA,NA
NAGASHIMA_NRG1_SIGNALING_UP,153,Up,NA,NA
KIM_WT1_TARGETS_UP,196,Up,NA,NA
KIM_WT1_TARGETS_8HR_UP,150,Up,NA,NA
ELVIDGE_HYPOXIA_DN,127,Up,NA,NA
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,63,Up,NA,NA
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,151,Up,NA,NA
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,76,Up,NA,NA
DODD_NASOPHARYNGEAL_CARCINOMA_DN,1120,Up,NA,NA
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP,561,Up,NA,NA
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP,637,Up,NA,NA
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,22,Up,NA,NA
PROVENZANI_METASTASIS_UP,159,Up,NA,NA
ENK_UV_RESPONSE_EPIDERMIS_UP,238,Up,NA,NA
ENK_UV_RESPONSE_KERATINOCYTE_DN,457,Up,NA,NA
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,108,Up,NA,NA
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,302,Up,NA,NA
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,282,Up,NA,NA
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,203,Up,NA,NA
MISSIAGLIA_REGULATED_BY_METHYLATION_DN,110,Up,NA,NA
PEREZ_TP53_TARGETS,761,Up,NA,NA
AUNG_GASTRIC_CANCER,39,Up,NA,NA
HUMMERICH_SKIN_CANCER_PROGRESSION_DN,77,Up,NA,NA
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,100,Up,NA,NA
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,259,Up,NA,NA
LUI_THYROID_CANCER_CLUSTER_4,7,Up,NA,NA
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER,125,Up,NA,NA
PATIL_LIVER_CANCER,616,Up,NA,NA
KORKOLA_TERATOMA,28,Up,NA,NA
WANG_METHYLATED_IN_BREAST_CANCER,32,Up,NA,NA
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN,772,Up,NA,NA
AMUNDSON_GENOTOXIC_SIGNATURE,86,Up,NA,NA
OXFORD_RALA_OR_RALB_TARGETS_UP,43,Up,NA,NA
MOHANKUMAR_TLX1_TARGETS_UP,346,Up,NA,NA
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN,528,Up,NA,NA
PUJANA_XPRSS_INT_NETWORK,151,Up,NA,NA
PUJANA_BRCA1_PCC_NETWORK,1349,Up,NA,NA
PUJANA_BRCA2_PCC_NETWORK,369,Up,NA,NA
PUJANA_ATM_PCC_NETWORK,1098,Up,NA,NA
PUJANA_CHEK2_PCC_NETWORK,670,Up,NA,NA
NUYTTEN_NIPP1_TARGETS_DN,696,Up,NA,NA
NUYTTEN_EZH2_TARGETS_DN,839,Up,NA,NA
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,141,Up,NA,NA
LIU_LIVER_CANCER,23,Up,NA,NA
WEI_MYCN_TARGETS_WITH_E_BOX,659,Up,NA,NA
CAFFAREL_RESPONSE_TO_THC_DN,27,Up,NA,NA
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,134,Up,NA,NA
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,34,Up,NA,NA
KOYAMA_SEMA3B_TARGETS_DN,314,Up,NA,NA
BENPORATH_CYCLING_GENES,546,Up,NA,NA
AMIT_EGF_RESPONSE_480_HELA,141,Up,NA,NA
GEORGES_TARGETS_OF_MIR192_AND_MIR215,716,Up,NA,NA
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,64,Up,NA,NA
ZUCCHI_METASTASIS_DN,31,Up,NA,NA
BASSO_B_LYMPHOCYTE_NETWORK,123,Up,NA,NA
YAGI_AML_RELAPSE_PROGNOSIS,30,Up,NA,NA
GOLUB_ALL_VS_AML_DN,20,Up,NA,NA
MANALO_HYPOXIA_DN,257,Up,NA,NA
PEART_HDAC_PROLIFERATION_CLUSTER_DN,70,Up,NA,NA
SASAKI_ADULT_T_CELL_LEUKEMIA,148,Up,NA,NA
HASLINGER_B_CLL_WITH_17P13_DELETION,18,Up,NA,NA
BROWN_MYELOID_CELL_DEVELOPMENT_UP,100,Up,NA,NA
ASTIER_INTEGRIN_SIGNALING,44,Up,NA,NA
ZHAN_MULTIPLE_MYELOMA_PR_UP,38,Up,NA,NA
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,25,Up,NA,NA
YAGI_AML_SURVIVAL,105,Up,NA,NA
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,399,Up,NA,NA
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,28,Up,NA,NA
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,376,Up,NA,NA
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,272,Up,NA,NA
BLALOCK_ALZHEIMERS_DISEASE_DN,1010,Up,NA,NA
YAMAZAKI_TCEB3_TARGETS_UP,149,Up,NA,NA
MACLACHLAN_BRCA1_TARGETS_DN,14,Up,NA,NA
IVANOVA_HEMATOPOIESIS_STEM_CELL,177,Up,NA,NA
KANG_DOXORUBICIN_RESISTANCE_UP,49,Up,NA,NA
BROWNE_HCMV_INFECTION_48HR_DN,350,Up,NA,NA
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,55,Up,NA,NA
BROWNE_HCMV_INFECTION_18HR_UP,145,Up,NA,NA
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,136,Up,NA,NA
SONG_TARGETS_OF_IE86_CMV_PROTEIN,57,Up,NA,NA
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,66,Up,NA,NA
IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR,479,Up,NA,NA
VERRECCHIA_RESPONSE_TO_TGFB1_C3,14,Up,NA,NA
BILD_E2F3_ONCOGENIC_SIGNATURE,186,Up,NA,NA
DOUGLAS_BMI1_TARGETS_UP,456,Up,NA,NA
MARSON_BOUND_BY_FOXP3_STIMULATED,787,Up,NA,NA
MARSON_BOUND_BY_FOXP3_UNSTIMULATED,958,Up,NA,NA
MARSON_BOUND_BY_E2F4_UNSTIMULATED,604,Up,NA,NA
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,36,Up,NA,NA
FOSTER_TOLERANT_MACROPHAGE_DN,331,Up,NA,NA
HELLER_HDAC_TARGETS_UP,258,Up,NA,NA
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,162,Up,NA,NA
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,245,Up,NA,NA
FUJII_YBX1_TARGETS_DN,180,Up,NA,NA
ACEVEDO_LIVER_CANCER_UP,798,Up,NA,NA
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN,381,Up,NA,NA
MITSIADES_RESPONSE_TO_APLIDIN_DN,226,Up,NA,NA
CHUNG_BLISTER_CYTOTOXICITY_UP,97,Up,NA,NA
WHITEFORD_PEDIATRIC_CANCER_MARKERS,106,Up,NA,NA
GRADE_COLON_CANCER_UP,700,Up,NA,NA
GRADE_COLON_VS_RECTAL_CANCER_UP,28,Up,NA,NA
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP,79,Up,NA,NA
WEST_ADRENOCORTICAL_TUMOR_UP,271,Up,NA,NA
WEST_ADRENOCORTICAL_TUMOR_DN,383,Up,NA,NA
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,44,Up,NA,NA
HUANG_DASATINIB_RESISTANCE_UP,74,Up,NA,NA
QI_PLASMACYTOMA_UP,178,Up,NA,NA
BLUM_RESPONSE_TO_SALIRASIB_UP,227,Up,NA,NA
BLUM_RESPONSE_TO_SALIRASIB_DN,315,Up,NA,NA
JIANG_TIP30_TARGETS_DN,17,Up,NA,NA
LEE_LIVER_CANCER_SURVIVAL_DN,161,Up,NA,NA
PARK_APL_PATHOGENESIS_DN,37,Up,NA,NA
RUIZ_TNC_TARGETS_DN,133,Up,NA,NA
CHANG_CORE_SERUM_RESPONSE_UP,194,Up,NA,NA
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,56,Up,NA,NA
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,394,Up,NA,NA
ZHANG_TLX_TARGETS_36HR_DN,168,Up,NA,NA
ZHANG_TLX_TARGETS_60HR_DN,239,Up,NA,NA
ZHANG_TLX_TARGETS_DN,79,Up,NA,NA
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,400,Up,NA,NA
MILI_PSEUDOPODIA_HAPTOTAXIS_DN,563,Up,NA,NA
CROONQUIST_IL6_DEPRIVATION_DN,91,Up,NA,NA
CROONQUIST_NRAS_SIGNALING_DN,69,Up,NA,NA
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,174,Up,NA,NA
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,151,Up,NA,NA
STEIN_ESR1_TARGETS,70,Up,NA,NA
KORKOLA_CORRELATED_WITH_POU5F1,17,Up,NA,NA
KOBAYASHI_EGFR_SIGNALING_24HR_DN,230,Up,NA,NA
FOURNIER_ACINAR_DEVELOPMENT_LATE_2,258,Up,NA,NA
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,159,Up,NA,NA
CAIRO_HEPATOBLASTOMA_CLASSES_UP,531,Up,NA,NA
WINNEPENNINCKX_MELANOMA_METASTASIS_UP,151,Up,NA,NA
DANG_REGULATED_BY_MYC_DN,209,Up,NA,NA
WHITFIELD_CELL_CYCLE_S,136,Up,NA,NA
KARLSSON_TGFB1_TARGETS_UP,111,Up,NA,NA
MARTENS_BOUND_BY_PML_RARA_FUSION,328,Up,NA,NA
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,90,Up,NA,NA
CHICAS_RB1_TARGETS_LOW_SERUM,66,Up,NA,NA
CHICAS_RB1_TARGETS_CONFLUENT,435,Up,NA,NA
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,300,Up,NA,NA
LU_EZH2_TARGETS_UP,199,Up,NA,NA
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,278,Up,NA,NA
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN,424,Up,NA,NA
CHYLA_CBFA2T3_TARGETS_UP,251,Up,NA,NA
WIERENGA_STAT5A_TARGETS_DN,133,Up,NA,NA
WIERENGA_PML_INTERACTOME,32,Up,NA,NA
PILON_KLF1_TARGETS_DN,1644,Up,NA,NA
JOHNSTONE_PARVB_TARGETS_2_UP,112,Up,NA,NA
JOHNSTONE_PARVB_TARGETS_3_DN,784,Up,NA,NA
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A,506,Up,NA,NA
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B,378,Up,NA,NA
BRUINS_UVC_RESPONSE_LATE,900,Up,NA,NA
BRUINS_UVC_RESPONSE_MIDDLE,74,Up,NA,NA
PASINI_SUZ12_TARGETS_DN,265,Up,NA,NA
DELPUECH_FOXO3_TARGETS_DN,35,Up,NA,NA
LEE_BMP2_TARGETS_DN,750,Up,NA,NA
FEVR_CTNNB1_TARGETS_UP,469,Up,NA,NA
KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3,701,Up,NA,NA
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,234,Up,NA,NA
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP,473,Up,NA,NA
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,323,Up,NA,NA
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D,530,Up,NA,NA
PLASARI_TGFB1_TARGETS_10HR_DN,186,Up,NA,NA
KRIEG_HYPOXIA_NOT_VIA_KDM3A,612,Up,NA,NA
RAO_BOUND_BY_SALL4_ISOFORM_B,369,Up,NA,NA
RAO_BOUND_BY_SALL4,170,Up,NA,NA
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,188,Up,NA,NA
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,178,Up,NA,NA
GENTLES_LEUKEMIC_STEM_CELL_DN,9,Up,NA,NA
ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY,1133,Up,NA,NA
EPPERT_PROGENITOR,118,Up,NA,NA
